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Controlling the conformation and activity of biomolecules in a
reversible manner is a fascinating challenge1−3 that has an
outstanding potential for the study of and interference with
complex processes in living cells.4,5 Spatial and temporal
control of cellular processes could provide unparalleled
opportunities for studying organism development or disease
progression.6 As stated recently by Woolley and co-workers,7
an ideal mode for reversibly controlling living systems would
combine in itself high spatial resolution and high temporal
resolution using a mode of control orthogonal to most cellular
processes.
Light seems to be an ideal external control element for in situ
chemical and biological manipulation because it oﬀers a high
level of spatiotemporal resolution, is generally noninvasive (at a
range of wavelengths), is orthogonal toward most elements of
living systems, and does not cause the contamination of the
sample.2 Furthermore, its wavelength and intensity can be
precisely regulated. These unique properties have led to the use
of light in the study of ﬂuorescently labeled small molecules8
and proteins (such as GFP9) in cells and to recent inspiring
developments in the area of bioorthogonal introduction of
photoactive compounds into biomolecules.10
One of the most widely used methods for the introduction of
light-sensitivity into biological molecules is through function-
alization with bistable molecular photoswitches. This approach
has been used to photoregulate a multitude of important
biological processes (Figure 1), such as nucleic acid structure
and function, transcription and translation, protein folding,
enzyme activity, protein−ligand interactions, peptide structure
and function, membrane transport, and receptor modulation,
including signaling.
This review aims at providing a comprehensive and critical
literature review on reversible photocontrol of biomolecules’
structure and function with molecular photoswitches. For the
information on photocaged, i.e. irreversibly controlled, systems,
the reader is referred to other recent reviews.2,6,11−13
Information on photocontrolled cell adhesion to surfaces can
be found in recent reviews by Mendes14 and Feringa et al.15
1.2. Introduction to Molecular Photoswitches
Several essential biological processes, such as vision16 and
photosynthesis,17 are fueled by light. A chromophore in the
protein structure absorbs a photon, which results in a chemical
transformation that may induce a change in the conformation
of the attached protein. These light-activated processes are
usually completely reversible, and the chromophores can switch
between two or more isomeric forms, hence the commonly
used term “photoswitches”.3
A variety of synthetic photoswitches, that can undergo a
reversible change in their structure upon irradiation with light,
have been designed (Table 1). They are commonly
characterized by the absorption maxima of their isomeric
forms, as well as by the photostationary state (PSS), deﬁned as
the equilibrium composition during irradiation. For biological
applications, these compounds require a fast switching process
and large extinction coeﬃcient with high quantum yield at
wavelengths that are nondestructive for a living cell. In selected
cases, high fatigue resistance in an aqueous environment is an
important prerequisite.
1.3. Overview of the Most Commonly Used Photoswitches
and Their Properties
Many strategies for the reversible photocontrol of biomolecules
have been explored with a wide variety of chromophores (Table
1). The chromophores switch upon irradiation between the cis
and trans isomers (azobenzenes, stilbenes, and hemithioindi-
gos) or interconvert between closed and open forms
(spiropyrans, diarylethenes, and fulgides). This results in a
change in geometry, which can be especially large in the cases
of azobenzenes and hemithioindigos or small as in diary-
lethenes. Besides this change, photoisomerization may also alter
the polarity and charge distribution of the compound.
1.3.1. Azobenzenes. Azobenzenes form one of the largest
and most studied classes of photochromic molecules.18,19 They
exist in two isomeric states, trans and cis, with the former being
∼10 kcal/mol more stable than the latter (Table 1A). The
planar conformation of the trans isomer, although its actual
geometry is still actively disputed and substituent-depend-
ent,18,20,21 places it in the C2h point symmetry group and results
in a zero dipole moment. The UV−vis spectrum of
unsubstituted trans-azobenzene shows two absorption maxima:
a strong one around 320 nm resulting from the symmetry-
allowed π−π* transition and a weaker one around 430 nm
indicative of the symmetry forbidden n−π* transition. The
absorption at about 320 nm leads to rotation around the N−N
bond and the formation of the cis isomer. The transition
associated with the signal at 430 nm is related to the trans to cis
isomerization via one of several possible pathways.22 The trans
to cis isomerization is accompanied by a considerable change in
polarity (the dipole moment of the cis form is ∼3 D) (Table 1).
The reverse, cis to trans, isomerization occurs thermally or can
be achieved by irradiation with visible light (>460 nm).
Table 1. Selected Molecular Structures of Photoswitches
Introduced into Biomolecules
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Azobenzenes remain the most widely used photoswitches in
biological applications.7 The reasons behind this include23 their
easy synthesis, relatively high photostationary states and
quantum yields, fast photoisomerization, and low rate of
photobleaching. While the medium has a rather small inﬂuence
on the photochemistry, it has been shown that the kinetics of
the thermal step is strongly inﬂuenced by the secondary
interactions with proteins.24 Recent reports suggest that the
diﬀerence in energy of the photostates and the height of the
thermal barrier for cis to trans isomerization (∼18 kcal/mol) are
suﬃcient to drive conformational changes in proteins, allowing
for the photochemical control of protein folding and
unfolding.25 Furthermore, a new classes of azobenzene
molecules were recently reported from the groups of
Temps26 and Woolley,27 which can be switched between
trans and cis forms using visible light. This allows avoiding the
use of UV light, which is unable to penetrate into tissues and
can cause severe damage to living cells.
The isomerization rate and the photostationary state are
heavily aﬀected by solvent and substituents present in the
azobenzene unit.28 For example, compounds with a para-EWG
substituent and a para′-EDG substituent (so-called “push−pull
azobenzenes”) have an increased rate of thermal cis to trans
isomerization in more polar solvents,29 while the quantum
yields for the cis to trans photoisomerization of azobenzene are
increased in apolar solvents.30 Azobenzenes can also undergo
reduction under physiological conditions, which may be a
limitation to their application in vivo.31 Recently it has been
shown, however, that peptides modiﬁed with azobenzenes are
not reduced by glutathione in vivo7 or in vitro32 and their
photoswitching behavior has been conﬁrmed in living zebra-
ﬁsh.33,34 For more information on the tailoring of azobenzene
properties for the applications in biological systems, the reader
is referred to section 3 of this paper and to other reviews.7,35
1.3.2. Stilbenes. The stilbene system (Table 1, B), which is
a special case of the general class of diarylethene chromophore
(see section 1.3.4), is isoelectronic to azobenzene, and it
undergoes an analogous E−Z isomerization.36 The mechanism
of stilbene photoisomerization has been extensively studied.37 It
diﬀers slightly from the one of azobenzene, as the excited state
of the E form, obtained via the π−π* transition, is
metastable.36,37 The isomerization, induced by the irradiation
at the absorption maximum of 313 nm (for unsubstituted
stilbene) results in the formation of a cis form, in which the
angle between the planes of the phenyl rings is 43°.37
Importantly, the barrier of the thermal Z−E reisomerization
is 41−46 kcal/mol; that is, thermal isomerization is negligible at
room temperature.37 From the point of view of photocontrol of
biological systems, a major drawback of stilbenes is their
tendency to undergo irreversible, cyclization/oxidation in the
cis form.38
1.3.3. Spiropyrans.39 The photochromic behavior of
spiropyrans stems from the fact that the Cspiro−O bond
undergoes heterolytic cleavage upon UV irradiation (360−370
nm), resulting in the formation of a zwitterionic conjugated
system, known as the merocyanine form (Table 1, C).40,41 This
isomerization is accompanied by a very large (8−15 D)42,43
change in polarity and is reversible both thermally and
Figure 1. Overview of the main biological processes (highlighted in orange), which can be photoregulated by the incorporation of molecular
photoswitches into biomolecules (shown in blue boxes).
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photochemically, by irradiation with visible (>460 nm) light.
The equilibrium between the merocyanine state and the
spiropyran state is shifted toward the former for compounds
with a nitro substituent in the phenyl ring.44,45 The same eﬀect
is observed with increased polarity of the local environ-
ment.44,46 In rare cases the reverse photochromism is observed;
that is, irradiation with visible light shifts the equilibrium
toward the open state and UV irradiation restores the closed
form.47,48 The importance of spiropyrans as regulatory
elements stems mainly from the large change in polarity
upon photoiomerization, which is reﬂected by changes in
hydrophilicity/hydrophobicity. In biological context, the
merocyanine form of the spiropyran switch has been found
to interact strongly with model proteins.49
1.3.4. Diarylethenes.50,51 The photochromism of diary-
lethenes is caused by reversible, photochemically induced
cyclization, due to the presence of a hexatriene moiety in the
open form. The ﬁrst examples of thermally irreversible
photochromic diarylethenes (Table 1, D, shown with
thiophenes) were reported in the 1960s.52 Theoretical studies53
attribute the thermal stability of both isomers to the low
aromatic stabilization energies of the heterocyclic acryl groups,
such as furyl or thiophenyl, introduced on both sides of the
bridging Z-alkene moiety. Electron-withdrawing groups on the
aromatic rings decrease the thermal stability of the closed
state.54 Diarylethenes show very high fatigue resistance, as the
switching cycles can usually be repeated up to 104 times.50 The
eﬀects of substitution on the absorption wavelengths and
quantum yields of ditheinylethenes were studied in detail and
resulted in important guidelines for tailoring the properties of
these molecular switches.50
1.3.5. Thiophenefulgides.55 As in the case of diary-
lethenes, the photochromic behavior of fulgides stems from
their reversible photochemical cyclization of the hexatriene
moiety, which results in the formation of a cyclohexadiene ring
(Table 1, E).56,57 When the carbon atoms that make up the C−
C-double bond are substituted, and when there is a
heteroaromatic ring present in the structure of the compound,
this reaction is thermally irreversible.58,59 Quantum yields
depend on the steric bulk of the substituents around the
cyclohexatriene, as these substituents inﬂuence the conforma-
tion of the fulgides in the ground state.60,61 By changing the
electronic properties of the substituents, it is possible to adjust
maximum absorption wavelengths over a wide range.57
1.3.6. Hemithioindigos. The photoisomerization of hemi-
thioindigos (Table 1, F) involves the Z to E isomerization of
the oleﬁnic bond and results in a considerable change in the
orientation of the dipole moment.62 Hemithioindigos show
little fatigue over many switching cycles.62 The photoswitching
is induced by irradiation at 400−410 nm (Z to E) and 480−490
nm (E to Z),63 and it takes place on a picosecond time scale.64
The thermal E−Z reisomerization is very slow, especially in
organic solvents.63 A strong inﬂuence of substituents on the
dynamics of photoisomerization has been reported.65 Model
studies on hemithioindigo-modiﬁed chromopeptides have
shown that they can exert forces strong enough to drive
structural changes in the peptides.64
2. INTRODUCTION OF MOLECULAR
PHOTOSWITCHES INTO NUCLEIC ACIDS
The prospect of reversible spatial and temporal control of
replication, transcription, and translation processes using light
makes photoswitchable nucleic acids and their analogs
attractive targets. Various groups have used light to alter the
structure and binding properties of nucleic acids and nucleic
acid analogs by employing photochromic molecules introduced
in diverse structural positions, including the phosphate
backbone, the nucleobase, and ribose moiety in native nucleic
acids. The resulting photosensitive oligomers have allowed the
initiation or inhibition of nucleic acid hybridization simply by
using the proper wavelength of light. The modular introduction
of these switchable units into DNA strands using automated
nucleic acid synthesizers has allowed diverse applications
ranging from photoswitchable RNA silencing, reversible control
of gene transcription, reversible aptamer recognition, and the
reversible photocontrol of DNAzymes. The following section
details the introduction of photoresponsive moieties into
nucleic acid and nucleic acid analog structures. Approaches of
photocaged nucleic acids, that is oligomers with photolabile
protecting groups, and light initiated nucleic acid cross-linking
have been recently reviewed2,66,67 and are often restricted to
low or nonexistent reversibility and, therefore, lie outside the
scope of this review.
2.1. Molecular Switches as Phosphate Backbone Linkers in
Hairpin Structures
The photochromic molecules stilbene and azobenzene have
both been derivatized toward incorporation into the phosphate
backbone of DNA oligomers.68−76 These approaches can be
summarized as follows: the trans form of the switches act to
form unusually stable hairpins in self-pairing sequences, and the
cis forms act to destabilize the hairpin structure (Figure 2). The
overall eﬀects of switching on duplex structure are limited
compared to the examples discussed later (vide inf ra). The
stability of the trans form may seem counterintuitive, as the cis
form could hypothetically juxtapose the neighboring strands in
a hairpin-like backbone conﬁguration predisposing the strands
Figure 2. Stilbene as a nucleic acid linker in hairpins. (a) Stilbene
derivatives from Letsinger and co-workers (1)69 and Lewis and co-
workers (2)70,71 diﬀer by their spacer units. (b) Crystal structure of a
stilbene-linked DNA hairpin. C is gold, N is blue, O is red, and P is
gray. Stilbene carbons are highlighted in green, and H is omitted for
clarity. Adapted from coordinate data (1CS7)77 from the protein
databank, using PyMOL software.
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to hybridize. However, the system is better deﬁned as trans-
stilbene and trans-azobenzene linker units acting as eﬃcient
π−π stacking hydrophobic caps (Figure 2b). The cis forms of
these switches are less eﬃcient at π−π stacking due to their
shape, and in some of the cases described, the cis geometry is
too short a linker to properly stack with the underlying helix.
Thus, the term “backbone linkers” is used here, as the
incorporation of these switchable units does not carry much
similarity to native phosphate backbone structure, nor are they
similar in internucleobase distance. Instead, these switches act
as linkers between two nucleic acid oligomer strands.
Letsinger and Wu were the ﬁrst to incorporate a photo-
switchable unit into nucleic acid structure in the form of
stilbene as a backbone linker of two DNA oligonucleotides
(Figure 2, 1).69 An initial publication using a non-self-
complementary strand showed heteroduplex formation was
energetically disfavored by the linker to a slight degree (a Tm
shift of ∼−4 °C).68 When self-complementary strands were
employed, such as GCG-[ST]-CGC (where [ST] is 1), melting
temperature (Tm) values were uncharacteristically high (>80
°C). Furthermore, the Tm values calculated were signiﬁcantly
higher than those of the native duplex structures in equimolar
salt concentrations. Combining these factors with previously
published photochemical analyses68 indicated that hairpin
structures, stabilized by the switchable unit, were likely the
cause of the high stability. This premise was also applied to
explain the unusual stability of (TTTTTT-[ST])2-AAAAAA as
a doubly stabilized triplex structure, and the observation of an
increased aﬃnity for DNA intercalators, even for strands as
short as trimers. Photoreversibility of the hairpin switch was
also observed. Following irradiation, the cis form of the stilbene
unit was found to destabilize hairpin structures, for instance in
the strand T6-[ST]-A6, a shift of 10 °C was observed (Tm(trans)
= 59 °C and Tm(cis) = 49 °C, 100 mM NaCl). Interestingly,
when a G-C base pair was next to the switch, the stilbene unit
became nonresponsive to light, probably due to quenching.69
Follow-up work from Lewis and co-workers, using a similar
stilbene switch with a modiﬁed spacer, served to clarify the
unusual thermal stability (Figure 2, 2).70,71 Photocontrol of
hairpin formation was achieved using a diether-linked switch.
When comparing the quantum yields of the random coil form
of a dT4[ST]dA4 in methanol to a hairpin-folded structure in 1
M NaCl aqueous buﬀered solution, it was found that the trans
to cis isomerization disappeared (0.37 in methanol versus
<0.001 in aqueous media), while the cis to trans isomerization
was diminished but still high (0.36 versus 0.17, respectively).
Similar to Letsinger and Wu’s approach, the diether-linked
stilbene derivative gave unusually large Tm values (61−50 °C in
aqueous systems) when in the trans form. Those values
dropped signiﬁcantly (33−26 °C) with the cis-isomer of the
switch. In some cases, side reactions dominated the photo-
reaction (λ = 340 nm), depending on solvent pH or
composition, such as ethanol/water mixtures. When Lewis
and Liu tested the photoreversibilty of hairpin formation, they
made two interesting observations. First, when the transition
from cis to trans takes place, it occurs readily and gives
quantitative trans formation, indicating the DNA may act as
template. Second, trans to cis isomerization in the folded state
was not observed. The authors gave two explanations:
extremely stable trans-hairpin association and/or photoquench-
ing from the neighboring base pairs. In a later study, a number
of hairpins and their respective crystal structures helped to
clarify the quenching eﬀect (Figure 2b).71 Neighboring
pyrimidine nucleobases were capable of acting as electron
acceptors. If the neighboring bases to the switch were G:G
(noncanonical pairing), eﬃcient photoisomerization was
restored.
Yamana and co-workers synthesized an azobenzene DNA
oligomer linker with spacer units of diﬀering functionality and
length between the switch and the nucleic acids (Figure 3, 3−
5).72−74 The results mirror the studies described above; that is,
very stable hairpin formation was found in the trans state of the
azobenzene. In organic solvents and with unfolded strands,
isomerizations were fully reversible. However, in the folded
state the isomerization eﬃciency from trans to cis was reduced.
An adapted design, using ether-linked azobenzenes, showed
the potential eﬀects of subtle changes in spacer length between
the DNA and the switch (Figure 3, 6 and 7).76 Sugimoto and
co-workers, based on a crystal structure from the studies
described above,71 designed and synthesized two azobenzene
derivatives diﬀering in length by two methylene units in the
spacer region between the DNA and the switch (6 versus 7).
The aim was to provoke the most dramatic change in hairpin
stability based on the conformation of the azobenzene switch
by limiting degrees of freedom in the spacer units. Preliminary
irradiation experiments monitored by HPLC indicated cis to
trans isomerization of the two azobenzene linkers proceeded
eﬃciently in the folded state of linked pentamers with
comparable values (95.8% for 6 and 97.1% for 7). Unlike the
previous reports using stilbene, trans to cis isomerization also
Figure 3. Azobenzenes that have been derivatized for linking two nucleic acid strands.72−76 Compound 6 is highlighted in the center, along with the
distances between the external oxygen atoms in the trans and cis forms. The change in hairpin stability for this compound is attributed to the 2.86 Å
change in distance between the ends of the two isomers.
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proceeded eﬃciently in the folded state, again with comparable
values (81.7% for 6 and 86.1% for 7). Azobenzene has added
reactivity of thermal isomerization from the cis to the trans
state, and it was determined that the cis form remained stable
up to 60 °C for both 6 and 7. After subjecting the two
alternatively substituted strands to thermal denaturation
experiments, the diﬀerence between the two linker units was
clear. Photoinduced isomerization of 6 from trans to cis resulted
in a Tm shift of 20 °C (57.5 to 37.5 °C), while similar
photoinduced isomerization of 7 resulted in a shift of less than
2 °C (49.7 to 47.9 °C). This large discrepancy was explained by
the diﬀerent relative changes in loop size between the two
switches (see distance labeled in Figure 3). Namely, the
additional methylene units in 7 allowed more conformational
freedom before and after irradiation while cis-6 forced the DNA
hairpin to become conformationally strained. Reversibility was
conﬁrmed by successive irradiations using UV monitored
thermal denaturation experiments over ﬁve cycles.
Xi and co-workers investigated a meta-substituted azoben-
zene linker (8) for on/oﬀ regulation of in vitro DNA
polymerization.75 The authors presented data showing that
UV irradiation of three diﬀerent strands of switch-modiﬁed
DNA reduced polymerization activity of E. coli Pol I. Gel
electrophoresis patterns supported UV irradiation inhibiting
polymerization. However, no data were given showing the
isomerization eﬃciencies of the switch, nor was any stability
information (melting curves, CD, etc.) reported in order to
correlate DNA structure with the state of the switch.
Furthermore, the authors provided a structural explanation
that disagrees with that of the previously described systems.
They proposed the cis form of the switch favored hairpin
formation and the trans form promoted duplex formation
impacting the polymerization rate of the enzyme. Though it is
possible that the meta-substituted switch had diﬀerent structural
propensities than the previously reported para-substituted
systems 3−7, the research could beneﬁt from UV and CD
measurements of the switch incorporated to DNA to support
the proposed hypothesis.75
A prevalence of literature68−76 shows the interesting
structural, functional, and photophysical properties of stilbene-
and azobenzene-linked nucleic acid strands. From a funda-
mental perspective, the data gleaned from these experiments is
invaluable in the design of future switchable oligomers. The far-
reaching eﬀects of the stilbene-linked approaches may be
limited by the unusual stability of the hairpins themselves. As
the switch capped hairpins are so stable, on−oﬀ reversibility is
diﬃcult to achieve for longer strands at reasonable temper-
atures. Furthermore, the propensity for quenching eﬀects from
pyrimidines could also be a limitation. The work by Sugimoto
and co-workers76 shows, on the other hand, that employing
Figure 4. Postsynthetic modiﬁcation of DNA by alkylation of a thiophosphate with an iodine derived azobenzene switch.78 Beginning with the
epimerically pure thiophosphate allowed for access to a covalently linked switch in epimerically pure form.
Figure 5. Sugar-linked azobenzenes for light controlled DNAzymes. (a) 2-Aminodeoxyuridylate is covalently modiﬁed via amide bond formation
with three diﬀerent azobenzenes (AB): ortho- (o-9), meta- (m-9), and para-azobenznene (p-9). (b) Introduction of azobenzene-modiﬁed uracil
derivatizes to 10−23 DNAzyme at position N8 (red). T is unmodiﬁed DNAzyme. The arrow indicates the cleavage site of bound RNA. (c) krel values
for dark-adapted (trans azobenzene, open bars) and UV irradiated deoxyribozymes (cis azobenzene, blue bars) normalized to the wild-type
DNAzyme (ﬁrst bar). Reproduced with permission from ref 79. Copyright 2006 Wiley-VCH Verlag GmbH & Co. KGaA.
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azobenzene with a proper linker length may remedy the
quenching eﬀects as well as increase reversible behavior even at
moderate temperatures.
2.2. Molecular Switches Ligated to Nucleotides
Photoswitchable units have been introduced to nucleotide
monophosphates in nucleic acid oligomers via two methods:
alkylation of a thiophosphate-modiﬁed backbone and amidation
of the ribose moiety on a 2′-aminodeoxyuridylate analog
(Figures 4 and 5, respectively). In both cases, azobenzene was
employed for similar reasons as in other approaches discussed
here: highly eﬃcient light-induced and thermal isomerization
rates as well as facile introduction of the switchable unit, as
synthetic anchoring methods are well-known for azobenzenes.
Alkylation of the thiophosphate-modiﬁed backbone of
nucleic acid oligomers allowed for introduction of an
azobenzene switch after oligonucleotide synthesis, a unique
attribute in the discussed approaches.78 Gupta and co-workers
introduced a thiophosphate group at a single position in a series
of nucleic acid strands, and separation of the R and S
thiophosphate analogs was achieved using RP-HPLC. When an
excess of iodoacetic amide-modiﬁed azobenzene was used
(Figure 4), alkylation took place at the thiophosphate positions.
Switching of the azobenzene unit was achieved with 365 nm
light (E → Z isomerization) to a photostationary state of 17%
cis isomer (beginning with 8% Z). Reversibility was achieved by
irradiating with 430 nm light to a photostationary state of 89%
trans isomer. Both isomerization processes could be followed
by RP-HPLC. Following alkylation of a poly-T8 strand of DNA
between T7 and T8 with azobenzene, the melting temperature
with a poly-A8 strand was shown to increase signiﬁcantly (pH =
7 and 1.0 M NaCl): +12.9 °C from the native strand and +9.8
°C from the thiophosphate analog. Modiﬁcation of native
nucleic acids to contain a single thiophosphate position has
been known to increase stability slightly [∼1−3 °C].78
Following irradiation with 365 nm wavelength light, the
melting temperature shifted from 35.2 to 28.2 °C (a total
change of −7.0 °C). The same trend was seen when
azobenzene was introduced to a poly-A8 strand between A7
and A8 following incubation with a poly-T8, though these shifts
were slightly less pronounced. That is, introduction of the
azobenzene unit increased stability relative to the native
oligomer (+6.0 °C) and the thiophosphate analog (+5.1 °C),
and irradiation to achieve the cis isomer destabilized the duplex
(a Tm shift of −5.0 °C). Moving the azobenzene modiﬁcation
toward the center of the nucleic acid oligomers led to lower Tm
values than azobenzene introduction near the ends. However,
the Tm values still indicated higher stability than the unmodiﬁed
oligomers in most cases, and in all cases photocatalyzed E → Z
isomerization destabilized the duplex. The R thiophosphate
analogs generally gave higher Tm values with larger changes in
Tm than the S thiophosphate analogs. The isomerization
processes were also shown to be reversible following irradiation
with λ = 430 nm light, yielding superimposable melting curves
with the starting oligomer. Circular dichroism studies were
performed that gave some evidence of intercalation eﬀects from
the azobenzene. Further studies need to be performed using
this approach, as the temperatures at which the Tm data were
obtained in many cases seem to not be low enough to establish
sigmoidal melting transitions. Because of this, the results shown
could vary, as Tm values are generally reported as the
temperature at 50% transition, and this is only estimated in
this study. Molecular modeling and/or further structural
characterization studies would also greatly enhance the
understanding of this unique approach as well as oﬀer a ﬁrmer
foundation for further functionalization.
Keiper and Vyle used photoswitchable nucleotide derivatives
to gain spatiotemporal control of 10−23 deoxyribozyme, a well-
known biocatalyst for RNA cleavage.79 Introduction of ortho-,
meta-, and para-carboxyl-substituted azobenzene units onto a
2′-amino derived deoxyuridylate unit was achieved via
succinimide ester activation (Figure 5). The resulting uracil-
azobenzene derivatives: o-9, m-9, and p-9 were introduced to
10−23 deoxyribozyme sequences at a speciﬁed position (Figure
5a and b) and were tested for trans → cis isomerization
eﬃciency showing PSS of 86%, 75%, and 61%, respectively.
Thermally reversed isomerization took place rapidly for p-9,
while o-9 and m-9 were highly stable to thermal isomerization.
Irradiation with 435 nm of light provoked complete isomer-
ization back to the trans state in 2 min.
It was subsequently shown that 10−23 deoxyribozyme (DR)
activity could be controlled by light (Figure 5c) under multiple-
turnover conditions using these modiﬁed nucleotides with
eﬃciencies diﬀering nearly an order of magnitude in response
to light.79 The RNA cleavage rates of the three deoxyribozymes
o-DR, m-DR, and p-DR were compared to those of wild-type
10−23 deoxyribozyme both during irradiation with 366 nm
light and under dark-conditions (Figure 5b and c). In all three
cases, RNA cleavage rates were comparable to those of wild-
type 10−23 deoxyribozyme while the samples were under UV
irradiation with o-DR operating at 100%, m-DR operating at
90%, and p-DR operating at 50% wild-type activity. These rates
were signiﬁcantly diﬀerent under dark-adapted conditions, with
o-DR and p-DR giving kirr/kd‑a of 9:1 and m-DR of 8:1 (Figure
5c). The results were derived from analysis by PAGE and RP-
HPLC. Reversible control of catalytic activity under multiple
turnover conditions in situ was shown by irradiating light of 366
nm wavelength to turn on the catalyst (trans → cis
isomerization, irradiated DR) and irradiating with 435 nm
light to turn oﬀ the catalyst (cis → trans isomerization,
analogous to dark-adapted DR). Though the diﬀerences in
activity were lower, they were still signiﬁcant with all three kirr/
kd‑a = ∼4. Diminished rates of reaction were hypothesized to be
due to reduced photoisomerization of cis → trans, possibly
brought about by the RNA substrate or kinetic folding traps. It
should be noted, however, that upon further irradiation at 366
nm the biocatalysts all returned to initial cleavage rates,
conﬁrming reversibility.
Both of the approaches described in this section use unique
methods to introduce the switchable unit to DNA oligomers. In
diverging from more traditional design methods to alter nucleic
acid structure, the approaches described seem to leave changes
in hybridization energy or alterations to catalytic activity to
chance. What is gained on the other hand is the potential to
ﬁnd new methods to alter the structure of nucleic acid
oligomers, as the example from Keiper and Vyle shows.79
Structural studies or in silico calculations to further explain the
observed behaviors are eagerly awaited.
2.3. Nucleobase-Derived Molecular Switches
A relatively new method for the introduction of a photo-
switchable unit into nucleic acid oligomers involves the
substitution of a photoswitchable alkene unit onto a
nucleobase, eﬀectively making the π system of the nucleobase
part of the switch. Though this approach has involved more
complicated syntheses, the results were new diarylethenes-type
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switches (see e.g. Figure 6a), which may have interesting
physical and photochemical properties on their own outside the
realm of nucleic acids. Furthermore, the approach sought to
discover new methods to distort or enhance nucleobase
hybridization, as the eﬀects of Z−E isomerization of these
alkene units on nucleobase structure were unknown at the time
of study.
Ogasawara and Maeda were the ﬁrst to apply this
methodology, synthesizing a phenyl- (10), 2-naphthyl- (11),
and 2-ﬂuorenyl (12), C8-substituted deoxyguanosine (Figure
6).80 The three derivatives were then incorporated into DNA
12-mers via automated synthesis, and photoisomerization and
hybridization studies were performed for comparison. The E
forms of 10, 11, and 12 were irradiated for 5 min at 370, 410,
and 420 nm, resulting in 86, 63, and 77% conversion to the Z
form, respectively. Irradiating for 2 min at 254, 290, and 310
nm returned the substituted alkenes to the E states with
photostationary states of 94, 87, and 77% E. In all cases the
photosensitive units were shown to be thermally stable up to 80
°C, allowing for Tm calculation below this value. The
incorporation of the photoswitchable deoxyguanosine unit
into a single, midsequence position of a 12-mer destabilized the
duplex for all three derivatives. Tm values were less than that of
the native duplex. While irradiation of 10 from the E to the Z
form using UV light caused a signiﬁcant shift in Tm (−7.9 °C),
the E to Z isomerization of 11 and 12 had less signiﬁcant
impact on hybridization (−1.6 and −1.4 °C, respectively).
Previously performed molecular modeling and NMR studies
indicated that the Z form of 10 forced the nucleobase to adopt
a syn conformation relative to the sugar moiety, a conformation
that inhibited duplex formation.81 The E form of the switch
allowed the anti conformation of the nucleobase (relative to the
sugar) to occur, which favored duplex formation. The
diminished change in Tm in the ﬂuorenyl- (12) and naphthyl-
(11) derivatives depending on Z or E isomerization is
rationalized in that the large R substituents destabilized the
duplex regardless of isomerization state due to steric
interactions in both the E and Z states of the switch. This
was supported by lower Tm values in the E state [39.6 °C
naphthyl- (11) and 37.5 °C for the ﬂuorenyl- (12)] as
compared to the stilbene derivative (43.4 °C).
As the stilbene derivative 10 seemed the most promising for
spatiotemporal control of nucleic acid hybridization, multiple
incorporations of 10 into 20-mer sequences were studied.80
Incorporation of one, two, and three units 10 into a 20-mer
strand destabilized the duplex, though to less a degree than for
the 12-mers described above. Furthermore, the increase in
number of photoisomerizable units incorporated in the 20-mer
strand resulted in increased changes in Tm upon irradiation
from the E to the Z state, as one may expect. The most
dramatic change occurred in the incorporation of three units,
which eﬀectively acted as an on−oﬀ switch for hybridization in
that the E forms allowed duplex formation with a Tm of 60.2 °C
while the Z forms resulted in no observable sigmoidal transition
by UV thermal denaturation experiment (Figure 6b, 100 mM
NaCl). CD measurements gave evidence of only single
stranded DNA in solution in the Z form. This process was
shown to be photoreversible, as irradiation with 254 nm light
again initiated duplex formation. A serendipitous discovery
arose in that the E form of the stilbene switch 10 was found to
be six times as ﬂuorescent as the Z form monitoring at 450 nm,
allowing for reversible ﬂuorescent monitoring of nucleic acid
hybridization.
Spada and co-workers performed an independent study using
a ribose diacetylated 10 monomer in supramolecular G
architectures.82 NMR and CD studies indicated the diacetylated
10 monomer formed ribbon-like architectures in high
concentration in acetonitrile. This supramolecular assembly
could be directed to form G-quadruplex-like octameric
assemblies in the presence of potassium. When 10 was
irradiated to the Z form, the octameric assembly was inhibited,
while irradiation to the E form again allowed assembly to the G-
quadruplex-like octamer. The isomerization process remained
selective and highly reversible. As the studies using this
switchable system were restricted to assembly in organic media
and only in monomeric nucleotide form, the far reaching
prospects from a biological standpoint remain to be seen.
In a later publication, Ogasawara and Maeda presented an
application for the ﬂuorenyl- (12) derivative in a G-quadruplex
aptamer for thrombin.83 The group substituted the switch-
nucleobase into various positions and in various numbers
ranging from single substitutions and up to four substitutions at
selected positions in the aptamer using automated solid phase
oligonucleotide synthesis. Of the 12 derivatives tested, two
candidates gave the clearest on−oﬀ behavior, before and after
irradiation. Prior to irradiation, the strands showed CD spectra
and thermal denaturation curves indicative of quadruplex
formation, and after UV irradiation, all spectroscopic evidence
of quadruplex formation disappeared and the resulting spectra
were indicative of unfolded single stranded oligonucleotides.
Accompanying molecular modeling indicated that the ﬂuorenyl
moieties were forced into a steric clash with one another when
in the cis, post-UV-irradiated state. A single candidate was then
chosen and subjected to electrophoretic mobility shift
monitored binding experiments with native thrombin. The
Figure 6. (a) Structure of photochromic nucleobase derivatives (10−
12). (b) Comparison of UV-monitored thermal denaturation curves
(260 nm) for an oligonucleotide modiﬁed with three 8STG (10)
derivatives. Positions of modiﬁcation are X (see inset). Conditions: 10
mM phosphate buﬀer (pH 7.0) and 100 mM NaCl. Solid black line:
before irradiation (E isomer). Gray line: after 5 min of irradiation with
370 nm light (Z isomer). Dashed black line: after 2 additional min of
irradiation at 254 nm (E isomer). Reproduced with permission from
ref 80. Copyright 2008 Wiley-VCH Verlag GmbH & Co. KGaA.
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results indicated the ﬂuorenyl-modiﬁed oligonucleotide 12
continued to act as an aptamer when the switch was in the E
form. Following irradiation, the thrombin-aptamer complex was
disassembled. These results compared well to the aﬃnities of
the native aptamer, and the process was shown to be
completely reversible.
Singer and Jaschke have taken a similar approach synthesiz-
ing a diarylethene derivative that incorporated adenosine into
the photoswitch (13, Figure 7).84 Unlike the previously
described systems of Maeda and Spada,80,82 in this approach
a covalent bond is formed between the nucleobase and the
switchable unit upon irradiation, introducing chirality to the
normally achiral nucleobase unit. As this approach required
modiﬁed substitutions at two positions on the adenosine
nucleobase, the synthetic requirements were more rigorous,
potentially limiting the further-reaching applications of this
approach. Instead of investigating the base-pairing properties of
the synthetic nucleobase-switch hybrid in oligomer form, the
group opted to investigate nucleobase association in monomer
form in organic solvent. Though these results cannot be
extrapolated to any great degree to control properties in
oligomer systems, a proof of concept that 13 can form
hydrogen bonds with thymine in acetonitrile was established.
The study also showed how substituent eﬀects could be used to
shift the maximum of absorbance of the switches, allowing for
orthogonal triggering of cyclization by altering the wavelength
of light. Though extensive evidence for the potential of this new
class of switches was shown, it remains to be seen whether or
not this approach will be useful in an oligomer format.
2.4. Molecular Switches as Nucleoside Surrogates
The incorporation of switches as nucleoside surrogates remains
the gold standard in photoswitchable nucleic acids.85 The
approach, pioneered by Komiyama, Asanuma, and co-work-
ers,86 retains the facile synthetic methods of solid phase nucleic
acid oligomer synthesis using a phosphoramidite-functionalized
switch as nucleoside surrogate. Azobenzene has served as the
best choice in terms of its ease of synthetic modiﬁcation and
the large impact it has on hybridization depending on the
isomer. Spiropyran has also been applied, albeit with less
dramatic eﬀects.87 As a result of the ease of the synthesis and
function, this approach has seen the most applications with the
furthest reaching results.
The method has been generally applied as the installation of
the switch into a sequence as an additional nucleoside.86
Azobenzene intercalates between the neighboring pairing bases
in the trans form. Following irradiation, the cis form destabilized
the duplex, hypothesized to be due to diminished ability to
intercalate. There were two generations of the azobenzene-
based nucleoside analogs. The ﬁrst example described used a
racemic switch (Figure 8, 14).88 The diastereomeric oligomers
were then separated by RP-HPLC. When incorporated into the
middle of a poly-A 7mer, one diastereomeric oligomer actually
induced an increase in Tm (∼ +1 °C) from the native strand
when added to the complement in an equimolar amount. The
other diastereomer reduced duplex stability (∼ −4 °C).
Following irradiation of these two samples with UV light, a
reduction in Tm values was obtained. The more stable
diastereomeric duplex showed a shift of 8.9 °C (24.8 to 15.9
°C) in Tm, and the less stable diastereomeric duplex shifted 5.2
°C (19.9 to 14.7 °C) in equimolar salt concentrations. The
process was also shown to be reversible with melting curves
obtained following reisomerization nearly superimposable to
the original. Solution-phase NMR structures of diastereomeri-
cally pure hexameric strands provided support that the R
isomer was the more stable of the two and caused a larger
change in Tm.
89 Structural evidence also supported the notion
that the trans isomer of azobenzene readily intercalated
between two pairing bases (Figure 8b). A thorough
thermodynamic study on position and number of incorporated
azobenzenes has been performed as well.90
Stretches of polypyrimidines in oligonucleotides can be used
to form triplex structures.91 This motif in nucleic acid structure
is a commonly used method to prevent gene expression in vivo,
dubbed the antigene approach.92 Asanuma, Komiyama, and co-
workers have shown that triplex formation can be regulated
using azobenzene modiﬁed nucleobase surrogates.93,94 Similar
to the above-described approaches, the trans form of the switch
stabilized triplex formation while the cis isomer caused a drop in
Tm. The largest drops in Tm were observed when two
azobenzene switches were introduced into a poly-T 13mer
(ΔTm > 48 °C). As an interesting addition to the above studies,
a meta-azobenzene modiﬁed switch was also synthesized and
studied. The largest discrepancy in Tm following cis to trans
isomerization was observed when a single para-substituted
azobenzene was employed in the center of the poly-T strand
(ΔTm > 30 °C). The meta-substituted azobenzene, on the other
hand, oﬀered the largest gap in Tm when placed at the end of
Figure 7. Diarylethene-derived deoxyadenosine.84 Chirality is
introduced to the central unit following covalent bond formation
initiated by light.
Figure 8. Komiyama, Asanuma, and co-workers’ ﬁrst generation
azobenzene nucleoside surrogate.88,89 (a) The switch was incorporated
via automated solid phase methods similar to those of a standard
nucleoside. The diastereomeric mixture was then puriﬁed via RP-
HPLC. (b) Solution NMR structure of the R epimer nucleoside
surrogate in a DNA duplex. C is gold, N is blue, O is red, and P is gray.
Carbons from the synthetic azobenzene nucleoside surrogate are
highlighted in green, and H is omitted for clarity.
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the poly-T strand (ΔTm = 19.2 °C), indicating a diﬀerent steric
consequence for this light mediated structural change.
As a testament to the modularity of the approach, this
method saw rapid applications in the photocontrol of T7 DNA
polymerase activity in vitro.95 The azobenzene nucleoside
surrogate was substituted into an oligomer strand that acted as
a blocking unit, dubbed modulator, by forming a duplex with
the polymerase-template strand (Figure 9). In the dark, the
FITC modiﬁed primer strand was extended from an 18mer to a
34mer. Following irradiation with light, isomerization of the
switch occurred, reducing the stability of the blocking oligomer
with the template strand. The same primer strand could then
be extended to a 54-mer. The authors were careful to note that
the Tm value of the cis form was still higher than the reaction
Figure 9. Application of the ﬁrst generation azobenzene surrogate in the photocontrolled polymerization by T7 Pol I.95 In the trans form the
azobenzene-modiﬁed strand labeled modulator (red) blocked polymerization of FITC labeled DNA primer (green) to longer strand lengths.
Irradiation with UV light favored the cis state and destabilized the association of the modulator with the template strand so the polymerase could
continue.
Figure 10. Photocontrol of 8−17 DNAzyme. (a) DNAzyme constructs synthesized. Catalytic core is in bold. Incorporation of 14 into 8−17
DNAzyme was done at positions marked Az. Two switches were introduced into (i) the 7-nt substrate binding arm (15); (ii) the 8-nt substrate
binding arm (16); and (iii) the “required” G-C position in the catalytic core (17). (b) Gel showing time dependent cleavage of 5′-32P labeled RNA
by excess 8−17 DNAzyme. Control experiments with unmodiﬁed DNAzyme are labeled wt. trans-16 is 16 irradiated with 422−438 nm light. cis-16
is 16 irradiated with 322−338 nm light. (c) Cleavage rate modiﬁcation by wavelength-speciﬁc light. DNAzyme started in the trans form and was then
irradiated with UV light (“UV” arrow) to favor the cis form. Subsequent irradiation with visible light (“Vis” arrow) returned the DNAzyme to the
trans state and the original cleavage rate. Irradiation times were approximately 40 min. Adapted with permission from ref 96. Copyright 2004 Elsevier
B.V.
Figure 11. Incorporation of an enantiopure nucleoside surrogate for photocontrol of RNA digestion.101 (a) Asanuma and co-workers’ second
generation azobenzene nucleoside surrogate (18).97,98 (b) Cartoon showing the mechanism for photoresponsive oligomer sequestering of a DNA
antisense strand. Following UV light irradiation, the photoresponsive strand liberates the antisense DNA, allowing it to recognize complementary
RNA. RNase H recognizes hybridized RNA and performs degradation upon antisense duplex formation with RNA.
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temperature (34 °C). That is, the strand should still have been
in association with the template strand, though the stability
should have been diminished. Exact Tm values were diﬃcult to
calculate based on fast thermal isomerization of the azobenzene
switch at reaction temperature.
The ﬁrst generation azobenzene nucleoside surrogate was
also employed for spatial and temporal control of RNA-cleaving
8−17 DNAzyme (Figure 10).96 This approach predated that
previously discussed by Keiper and Vyle,79 though the intended
eﬀect is largely the same (vide supra). The switch and the
DNAzyme employed here were diﬀerent, and this approach
focused on single-turnover kinetics. Liu and Sen substituted
two azobenzene nucleoside surrogates (Figure 10, 15−17) in
either the substrate binding arm or the catalytic core of the
DNAzyme. The results of this investigation indicated that the
introduction of 14 in two positions on the substrate binding
arm allowed for photocontrol of DNAzyme activity. In the trans
form (under visible light irradiation) the DNAzyme was active,
and in the cis form (under UV irradiation) the DNAzyme
showed 6-fold lower catalytic rates (Figure 10b). This process
was shown to be reversible on the basis of wavelength of
irradiation (Figure 10c). Interestingly, the inverse eﬀect was
seen when two positions on the catalytic construct were
substituted with 14 (Figure 10, 17). UV irradiation to the cis
form led to a 5-fold increase in activity.
For a single incorporation site, racemic synthesis followed by
puriﬁcation of the diastereomeric oligomer is a useful approach.
However, for the incorporation of n switches, the number of
diastereomers increases 2n for each incorporation. For this
reason the enantiopure synthesis of a second generation of the
azobenzene nucleoside surrogate (Figure 11, 18) from
Asanuma, Komiyama, and co-workers remains more useful.97,98
The second generation was based on the chiral starting material
D-threoninol. This starting material was chosen due its
similarity to the structure used in the ﬁrst generation approach
and access to the chiral starting material. Comparison with the
L-threoninol derived enantiomer showed the D-threoninol
derived compound formed more stable duplexes in the trans
form, could be incorporated at multiple sites without massively
destabilizing duplex formation, and gave more dramatic shifts in
Tm upon irradiation. Incorporation of this switch in a 20-mer
could be performed easily using automated solid phase
methods with substitutions of the enantiopure surrogate 18
in up to 10 positions without large problems with stability.
“Clear-cut” photoregulation and reversibility were well
characterized.99 Structural modiﬁcations to the azobenzene
switch were also performed to investigate the eﬀects of
increased sterics.100 Surprisingly, in these cases, the introduc-
tion of methyl groups to the 2′ and 6′ positions on the
azobenzene resulted in an increase in stability of the duplex for
both the cis and the trans positions.
Photoregulation of RNA digestion by RNase H could be
performed by substitution of the second generation nucleoside
surrogate switch 18 (Figure 11a) into a DNA sense strand,
allowing photocontrol of hybridization with a DNA antisense
strand (Figure 11b).101 A series of DNA strands were
synthesized with an increasing number of azobenzene switches.
These strands were the complementary sequence of the DNA
antisense strand. Thus, in the trans form of the switch,
hybridization takes place and the antisense DNA strand was
sequestered. UV irradiation liberated the antisense strand,
allowing it to hybridize target RNA. Once the duplex of the
antisense DNA and RNA was formed, RNase H could bind the
hybridized RNA and digest it. Asanuma and co-workers showed
Figure 12. Photocontrol of transcription. (a) Incorporation of second generation nucleoside switch surrogate (18) into template (T) and
nontemplate (N) dsDNA at positions X. The T7 RNAP promoter region is labeled and divided into the loop-binding and unwinding regions. (b and
c) Nontemplate (N) switch insertion positions in the (b) loop binding region and the (c) unwinding region and the eﬀect of UV light on
transcription rate. N-Nt is unmodiﬁed dsDNA. Two gel bands account for full length and full length plus one. They were summed as total product.
White bars were before UV irradiation (−). Gray bars were after UV irradiation (+). Adapted with permission from ref 102. Copyright 2006
American Chemical Society.
Chemical Reviews Review
dx.doi.org/10.1021/cr300179f | Chem. Rev. 2013, 113, 6114−61786124
that when three or more azobenzene switches were
incorporated into the sense strand, highly eﬃcient on−oﬀ
control of RNA digestion took place using UV light.
Degradation of RNA was monitored by PAGE, and
conﬁrmation of the proposed mechanism was performed by
ﬂuorescent tagging of the RNA strand with FITC and the
antisense strand with dabcyl. Upon UV irradiation, the DNA
sense strand released the dabcyl tagged antisense strand,
allowing it to hybridize the FITC tagged RNA strand. When in
close proximity, dabcyl acts as a ﬂuorescent quencher of FITC.
The second generation azobenzene nucleoside surrogate
design has also been used to photoregulate transcription by
incorporation into the T7 RNA polymerase (T7 RNAP)
promoter region of DNA (Figure 12).102 Asanuma and co-
workers introduced the switch nucleoside in a series of 10
diﬀerent positions on the template promoter region of T7
RNAP as well as on the nontemplate strand (see Figure 12a, for
labels). The authors were careful to note that this approach
diﬀered from their other studies, as the focus was not control of
hybridization, as the Tm is far above the temperature at which
they are working. Instead, they were looking to change the local
structure of the DNA duplex using light. The incorporation of
the azobenzene switch into the 35-mer duplex sequence
resulted in an isomerization to form between 20 and 40% of the
cis isomer under UV irradiation. These values were
uncharacteristically low for azobenzene substitution into
DNA. We speculate this may be due to the length of sequence
used, as the majority of the studies thus far have focused on
sub-20-mer lengths. Incorporation of the switch was focused on
the unwinding region and the loop-binding region of the T7
RNAP with the largest photoinduced change in activity,
pointing to the cis form of the switch as the more active.
Incorporation of the switch on the template strand resulted in
diminished rates of conversion relative to the native strands
even in the cis state while the rates of conversion, when the
azobenzene was on the nontemplate strand, remained
comparable to those of the native strand under UV irradiation
(Figure 12b). A similar eﬀect was seen when the switch was
introduced to the unwinding region of the duplex (Figure 12c).
Interestingly, the changes in relative transcription rates before
and after irradiation remained similar whether the switch was
on the template or nontemplate strand in the loop binding
region or in the unwinding region (on average 1.5−2.0-fold
increase under UV irradiation). A kinetic study revealed that
azobenzene substitution in the loop-binding region primarily
aﬀected Km, while those substitutions in the unwinding region
aﬀected kcat. In other words, incorporation of the azobenzene in
the loop-binding region aﬀected enzyme binding, while
incorporation in the unwinding region aﬀected the rate of
NTP incorporation. This eﬀect, though it may be intuitive, is
none-the-less elegant in application and proof. Incorporation of
two switches, one in the loop binding and one in the unwinding
region, resulted in an even larger discrepancy of on−oﬀ
transcription behavior, with a 7.6-fold increase in rate of
transcription when the cis form was present.102
Azobenzene nucleoside surrogate 18 was also used to
modulate the binding of thrombin to a G-quadruplex
aptamer.103 This approach diﬀered from the above-discussed
Ogasawara and Maeda’s inhibition of thrombin,83 as the
azobenzene switches were introduced to a complement strand
for the aptamer rather than the aptamer itself (see Figure 13 for
design). Photocontrol of the complement of the aptamer
allowed for photoregulating of the aptamer concentration in
solution without needlessly aﬀecting the quadruplex structure
and accidentally reducing thrombin−aptamer association
(Figure 13). The aptamer sequence and a series of complement
strands with varying incorporation of azobenzene switch
positions and number were ligated together by a PEG strand.
The eﬀects of azobenzene position and state were tested for
melting temperature, binding aﬃnity to thrombin, and a
clotting assay (a test for thrombin activity). To eﬃciently
control hybridization of the aptamer and the complement, a
minimum of one azobenzene per two nucleotides had to be
used.103 As thrombin is known to promote clotting, it was
hypothesized that irradiation with UV light would liberate the
aptamer, which would then bind thrombin, and clotting would
decrease. Thus, following melting temperature experiments,
blood clotting experiments were performed and the optimal
azobenzene modiﬁed complement was chosen as the strand
that gave the largest discrepancy in clotting time under UV
irradiation and in the dark. The optimal azobenzene modiﬁed
complement−aptamer conjugate was then employed in a
microﬂuidic channel to show how this system could be used for
spatial control of clotting. The cis form of the azobenzene-
Figure 13. Photomodulation of thrombin activity via light controlled aptamer formation. The complement for the aptamer was modiﬁed with
azobenzene switches and ligated to the aptamer sequence via a PEG chain. Under UV irradiation, duplex formation was discouraged, allowing the
aptamer to fold for thrombin binding, inhibiting clotting. Visible light irradiation shifted the equilibrium to duplex formation, restoring thrombin
activity by forming a duplex with the aptamer sequence. Reproduced with permission from ref 103. Copyright 2009 National Academy of Sciences,
USA.
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modiﬁed complement was formed using UV light, and the
aptamer−thrombin complex was then annealed in a micro-
ﬂuidic chamber. Using radiation with visible light, clotting could
be initiated in speciﬁc regions of the microﬂuidic chamber with
submillimeter resolution in a matter of seconds.
An interesting investigation into the use of L-threoninol
derivative 19 as a nucleoside surrogate was performed to assess
the eﬀect of stereochemical features of these hybrids (Figure
14).104 Using this system, the inverse photocontrol process was
achieved. Irradiation with UV light to achieve the cis form of the
switch resulted in duplex formation and trans-azobenzene
destabilized duplex structure. The inclusion of 19 in nucleic
acid oligomers characteristically lowered the Tm values between
1 and 3 °C when in the more stable cis form, depending on the
steric eﬀect of the R-substituent (Figure 14). After irradiation
with visible light to achieve trans-19, the Tm values could be
lowered between 7.3 and 0.9 °C from the cis form duplex, again
depending on the size of the R-group. Characteristically, more
sterically demanding substitutions to the azobenzene gave
larger Tm shifts, with tBu substitutions showing the largest
eﬀect. The reversibility of the system could be achieved with up
to ﬁve “on−oﬀ” cycles conﬁrmed by ﬂuorophore and quencher
tagging of the modiﬁed strand and its complement. However,
in this case, the system had to be properly tuned with
temperature to achieve this behavior. Furthermore, thermal
isomerization was hypothesized to be a complication at higher
temperatures, as complete hybridization was never achieved
(∼30% of the modiﬁed strand remained single stranded).
Molecular modeling of the cis and trans states of the switch in
the duplex showed that cis-19 situated the switch outside of the
duplex into the minor groove, while trans-19 forced the
sterically modiﬁed switch unit into the complement strand,
causing duplex distortion. This remains the only system
published to date in which the opposite hybridization behavior
could be achieved for an established switchable system. This
additional dimension of photocontrol could, in principle, cause
two separate hybridization consequences with a single wave-
length of light. In other words, UV irradiation would cause
some strands to form duplexes while others would hybridize at
a given temperature in a single ﬂask. Such spatial and temporal
control might be applied to some of the biological systems
discussed above as well as have broader impacts in DNA-based
logic systems or nanotechnology, and recent reports seem to
indicate these applications are expanding.105−108
The extension of the nucleoside surrogate methodology has
recently been applied to peptide nucleic acids (PNAs).109 The
move to this nucleic acid derivative allows expansion of scope
as PNAs have been shown to be able to perform strand invasion
on nucleic acid duplexes, elicit enhanced stability compared to
native nucleic acids under physiological conditions, and cross
cell membranes, while retaining the modularity of solid phase
peptide synthesis. Staﬀorst and Hilvert showed109 that the
synthetic incorporation of azobenzene at the ends of PNA
oligomers (neighboring the nucleobase) could be performed
eﬃciently by synthesizing two strands: AcGlyLys-[Az1]-
(cattcatac)[Az2]-LysGlyCONH2, for duplex formation, and
Figure 14. Development of a switch with inverse behavior.104
Substituted L-threoninol derivative 19 served to give the inverse
hybridization eﬀects of the D-threoninol second generation derivative
18. Under UV irradiation, duplex was favored with 19 while visible
light and/or heat disfavored hybridization. R is a range of sterically
diﬀerent alkyl groups.
Figure 15. Triplex formation with azobenzene-modiﬁed PNA blocks gene transcription. (a) Peptide nucleic acid (PNA) derivative 20 was
substituted as a surrogate base at the ends of a PNA oligomer, allowing for photomodulated triplex formation and consequently control of
transcription. (b) Modulation of transcription by triplex formation. PNA is red. Azobenzene is green. Transcribed RNA is blue. Template DNA is
black. (c) Formation of egfp transcripts (960 nt) and torA (414 nt, control) genes monitored by gel electrophoresis. The concentrations refer to
amount of PNA added. t = ct5c PNA containing azobenzene at the C-terminus. c = the same strand of PNA under irradiation with 360 nm light. r =
reference PNA (minus the switch). Reproduced with permission from ref 109. Copyright 2010 Wiley-VCH Verlag GmbH & Co. KGaA.
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AcGlyLys-[Az1](t7)[Az2]-LysGlyCONH2, for triplex formation
(see Figure 15a, 20 for the structure). [Azn] signiﬁes potential
sites of azobenzene modiﬁcation. Similar to the other discussed
azobenzene derivatives, the switch existed up to 90% in the
trans state and was isomerized up to 87% in the cis state with
UV light. Thermal inversion back to the trans state was a facile
process, especially at temperatures above 80 °C. Furthermore,
irradiation with 425 nm light formed an 80:20 mixture of trans.
The cis isomer was stable for hours up to 60 °C, allowing the
monitoring of thermal denaturation curves below this temper-
ature. Both substitution at the C-terminus and N-terminus
further stabilized the duplex and triplex formation in the trans
state to a substantial amount: ∼ +7 °C for the duplex with little
variation between the N and C terminal substitution and +15
and +9 °C for the triplex at the C-terminus and the N-terminus,
respectively. Following UV irradiation, all hybridization states
were weakened, though the PNA strand with the switch in the
cis state was still more stable than an unmodiﬁed PNA strand.
As photomodulation of triplex formation gave the most
dramatic diﬀerences before and after irradiation, Staﬀorst and
Hilvert investigated the spatial and temporal regulation of gene
transcription using azobenzene-substituted PNA strands.109 As
stated earlier, PNAs can perform strand invasion. This principle
has been applied to arrest transcription in vivo using triplex
forming PNA strands. An analogous study was performed in
vitro using the system described.109 Comparison of the
expression of the gene egfp with the control torA in the
presence of an azobenzene modiﬁed triplex forming oligomer
served as the test case (Figure 15b and c). Investigating a series
of modiﬁed PNAs at seven concentrations between 0 and 125
μM showed that the trans isomer eﬃciently performed strand
invasion on the egfp gene inhibiting transcription, while the cis
isomer (formed via continuous irradiation with 360 nm light)
showed a reduced ability to inhibit translation. Both
azobenzene-modiﬁed oligomers were more eﬃcient inhibitors
than unmodiﬁed PNA. In an exquisite series of control
experiments, the authors compared mixed sequences of the
PNA strands and the gene, showing clear examples of speciﬁc
triplex mediated inhibition of polT7 mediated transcription
controlled by light.
2.5. Supramolecular Approaches to Photoresponsive
Nucleic Acids
Supramolecular approaches to reversibly control nucleic acid
hybridization consist of using a photochromic molecule that
associates or dissociates from nucleic acids upon wavelength-
speciﬁc irradiation of light. These approaches are attractive, as
they circumvent the diﬃculty of introducing a switchable unit
into the complex structure of nucleic acids. Furthermore, the
potential for facile introduction to living systems exists, as the
approach depends on small molecules rather than nucleic acid
derivatives, potentially avoiding the need of transfection
reagents to introduce the switchable small molecules into cells.
Andreásson and co-workers have recently reported evidence
that cation-modiﬁed spiropyran 21 intercalates into nucleic
acids in its open form, i.e. after exposure to UV light.110 UV/vis
spectra of 21o in the presence of calf thymus DNA showed a
signiﬁcant blue shift in absorbance maximum from 512 to 420
nm in addition to a 45% hypochromic shift (i.e., decrease in
absorbance), while the closed form of the cationic spiropyran
(21c) showed no change in UV/vis spectrum in the presence of
calf thymus DNA (Figure 16c). Both the blue shift and the
hypochromicity were indicative of intercalation, as the
hydrophobic environment between the nucleobases should
favor a charge neutral resonance structure of 21o while the
zwitterion of 21o should be favored in an aqueous environ-
ment. Comparison with the spectrum of 21o in chloroform and
water supported this argument. Further experiments using ﬂow
oriented linear dichroism also suggested intercalation, giving a
value of 80 ± 5° for the angle between the transition moment
of 21o at 420 nm and the helix axis. These experiments also
showed that intercalation could be triggered by light and was
reversible as well as provided evidence that the light triggered
events were due to the binding of the switch to calf thymus
DNA and not due to switch decomposition (Figure 16).
The authors indicated cationic spiropyran 21 could be
employed as a nucleic acid probe due to its distinctive blue
shift, which occurred only with the open form despite a
moderate binding value of 2 × 104 M−1.110 The eﬀects of light-
triggered spiropyran binding on hybridization or enzyme
Figure 16. Photoswitchable nucleic acid intercalation. (a) Closed
(21c) and open (21o) isomers of spiropyran derivative 21. (b) UV/vis
spectra of closed form (top) and open form (bottom) alone (blue
line) and in the presence of calf thymus DNA (red line). The green
line is a corrected spectrum for 100% spiropyran binding to DNA. (c)
Flow oriented linear dichroism study of spiropyran 21 and calf thymus
DNA. The green line is the start. The blue spectrum is after 5 min of
UV irradiation. The red spectrum is after 5 min of visible light
irradiation. The black spectrum is an additional 5 min of UV
irradiation. The inset is the negative of the absorption spectrum for
comparison. Reprinted with permission from ref 110. Copyright 2008
American Chemical Society.
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recognition remain to be seen, which currently limits
application in biological settings, though the possibilities for
this small molecule remain attractive. Further investigations
would also require a comparison between repeated UV
irradiation and potential competing nucleic acid cross-linking.
Nakatani and co-workers have developed a system they refer
to as a “molecular glue for DNA”: comprising a naphthyridine
carbamate dimer connected by an azobenzene unit (22, Figure
17).111−113 The naphthyridine carbamate dimer had previously
been shown to stabilize duplex DNA containing G-G
mismatches, eﬀectively sequestering one of the mismatched
nucleobases via groove binding while concomitantly displacing
a neighboring nucleobase (Figure 17a).114 By introducing an
azobenzene to the dimer unit (22), the process could be
spatially and temporally controlled with light. Incubation of
trans-22 with the mismatched hybrid sequence 5′-(CTAA CGG
AATG)/5′(CATT CGG TTAG) gave a Tm value of 32.7 °C, an
increase from 25.6 °C in the absence of trans-22. Following
irradiation with UV light (5 min, λ = 360 nm) to form cis-22,
the Tm increased again, this time by 15.2 °C to Tm = 48.0 °C.
Interestingly, there was an increase in the photostationary state
of cis-22 to 75% in the presence of hybridized DNA. Cold-spray
ionization time-of-ﬂight mass spectrometry showed a distinct
peak for DNA hybrid + cis-22 while a mass for the duplex +
trans-22 could not be detected, oﬀering support that the cis-22
form binds DNA duplexes in the expected 2 to 1 ratio while the
trans-22 form does not.
Surface plasmon resonance (SPR) was used to monitor 22-
initiated DNA hybridization with a template strand attached to
a gold surface (Figure 17b−d), and it was subsequently shown
that the interaction was G−G mismatch speciﬁc and reversible
following irradiation with 430 nm light.111 By incorporating
two G−G mismatches into a DNA sequence, the Tm change in
the presence of 22 could be made very large. Using a special
SPR-photoreactor cell, a solution including 22 and comple-
mentary DNA could be continuously irradiated while hybrid-
ization was monitored by SPR (Figure 17b). When additional
tests with strands that substituted C, T, A, and G at position
“X” in Figure 17b (DNA-3X) were performed, hybridization
occurred immediately for the proper Watson−Crick partner C
and after irradiation with 360 nm of light for the G mismatch
indicating light induced transformation of trans-22 to cis-22
stabilized the duplex. Changing the irradiation conditions to
430 nm showed that the stabilization could be photochemically
reversed (Figure 17d).
Nakatani and co-workers have continued to investigate the
eﬀects of linker length on the binding activity of 22115 as well as
performed additional molecular modeling experiments to aid
the structure elucidation and the design of further “switchable
molecular glues for DNA”. While this approach could beneﬁt
from the development of small molecules that target
mismatches other than G−G, the approach has very clearly
elucidated an “on−oﬀ” hybridization response to light, while
other approaches described weigh the delicate balance between
energy of hybridization and temperature. Furthermore, by
avoiding synthetic modiﬁcation to nucleic acids, the supra-
molecular approach beneﬁts by retaining the modularity
inherent in modern nucleic acid techniques. A limitation in
this approach may be an inability to target speciﬁc sequences in
vitro. Further experiments with larger libraries of sequences
could illustrate how much of a potential complication this could
be.
2.6. Concluding Remarks
A number of methods have been developed for the photo-
control of nucleic acid structure and hybridization. A surprising
result of the studies described above is the number of
applications in which the nucleic acid oligomers are syntheti-
cally modiﬁed in diﬀerent ways without massive losses to
hybridization energy, and yet irradiation with light immediately
has an eﬀect on stability. This is no small feat, as synthetic
Figure 17. (a) Illustration of NCDA (22, red) assisted DNA
hybridization. (b−d) SPR diﬀerence imaging experiments showing
photoswitching. (b) Experimental setup and nucleic acid sequences
studied. Thiol terminated sequence DNA-3X acts as a probe, while
hairpin loop DNA4 acts a pseudocomplement. (c) SPR diﬀerence
images of the DNA3X array. Strands are arranged according to the
panel above, where “X” is a respective nucleobase. “State 1”: image
after addition of DNA4 and NCDA (22). “State 2”: image after 40 min
of irradiation at 360 nm. “State 3”: image after 430 nm of irradiation of
state 2 for 20 min. (d) Time course of intensities of the spots from
part c. Horizontal arrows (top) indicate irradiation. DNA 4 and
NCDA (22) were injected at 0 and 6 min, respectively. Reprinted with
permission from ref 111. Copyright 2008 American Chemical Society.
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modiﬁcations to nucleic acids are known to have complicated
eﬀects. The retention of solid phase synthetic methods for
nucleic acid oligomers allows for a number of strands to be
tested with varying numbers of switches incorporated in
diﬀerent positions, or with diﬀerent sequences. Such modularity
is key, not only to describing functional attributes of the light-
sensitive systems but also toward fast and eﬃcient applications
in enzymatic systems.
The outlook for spatial and temporal control of nucleic acids
remains bright, as new modiﬁcations continue to be published.
Ample examples exist that show the potential for these
approaches in vivo, including antisense and antigene tech-
nologies. Complications arising from excessive irradiation with
UV light in a biological setting remain to be tested.
Furthermore, using temperature to alter hybridization eﬀects
will also be limited in living systems. The development of
switchable units with absorption maxima outside the UV range,
in particular switching systems in the near-IR, would be
extremely beneﬁcial. We eagerly await the use of the above
applications in an in vivo setting.
3. PHOTOCONTROL OF PEPTIDE CONFORMATION
AND ACTIVITY
3.1. Introduction
The incorporation of molecular photoswitches into proteins
could in principle allow for reversible control of protein
structure and function via photoinduced isomerization. The
small conformational changes within large and complex
proteins are, however, diﬃcult to predict and interpret, which
limits their possible scope and applications.
It would be therefore advantageous to investigate the eﬀects
of photoinduced isomerization on structure and function in
smaller systems, such as short model peptides. Furthermore,
various bioactive peptides are present in living systems, oﬀering
the potential for the photocontrol of their biological activity,
thus reaching beyond inﬂuencing solely protein conformation.
Examples of such peptides include the hormones somatostatin,
insulin, and leptin or naturally occurring bioactive peptides such
as cyclosporin and apicidin. Additionally, photocontrol of
peptide structure could inﬂuence the properties of peptide-
based materials, such as polymers, gels, and ﬁbers. Three
diﬀerent methods used to incorporate photoresponsive
switches in peptides are depicted in Figure 18. This section,
inspired in its structure by a report from Renner and
Moroder,23 describes the most signiﬁcant photoresponsive
eﬀects observed on peptide conformation and properties using
these approaches. Novel molecular photoswitches and potential
future applications are also discussed. For another recent review
on photoresponsive peptides, the reader is referred to the work
of Ciardelli, Pieroni, and co-workers.116
3.2. Peptides with Photoresponsive Amino Acid Residues
Peptides are known to be good synthetic analogs of protein
motifs and can exist in disordered or regularly folded structures,
such as random-coil, β-sheet, and α-helix structures, depending
on reaction medium, pH, and temperature.17 Incorporating
photoresponsive amino acid residues into peptide structures
allows for photochemical control of molecular recognition and
organization.
Photoresponsive peptides were investigated for the ﬁrst time
by Goodman,117−121 who employed optical rotatory dispersion
(ORD) to demonstrate the eﬀects of photoisomerization and
the accompanying structural changes of peptide derivatives.
Copolymers of phenylazophenylalanine and γ-benzyl-glutamic
acid (Figure 18A) were used to photomodulate the ratio of
conformational states of these poly-α-amino acids. Changes in
Cotton eﬀect were observed upon irradiation, indicating a light-
induced change in the structure of the polypeptide backbone.
Photoregulation of azobenzene-modiﬁed poly(L-glutamic
acid) 1 was studied by Pieroni et al.122 Irradiation of the
trans-azobenzene-modiﬁed polypeptide at 350 nm induced
isomerization to the cis form. This process could be reversed to
give the trans isomer by irradiation at 450 nm or via thermal
isomerization (Figure 19). CD measurements of the peptides,
containing 13−56 mol % of azobenzene-derived amino acid
residues, dissolved in triﬂuoroethanol and trimethyl phosphate
(TMP), indicated the presence of an α-helix structure for both
the trans- and cis-isomers.
In aqueous solution, the photoresponsive peptide behavior
diﬀered and was shown to be dependent on pH or the presence
of surfactants.124 UV irradiation of the peptide in water, at pH
5−7, caused a decrease in ordered structure, which was then
restored via dark adaptation. However, at pH 7.6 the peptide,
containing 20 mol % of azobenzene units, showed the CD
pattern of a random coil structure and was no longer inﬂuenced
by photochemical isomerization. Addition of the surfactant,
Figure 18. Three approaches used to incorporate molecular switches
in peptides. (a) Copolymers of an amino acid and molecular switch-
functionalized amino acid derivative have been used to photomodulate
the conformational states of poly-α-amino acids. (b) Molecular
switches have been introduced into the backbone of both cyclic and
linear peptides. (c) Peptides have been cross-linked with a molecular
switch between side chains. Adapted with permission from ref 23.
Copyright 2006 Wiley-VCH Verlag GmbH & Co. KGaA.
Figure 19. Reversible light-induced variations (λ1 = 350 nm and λ2 =
450 nm) of the absorption spectra in azo-modiﬁed poly(L-glutamic
acid) 23. Reproduced with permission from ref 123. Copyright 1992
Elsevier B.V.
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dodecylammonium chloride (DAC), at its critical micelle
concentration, resulted in a coil-to-helix transition upon
irradiation at 350 nm (trans to cis). The mechanism for this
reversible, photomodulated process was explained by favorable
interactions of the apolar trans form and the hydrophobic core
of the micelles, which resulted in the coiled conformation of the
peptide. It was hypothesized that photoisomerization to the
more polar cis-azobenzene disrupted the hydrophobic inter-
actions and caused the peptide to separate from the micelles,
allowing the polypeptide chains to adopt an α-helix structure
(Figure 20).
Pieroni and co-workers achieved similar photoregulation of
polypeptide structures using spiropyran-containing poly(L-
glutamate)125,126 and poly(L-lysine) modiﬁed with spiropyr-
an127 or azobenzene units.128 The large diﬀerences in polarity
between the two forms of the switch units were suggested to
strongly aﬀect the conformation of the macromolecules.
Poly(L-glutamic acid), containing nitrospiropyran units,
dissolved in hexaﬂuoro-2-propanol (HFP) adapted a random
coil conformation, as revealed by CD spectroscopy. A “negative
photochromism” behavior was observed; that is, the opened,
merocyanine form of spiropyran was observed in a non-
irradiated sample. The authors hypothesized that HFP
stabilized the photoswitch in the merocyanine form via
protonation. Exposure to visible light for a few seconds
induced isomerization of the photoswitch to the spiropyran
form with full conversion, which was accompanied by a random
coil to α-helix transition of the peptide. Dark adaptation to the
merocyanine form restored the original random coil con-
formation.125 Similar photocontrol was observed for spiropyr-
an-modiﬁed poly(L-lysine), when appropriate amounts of
triethylamine (3−15%) were added to the HFP−polymer
solutions.127 The driving force for the photoinduced ordering
of the spiropyran-modiﬁed peptide was attributed to the
hydrophobic properties of the closed photoswitch that did not
disturb the formation of intramolecular H-bonds in the
polymer, which are responsible for its α-helical structure.
Isomerization to the merocyanine form, and subsequent
protonation, likely results in electrostatic repulsion between
the positively charged photochromic units, and as a
consequence, the α-helix structure is disrupted.
An interesting eﬀect was observed upon the addition of a
small amount of triﬂuoroacetic acid (TFA) to spiropyran-
modiﬁed poly(L-glutamate) dissolved in HFP. A random coil
structure for both the spiropyran- and merocyanine-modiﬁed
peptides was observed.126 It was proposed that the repulsive
electrostatic interactions in the now protonated peptide-switch
force the macromolecule to adopt an extended random coil
structure. Random coil to α-helix transitions were again
observed when methanol (5−40%) was added as a cosolvent.
It was hypothesized that the addition of methanol shifts the
equilibrium between the protonated and deprotonated
spiropyran units, favoring the neutral form.
Similar behavior was observed for spiropyran-129 and
azobenzene-128 modiﬁed poly(L-lysine). Poly(azobenzene-
sulfonyl-L-lysine) 24, dissolved in HFP, showed a typical CD
spectrum of a random coil for both the trans and cis
conﬁgurations of the azobenzene switch. When methanol was
added at concentrations below 15%, irradiation of the sample at
340 nm resulted in a coil to α-helix transition, indicated by the
increased CD ellipticity at 222 nm. At methanol concentrations
of 15% or higher, both trans- and cis-azobenzene-modiﬁed
peptides adopt an α-helical structure (Figure 21).
Ueno et al.130,131 investigated the photoisomerization of
azobenzene-modiﬁed poly(L-aspartate) in a solvent mixture of
1,2-dichloroethane (DCE) and TMP. CD spectroscopy
revealed an exclusive left-handed helix conformation for the
polypeptide with all-trans-azobenzene units using DCE as
solvent. This peptide structure could be changed to a
predominantly right-handed helix (74−81%) upon irradiation
to the cis form of the azobenzene at increased TMP
concentrations (25−30%). The peptide helix inversion was
accomplished with 9.7% azo groups incorporated in the
polymer.
These studies show that photoisomerization of photo-
chromic residues in polypeptide side chains can induce major
conformational changes in the peptide structure. The choices of
solvent, pH, and temperature were shown to be crucial for
tuning of the photoresponsive behavior of the polypeptides.
Further research could improve thermal stability and fatigue
resistance of the chromophores described, and determine the
scope of these polymer systems for future applications, which
include photocontrol of solution viscosity and the properties of
polypeptide-based materials. However, the need for multiple
chromophores to be incorporated in the peptide structure in
order to obtain these conformational changes is a limiting
factor in tuning the photoresponsive behavior. More recently
developed methods for incorporating molecular photoswitches
in peptides, discussed in the following sections, show enhanced
Figure 20. Schematic illustration of the proposed photoresponsive
eﬀect of azo-modiﬁed poly(glutamic acid) in the presence of DAC
micelles. Reproduced with permission from ref 124. Copyright 1988
Wiley-VCH Verlag GmbH & Co. KGaA.
Figure 21. CD elipticity at 222 nm and the content of the α-helix of
poly(azobenzenesulfonyl-L-lysine) 24 in hexaﬂuoro-2-propanol/meth-
anol (HFP/MeOH) solvent mixtures as a function of MeOH
concentration for samples irradiated at 417 (−) and 340 nm (- - -).
Reproduced with permission from ref 128. Copyright 1996 American
Chemical Society.
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photoresponsive behavior with a better control of the structural
changes elicited by the peptides.
3.3. Photoresponsive Molecular Switches Incorporation
into the Backbone of Peptides
3.3.1. Photoresponsive Switches in Cyclic Peptides.
The β-turn is a common motif in bioactive proteins and
peptides, shown to be important in various peptide−protein
and protein−protein interactions.132,133 Photoregulation of β-
turn conformations could be a useful step toward controlling
biologically active peptides (Figure 22).
Chmielewski and co-workers incorporated a photoresponsive
amino acid into β-turn mimicking cyclic peptides and
investigated the eﬀects of photoisomerization on their
conformation.134 A Gly-Gly-Pro-Asn sequence was ﬂanked on
both sides by two alanine residues that were then joined by 4-
[(4-aminomethyl)phenylazo]benzoic acid (AMPB) to give
peptide 25. trans-25 showed a β-strand conformation
interrupted by a bend at the Pro residue. Irradiation of trans-
25 resulted in the isomerization to the cis-form, and
consequently, the cyclic peptide adopted a typical β-turn
conformation.
More recently, Chmielewski et al. reported photoresponsive
cyclic peptide 26, in which the pharmacophoric tetrapeptide
turn sequence of the decapeptide somatostatin was incorpo-
rated.135 Somatostatin is a peptide hormone that regulates a
range of biological functions, including cell growth, and, hence,
is of interest in the treatment of certain cancers.136 Isomer-
ization of the trans isomer of somatostatin derived photo-
responsive cyclic peptide 26 to the cis form induced the
formation of a β-turn within the pharmacophore Phe-Trp-Lys-
Thr somatostatin sequence. An enhanced aﬃnity to a
somatostatin receptor was observed (Table 2).
Moroder and co-workers studied related photoswitchable
cyclic peptides containing various sequences of seven to eight
amino acids. In the ﬁrst approach, 4-(4-aminophenylazo)-
benzoic acid (APB, Figure 22) was incorporated in a cyclic
peptide comprised of the pharmacophore for thioredoxin
reductase (TRR) recognition (peptide 27, Figure 22).137,138
TRR enzymes are able to reduce oxidized thioredoxin (Trx)
proteins. Proteins reduced by Trx play an important role in
various biological processes (i.e., cell growth, apoptosis
inhibition, etc.).139 Photoisomerization of a photoresponsive
monocyclic APB-peptide was reversible, with both cis and trans
isomers adopting well-deﬁned conformations. Additional
conformational constraints were introduced via an intra-
molecular disulﬁde bridge to form a bicyclic APB-peptide
(peptide 28, Figure 22).140 However, this generated a so-called
“frustrated” system for both isomers. The use of an AMPB
chromophore introduced enhanced ﬂexibility and was found to
be of more use (peptides 29 and 30, Figure 22).141 The AMPB-
peptide 30 (Figure 22) was made water-soluble by replacing all
the residues outside the Cys-Ala-Thr-Cys-Asp motif with Lys
residues to investigate the photomodulation of the redox
potential under aqueous conditions (31, Figure 22).142,143
The redox potential was determined by performing thiol/
disulﬁde exchange experiments with GSH/GSSG (glutathione)
as a reference redox pair. The potential measured for the
Figure 22. Structures of the monocyclic and bicyclic peptides with azobenzene-based APB and AMPB linkers.134,135,137,138,140−146
Table 2. Binding Aﬃnities to a Somatostatin Receptor of
trans-26 and cis-26, Bearing the Pharmacophore Turn
Sequence of Somatostatin135
trans (μM) cis (μM)
IC50 3.6 ± 0.3 1.7 ± 0.1
Ki 2.6 ± 0.2 1.0 ± 0.1
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bicyclic trans-31 was very similar to that for the native linear
active site fragment of thioredoxin reductase (Table 3, entries 2
and 1, respectively). Irradiation at λ = 360 nm resulted in
photoisomerization of the switch-linked peptide backbone and
a concominant shift in oxidation potential for the cis-31 isomer
to a higher value (Table 3, entry 3). This redox potential closely
resembles that of a native enzyme, protein disulﬁde isomerase
(PDI). PDI catalyzes disulﬁde formation in protein folding by
connecting the proper cysteines linkages in proteins.144
Formation of the disulﬁde bridge using cis-31 proved to be
highly unfavorable, with a Kox value (Kox = kox/kred) that was
nearly 3 orders of magnitude lower than that of the trans-31
(Table 3, entries 2 and 3).
The ability of the AMPB-modiﬁed bicyclic peptide 31 to
mimic thiol/disulﬁde oxidoreductases was investigated by
catalyzing the oxidative refolding of reduced ribonuclease A
(RNase A). In both trans and cis conﬁgurations, the peptide
catalyzed the folding; however, higher initial rates were
observed for the cis isomer.143,145 Finally, a cyclic AMPB-
peptide 32 (Figure 22) was constructed with the Cys-Gly-His-
Cys-Lys active-site motif of PDI incorporated. Trans to cis
isomerization induced a conformational change in the cyclic
peptide, going from an extended to a β-turn conformation, as
observed by NMR (Figure 23).146
For further studies on the conformational and redox
properties of cyclic peptides, presented in Figure 22, the reader
is referred to a review by Moroder and co-workers.147
The kinetics of the photochemically controlled peptide
folding processes were studied with femtosecond time-resolved
UV/vis-spectroscopy for the following cyclic and bicyclic
peptides: APB-peptides,148 AMPB-peptides,149 a water-soluble
AMPB-peptide with the TRR sequence,150 and AMPB-peptides
with the PDI sequence146 (Figure 22). These studies were
recently reviewed in depth by Renner and Moroder.23
Ultrafast IR spectroscopy allowed for monitoring of
structural changes upon photochromic isomerization in cyclic
and bicyclic AMPB-peptides with TRR sequences. The study
was based on the change in two characteristic IR bands: the
amide I band (between 1625 cm−1 and 1725 cm−1) reﬂected
the carbonyl-stretching vibrations in the peptide backbone, and
the amide II band (below 1630 cm−1) reﬂected the structural
changes of both the peptide and the chromophore (Figure
24).151 The results obtained for 28 showed that the main
conformational changes of the backbone were completed after
only 20 ps. However, equilibration of the entire peptide was not
completed even 16 ns after irradiation (Figure 24).149,151,152
These studies also showed that light-induced conformational
rearrangements of the peptides could still be observed at
temperatures below the freezing point of the solvent.153
The changes in IR spectra observed for the cis to trans
isomerization of 27 closely resembled those of 28.154
Conformational relaxation of the peptidic portion was not
completed even after 3 ns, and modeling studies predicted that
it would require ∼23 ns for the peptide to completely relax.154
This contradicted the conclusions derived from the UV/vis
spectroscopy study148 and demonstrated IR spectroscopy to be
more sensitive for detecting the structural relaxation events.
Additional insight into the folding processes of the peptide
backbone could be obtained with the use of isotope labeled
Table 3. Apparent Redox Potentials and Kox Values (Kox =
kox/kred) of Linear and Bicyclic Peptides Containing the
Thioredoxin-Derived Cys-Ala-Thr-Cys Sequence at pH
7.0143
entry compd Kox (M) E′0 (mV)
1 H-Ala-Cys-Ala-Thr-Cys-Asp-Gly-Phe-OH 0.123 −210
2 trans-31 0.050 −200
3 cis-31 8 × 10−4 −146
Figure 23. Overlay of the structure of the cis-32 (gray backbone) and
trans-32 (blue backbone). The arrows highlight the structural
elements. Reproduced with permission from ref 146. Copyright
2006 Elsevier B.V.
Figure 24. Absorption spectra of the cis-28 (Top, solid line) and trans-
28 (Top, dashed line), transient diﬀerence spectra at selected delay
times (Middle) and stationary cis−trans diﬀerence spectrum measured
by the FTIR (Bottom). DMSO was used as a solvent. Reproduced with
permission from ref 152. Copyright 2003 National Academy of
Sciences, USA.
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azobenzene 35 (Figure 25a).155 The labeling shifted the
aromatic valence vibrations of the azobenzene out of the region
in which the peptide vibrations are observed to 1576 cm−1
(Figure 25b).
Photocontrol of cell adhesion was illustrated with photo-
responsive cyclic heptapeptide 33 (Figure 22).156 The Arg-Gly-
Asp (RGD) sequence is recognized by integrin cell-surface
receptors of a large number of adhesive extracellular matrices,
blood cells, and cell-surface proteins. Photocontrol of this
ubiquitous recognition system for cell adhesion could be used
to investigate or modify events of intermolecular adhesion.157
The binding aﬃnity of the cyclic azobenzene peptide 33 to
immobilized αvβ3 integrin was investigated with surface-
plasmon enhanced ﬂuorescence spectroscopy (SPFS) by
attaching a ﬂuorophore to the Lys side chain of peptide 33.
The conformationally more constrained trans-azobenzene-
modiﬁed cyclic peptide showed a higher binding aﬃnity for
αvβ3 integrin than the cis form (Figure 26). Shifting the
position of the Lys residue (peptide 34) was shown to reduce
integrin aﬃnity signiﬁcantly. However, the diﬀerence in aﬃnity
between the cis- and trans-peptides increased by more than a
factor of 2 and photomodulation of integrin aﬃnity was more
eﬃcient for peptide 34 (Figure 26).158
Rück-Braun and co-workers synthesized a cyclic, AMPB-
modiﬁed peptide derived from the binding site of the PDZ
domain of neuronal nitric oxide synthase (nNOS) (Figure
27).159 PDZ domains, approximately 90 residues long, are
frequently encountered domains found in a diverse collection
of signaling proteins that mediate protein−protein interac-
tions.160 The PDZ domain of nNOS heterodimerizes with the
PDZ domain of α-1-syntrophin. The internal recognition motif,
L-E-T-T-F, in the extended PDZ domain of nNOS is crucial for
binding. α-1-Syntrophin is present in skeletal muscle, and its
association with nNOS induces the production of second
messenger nitric oxide (NO) for muscle contraction.161 The
cyclic AMPB-peptide 36 (Figure 27) adopted a β-hairpin
structure analogous to the structure of the native protein
enabling 36 to act as a light-controlled ligand. The peptide was
immobilized via the Lys side chain on a chip to study the
interactions of the switchable peptide with α-1-syntrophin.
Surface plasmon resonance spectroscopy (SPR) revealed
almost no binding for the purely trans-36, while photo-
isomerization to cis-36 resulted in binding (KD = 10.6 μM).
The binding aﬃnity of the cis-36 was comparable to that of the
unmodiﬁed model peptide (KD = 5.4 μM).
159
Recently it was shown that peptide 36 could also be used in
vivo to photoregulate the contraction of muscle ﬁbers when
Figure 25. (a) Structure of D-labeled AMPB molecular photoswitch
35. (b) FTIR spectrum of the νCC stretching and amide I and II
regions of 35 in DMSO (black line, spectral resolution 2 cm−1) in
comparison with the unlabeled sample (dotted line). Reproduced with
permission from ref 155. Copyright 2008 The Royal Society of
Chemistry.
Figure 26. Aﬃnity of two ﬂuorescently labeled peptides 33 and 34 to surface-immoblized αvβ3 integrin.158 “cis” relates to the photostationary state
with ∼80% cis-azo isomer, and “trans” relates to the thermally relaxed molecule with 100% trans-azo isomer. Reproduced with permission from ref
23. Copyright 2006 Wiley-VCH Verlag GmbH & Co. KGaA.
Figure 27. Cyclic peptide 36 is related to the β-ﬁnger peptide of
nNOS with the added modiﬁcation of an AMPB photoswitch.159 Side
chains are abbreviated by their one-letter codes for clarity, with the
exception of the lysine side chain used for immobilization on a sensor
chip. Reproduced with permission from ref 159. Copyright 2009
Wiley-VCH Verlag GmbH & Co. KGaA.
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transfected to living cells.32 A ﬂuorophore (nitrobenzoxadia-
zole) was attached to the lysine residue to enable the
visualization of peptide uptake into skeletal muscle ﬁber
(Figure 28a), demonstrating that the modiﬁed peptide was
capable of crossing the membrane. C2C12 myotubes incubated
with trans-36 were shown to produce higher levels of NO than
cells exposed to the peptide in the cis conﬁguration.
The shortening of the sarcomere length of skeletal muscle
ﬁbers from the Flexor digitorum brevis (FDB) of three-month-
old mice could be observed in the presence of 36 (Figure 27).
FDB ﬁbers were stimulated to contract at 1 Hz. Addition of the
trans-isomer of the peptide resulted in no signiﬁcant change in
amplitude (Figure 28b). Illumination of the ﬁbers at 365 nm
reduced the amplitude. This eﬀect was shown to be irreversible
following attempted reisomerization of the photochromic unit
in the peptide to the trans form. The authors hypothesize that
the lack of reversibility could be explained by the loss of nNOS
from the sarcolemma caused by the perturbation of
syntrophin−nNOS interactions. This research constitutes a
unique example of the use of a photoswitch-modiﬁed peptide
for the control of physiological function, albeit not in a
reversible way.
3.3.2. Photoresponsive Switches as Mimics of the β-
Hairpin Motif. The stability of β-hairpins depends on the
interaction between linked antiparallel peptide strands (i.e.,
hydrogen bonding and side chain−side chain interac-
tions).161−163 Ghadiri et al. have shown that the incorporation
of an azobenzene photoswitch in a linear peptide could allow
reversible switching between inter- and intramolecular hydro-
gen bonding (in trans- and cis-azobenzene-modiﬁed peptides,
respectively) in which the chromophore functions as a β-turn
element.164
Hilvert et al.165,166 designed and synthesized a photo-
switchable β-hairpin 37 (Figure 29) by replacing the turn
residues D-Pro-Gly with an azobenzene switch in a 12-residue
peptide sequence derived from protein GB1167 (Figure 29).
MD simulations showed that [3-(3-aminomethyl)phenylazo]-
phenylacetic acid (AMPP) linker would be the most promising
conformational switch.165 NMR spectroscopy revealed that cis-
37 adopted a well-deﬁned β-hairpin structure resembling the
model peptide. However, the azobenzene unit introduced more
ﬂexibility, aﬀecting the intramolecular interactions between the
two strands. Higher order aggregates were formed if the
peptide was in a trans conﬁguration. This peptide could be
switched reversibly until the aggregates precipitated from
solution.166
Subsequently, Hilvert and co-workers168 inserted the same
AMPP-azobenzene moiety in a 36 amino acid sequence,
derived from avian pancreatic polypeptide (aPP), again by
replacing the β-turn segment (Figure 30). The modiﬁed aPP
showed the same degree of helicity as the natural aPP, and
reversible isomerization using light was observed. cis-AMPP-
aPP was tetrameric in solution and adopted a back-folded
structure (Figure 30), while trans-AMPP-aPP formed larger
aggregates. The observed photoswitching between two diﬀerent
tertiary structures could be a promising approach for
controlling larger and more complex peptide systems in the
future.
Another route to obtain well-folded, highly stable β-hairpins
proceeds via the inclusion of tryptophan (Trp) zippers in 12- or
16-residue peptides, as even two Trp-Trp pairs have been
shown to stabilize β-hairpin formation.169 Moroder and co-
workers synthesized a photoresponsive β-hairpin peptide 38
based on the Trp zipper motif (Figure 31) and could control
the degree of folding by irradiation of the incorporated AMPP
chromophore.170 Additional investigation with ultrafast UV
pump, IR probe spectroscopy combined with MD simulations
revealed the dynamics of the β-hairpin folding and unfolding
process. Trans to cis isomerization of 38 was completed within
picoseconds and resulted in the formation of a stable β-turn
Figure 28. (a) Fluorescence-based visualization of the uptake of
nitrobenzoxadiazole-labeled, photoswitchable peptide 36 into a single
skeletal muscle ﬁber from Flexor digitorum brevis from three-month-old
mice. (b) Recordings of sarcomere shortening in the presence of the
trans form and after illumination at λ = 365 nm for 15 min.
Reproduced with permission from ref 32. Copyright 2011 Wiley-VCH
Verlag GmbH & Co. KGaA.
Figure 29. Model hairpin sequence 37 containing a cis-azobenzene (3-
(3-aminomethylphenylazo)phenylacetic acid, AMPP) turn element
with the hydrogen bonding pattern of the β-hairpin.165−167
Figure 30. Backbone representation of the monomeric subunits of cis-
AMPP-aPP (pancreactic polypeptide) (left) and aPP (right) including
the side chains of aromatic residues. cis-AMPP is presented in light-
gray. Reprinted with permission from ref 168. Copyright 2006 Wiley-
VCH Verlag GmbH & Co. KGaA.
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structure in the peptide. However, the transition into a well-
ordered hairpin required an additional 30 μs and was shown to
be the rate-limiting step.171
Gogoll et al. incorporated a stilbene chromophore in
peptides. Despite the intrinsic drawbacks of this photoswitch
(see section 1.3.2), stilbene is an interesting alternative for the
more common azobenzene, as stilbene is not as sensitive to
reduction and E−Z photoisomerization is not thermorever-
sible.172,173 The linear peptide sequence Leu-Leu-Val-Ile-D-Phe-
Gly-Thr-Thr-Ala-Leu is known to fold into β-sheets and is
present in the TATA-box-binding protein (TBP). TBP is a
protein that binds to speciﬁc DNA sequences to initiate
transcription and is active in cells and tissues throughout the
human body.174 The D-Phe-Gly β-turn inducer in the peptide
sequence was replaced with a stilbene chromophore.173 The
observation of unfolded protein conformations for both the E
and Z forms of the photoswitch indicated that switching did not
induce β-hairpin formation.173 An alternative peptide 39
(Figure 32), based on the Trp zipper motif, was used to
overcome the lack of suﬃcient stabilizing forces between the
peptide strands in the ﬁrst system. NMR spectroscopy,
translational self-diﬀusion studies, and CD spectroscopy on
this second peptide sequence with the Z-isomer of stilbene
allowed the observation of β-hairpin formation to a
considerable extent, similar to the previous Trp zipper motif
reported by Moroder.170 Switching to the E-isomer in this case
disrupted the β-hairpin motif.175
3.3.3. Additional Motifs with Switches in the Peptide
Backbone. Gogoll et al.176 expanded their study to a larger
system, incorporating a stilbene chromophore into the turn
region of an artiﬁcial hydrolase (HN1). The hydrolytic activity
of HN1 depends on the spatial proximity of two helical
segments, in particular the histidine amino acids in those
segments (Figure 33). The catalytic activity of the photo-
responsive peptide was determined using the hydrolysis of
para-nitrophenyl acetate. The observed rate constants showed a
25% increase in activity for the Z isomer and a 12% decrease in
activity for the E isomer compared to unmodiﬁed HN1.
Isomerization of the stilbene unit to the Z-isomer was shown to
induce dimerization of the peptides, changing the arrangement
of the helical segments and, consequently, the catalytic activity.
A similar approach was used by Mascarenas and co-
workers177 to photoregulate the site-speciﬁc DNA binding
aﬃnity of a model peptide. Selected peptide segments were
linked by an azobenzene moiety. These segments consisted of
amino acids 226−248 from the basic regions (BR) of the yeast
transcription factor GCN4, a well-studied bZIP (basic leucine
zipper domain) protein known to recognize and bind DNA.
For this study an additional Gly-Gly-Cys linker was placed at
the C termini of the helices. trans to cis isomerization of the
azobenzene unit in the peptide resulted in 60−70 times more
eﬃcient DNA binding by the GCN4 derivative. The peptide
segments changed from a random coil to an α-helix structure
upon DNA binding (Figure 34), which could be followed using
CD spectroscopy. Sequence-speciﬁc DNA binding could be
controlled by irradiation with UV light. However, this process
was shown to be irreversible due to the stability of the DNA−
cis-azopeptide complex. Woolley et al.178 subsequently achieved
reversible binding/dissociation of azobenzene-modiﬁed GCN4-
bZIP proteins, which will be discussed in the following section.
Another important biological recognition event is the
interaction between an antigen and an antibody. Nakanishi et
Figure 31. NMR-derived structures of (a) cis-38 and (b) trans-38.
Reprinted with permission from ref 171. Copyright 2007 National
Academy of Sciences, USA.
Figure 32. Model hairpin 39 based on a Trp(W) zipper motif
containing a photoswitchable stilbene unit. Reprinted with permission
from ref 175. Copyright 2009 Wiley-VCH Verlag GmbH & Co. KGaA.
Figure 33. Schematic representation of the helical peptide HN1 and
the photoisomerization of the incorporated stilbene chromophore.
Reprinted with permission from ref 176. Copyright 2009 Wiley-VCH
Verlag GmbH & Co. KGaA.
Figure 34. Schematic illustration of the cis to trans isomerization of the
azo-peptide and the sequence-speciﬁc DNA binding of the cis form
accompanied by a random coil to α-helix transition. Adapted with
permission from ref 177. Copyright 2000 Wiley-VCH Verlag GmbH &
Co. KGaA.
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al.179 used a hapten peptide (Glu-azoAla-Gly2) that carried an
azobenzene switch at the amino acid side chain (similar to the
approach described in section 3.2). The monoclonal antibody
(Z1H01) was shown to reversibly bind and release the hapten
peptide upon irradiation. Freitag et al.180 demonstrated similar
changes in antigen−antibody interactions between a FLAG-tag
peptide and its analogs, with an azobenzene switch replacing
three internal amino acid residues and monoclonal anti-FLAG-
tag antibody M1.180 Two speciﬁc azobenzene-bearing FLAG-
tag peptide analogs showed signiﬁcant diﬀerences in binding
aﬃnities, with the cis form approaching the value of the natural
FLAG-tag peptide.
The introduction of molecular photoswitches has also been
used to regulate zinc ﬁnger binding to DNA.181 Zinc ﬁngers are
motifs that appear in transcription factors that can sequence-
speciﬁcally bind double-stranded DNA. The folding of zinc
ﬁngers into the active ββα secondary structure is coupled with
Zn2+ binding.182
A 59-amino acid photoresponsive double zinc ﬁnger, Sp1
(Figure 35), was prepared by conjugating an azobenzene
moiety to the N-terminus, which is known to recognize the
GGGGCG DNA sequence. The ligation site was chosen due to
the ease of modiﬁcation as well as the proximity to the DNA-
binding region.
Photoinduced trans to cis isomerization at λ = 365 nm took
place eﬃciently, and it did not inﬂuence the α-helix folding
structure according to CD measurements. Reisomerization back
to the trans form, upon irradiation at >420 nm, proceeded with
low conversion and could be brought to completion only after
denaturation of the protein. The retarded reversible isomer-
ization was explained by strong interaction of the cis form of the
photochromic unit with the folded protein. The dissociation
constants calculated by gel mobility shift assay were 0.73 ± 0.18
and 0.32 ± 0.08 μM for the trans and unmodiﬁed forms,
respectively. The KD value for the cis form could not be
determined. To estimate the diﬀerence in the binding between
the two photoisomers, the cleavage of a model DNA strand by
the AciI restriction enzyme was studied. AciI is known to bind
to the CCGC sequence of DNA. The activity of Acil can be
inhibited by the native zinc ﬁnger Sp1. In the presence of the
trans form of the photoresponsive zinc ﬁnger, no cleavage of
DNA by AciI was observed. After irradiation, the aﬃnity of the
photoisomerized zinc ﬁnger to DNA was diminished and over
50% DNA cleavage was observed in 30 min. Considering the
rise in interest in zinc ﬁnger proteins,183 this approach provides
a promising and simple methodology to control peptide
binding to DNA.
Nakatani and co-workers184,185 also investigated photo-
controlled binding of a small photoresponsive peptide, KR-
Az-R, where Az is AMPB (40, Figure 36), to RNA aptamers,
aiming to control the activity of riboswitches by light. In KR-
Az-R the AMPB moiety was ﬂanked on both sides with arginine
residues, which can interact with RNA by electrostatic
interactions and hydrogen bonding. The N-terminal lysine
residue was used to immobilize the photoresponsive peptide to
an agarose gel. The RNA aptamer sequence was optimized by
eluting random sequences through an agarose column
containing immobilized KR-A-zR over eight cycles of selection.
Three of the obtained RNA sequences were further
characterized with respect to photocontrolled binding to KR-
Az-R. The binding of RNA aptamer-19 to the peptide
immobilized via the N-terminal lysine residue on the gold
surface decreased by more than 90% upon trans to cis
photoisomerization, as measured by SPR, and the eﬀects
were completely reversible. In a follow-up study,185 another two
cycles of RNA sequence selection were applied, followed by in
silico analysis of the structure-binding relationship. The study
revealed the secondary structure of the selected aptamers and
showed that conserved residues were important for peptide
binding.
Various photoresponsive peptide systems have shown the
possibility of mimicking a β-turn upon irradiation and inducing
the formation of folded conformations (i.e., β-hairpins).
However, folded conformations are present in both isomers
and larger conformational diﬀerences between the two isomers
are desired to gain more control over the relative activities. The
use of a more rigid switch or perhaps alternate switches could
promote more dramatic conformational eﬀects in future
studies.172,186,187
3.4. Molecular Photoswitches as Amino Acid Side-Chain
Cross-Linkers
The α-helix is an additional key structural element in peptides
and proteins, including DNA binding motifs such as helix−
turn−helix structures and leucine zippers. Such motifs are
essential for many processes, including DNA replication,
recombination, scission, and transcription.188,189 Photocontrol
of α-helical content in peptides and proteins could in essence
oﬀer photocontrol of gene modiﬁcation and expression.
Woolley and co-workers achieved photocontrol over α-helix
folding by introducing two cysteine (Cys) residues into
peptides and cross-linking these with photoresponsive bridging
unit 41 (Figure 37), an iodoacetamide-modiﬁed azobenzene.190
Figure 35. Sequence and proposed structure of a photoresponsive zinc
ﬁnger motif. Reproduced with permission from ref 181. Copyright
2009 The Royal Society of Chemistry.
Figure 36. Photoresposive peptide trans-KR-Az-R (40) used in the
study of photocontrolled binding to RNA aptamers.184,185
Chemical Reviews Review
dx.doi.org/10.1021/cr300179f | Chem. Rev. 2013, 113, 6114−61786136
The Cys residues were introduced at i, i + 7 spacing in the JRK-
7 peptide to match the linker length of the switch in the cis
conformation (Figure 38a and b). As indicated by CD
measurements, the isomerization of the azobenzene switch
from the trans to cis conﬁguration increased helical content
from 12% to 48%. At ﬁrst it was expected that steric
interactions between residues i + 3, i + 4 and the cross-linking
switch would inﬂuence the photosensitive behavior.190
However, altering these two residues showed that steric
interactions did not seem to have a large eﬀect on the
conformational transition.191
Alternative Cys spacing was also investigated in this study.
Peptides with i, i + 4 spacing behaved similarly to the JRK-7
peptides described, and peptides with i, i + 11 spacing (FK-11,
Figure 38c) showed the reverse behavior, with signiﬁcant
helical content for the trans isomer (66%).193 The possibility to
alter the spacing of the cross-linking positions allowed
additional control over the peptides. It was shown to be
advantageous to have the dark-adapted, >99% trans state as the
inactive state of the system. The isomerization to the cis form
then resulted in the largest change in activity. To further
increase the versatility of the approach, a procedure was
developed to calculate the approximate distance between Cys
sulfur atoms in noncross-linked peptides to determine which
linkers would ﬁt in the S−S distance and stabilize/destabilize α-
helix formation.194
Kinetic measurements on JRK-7 and FK-11 azobenzene 41
cross-linked peptides (Figure 38), using time-resolved ORD
and IR techniques, showed fast isomerization of the azobenzene
photoswitch moieties (picoseconds), while peptide folding/
unfolding occurred at the 100 ns to 1 μs time scale.195,196 The
folding and unfolding kinetics were shown to be strongly
dependent on temperature, and lower temperatures resulted in
higher helical content but slower (un)folding rates.196,197 Single
13C18O isotope labeling provided further insights into the
rates of hydrogen bond formation for the α-helix structure.198
Two-dimensional IR spectroscopy on single site 13C18O
isotope-labeled peptides proved to be a useful method to
measure the extent of hydrogen bonding at any given position
along the helical peptide and allowed examination of the local
folding behavior in photoresponsive peptides.199
The practicality of compound 41 as a cross-linker was limited
by its poor water-solubility and the short half-life of the cis form
(∼12 min at 25 °C). Addition of sulfonate groups to the
aromatic rings of the azobenzene chromophore at the meta
position (compound 42, Figure 37) increased the water
solubility. The FK-11 peptide was cross-linked with the new,
sulfonated switch and showed similar conformational behavior
to that of the original photoresponsive peptide, with a longer
half-life of 35 min.200 Thus, an extended and more rigid, water-
soluble azobenzene cross-linker 43 (Figure 37) was prepared in
an attempt to generate larger conformational changes in the
peptide upon isomerization. However, irradiation of the switch
at 400 nm at room temperature yielded only small amounts of
the cis isomer and induced only small conformational changes
in the model peptides.201
Figure 37. Selected molecular photoswitches used for the cross-linking of peptide side chains.190,200−208
Figure 38. (a) Model showing the increased helicity induced in the
JRK-7 peptide upon trans to cis isomerization of the attached
azobenzene cross-linker 41. Primary sequences of the cross-linked
peptides: (b) JRK-7 (azobenzene reacted via Cys residues spaced i, i +
7); (c) FK-11 (azobenzene via Cys residues spaced i, i + 11).
Reproduced with permission from ref 192. Copyright 2005 Elsevier B.
V.
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An additional series of methanethiosulfonate (MTS)-bearing
azobenzene cross-linkers 44−47 (Figure 37) provided a large
range of thermal stabilities of the cis isomer.202 FK-11 peptides
were cross-linked with MTS-alkyl-, -amide-, -carbamate-, and
-urea-azobenzenes, and half-lives for the cis to trans isomer-
ization process ranged from 43 h to 26 s, respectively (Table
4).202 The MTS-dialkylaminoazobenzene 48 showed both a
considerable red-shift of the absorption and extremely short
half-lives for cis cross-linked JRK-7 and FK-11 peptides (Table
5, entry 1).203 The introduction of a piperazine substituent at
the azobenzene unit (compound 49, Figure 37) resulted in a
shift to shorter wavelengths relative to the related azobenzenes
bearing acyclic substituents along with longer half-lives of
thermal isomerization (Table 5, entry 2).204 Finally, a series of
ortho-amino-substituted azobenzenes was synthesized allowing
for photoswitching at longer wavelengths ranging from 435 up
to 530 nm (morpholine to pyrrolidine) and thermal relaxation
on time scales of seconds to minutes (Table 5, entry 3).
Moreover, these photoswitches showed enhanced resistance to
reduction because of the electron-rich nature of the
azobenzenes.205
Moroder and co-workers demonstrated photoresponsive
folding and unfolding of triple-helix structures in collagen
model peptides. The sequence Ac-(Gly-Pro-Hyp)n-Gly-X-Hyp-
Gly-Pro-Hyp-Gly-Pro-X-(Gly-Pro-Hyp)m-Gly-Gly-NH2 (Hyp =
hydroxyproline) was chosen for the model peptide, as the
tripeptide unit Gly-Pro-Hyp is known to stabilize the triple
helix structure.207,208 In the initial approach,208 mercaptopro-
line residues (X) were incorporated in the sequence (n, m = 2)
and cross-linked with an azobenzene chromophore 52 (Figure
37). Trans to cis isomerization at ambient temperatures
unfolded or distorted the triple-helix structure, and thermal
relaxation induced refolding. Subsequently, an approach
analogous to that followed by Woolley and co-workers (X =
Cys),190 was used to cross-link the peptide sequence (n = 3, m
= 5) with the azobenzene chromophore (Figure 39). Unfolding
in response to photoinduced isomerization of the triple helix
was limited and only observed in the region spanned by the
azobenzene switch.207 Additional folding studies and further
investigation into the optimal peptide sequence and structure of
the switch may be required to improve the photoresponsive
eﬀect.
Photocontrol over helix formation via side-chain cross-
linking with a biofunctional photochromic residue has been
taken a step further to control a biological process, exempliﬁed
here by the study on an 18-residue peptide sequence HDH-3
containing DNA binding residues. Cross-linking i, i + 11 Cys
residues in the HDH-3 peptide with an azobenzene switch 42
(Figure 37) resulted in DNA binding by the α-helix with high
aﬃnity and speciﬁcity (to the known QRE sequence) when the
switch was in the trans conﬁguration. Photoisomerization to the
cis isomer prevented the formation of an α-helix structure
between the Cys residues and signiﬁcantly reduced the binding
aﬃnity of the helix to DNA (Table 6).209
Another photoactive DNA-binding peptide, from the group
of Woolley, was based upon the introduction of an azobenzene-
derived cross-linker 42 (Figure 37) into the DNA-recognition
helix of the muscle-speciﬁc transcriptional activator MyoD.21
MyoD is produced in various cell types and relies on the
dimerization of a basic helix−loop−helix (HLH) domain for
DNA binding (Figure 40a). Cysteine residues were introduced
into positions 116 and 123 of MyoD and cross-linked, in i, i + 7
spacing, with 3,3′-bis(sulfonato)-4,4′-bis(chloroacetamido)-
azobenzene (BSBCA), to give photochemically active MyoD
Table 4. Absorption Wavelength of the trans Isomer and
Thermal Relaxation Half-Lives of cis-Azobenzene Cross-
Linked FK-11 Peptides in 5 mM Phosphate Buﬀer at
25°C.202
entry photoswitch λmax (nm) τ1/2
1 44 342 43 h
2 45 366 8 min
3 46 372 96 s
4 47 382 26 s
Table 5. Absorption Wavelength of the trans Isomer and
Thermal Relaxation Half-Lives of cis-Azobenzene Cross-
Linked Peptides
entry photoswitch λmax (nm) τ1/2
1 43 400 53.9 min (i, i + 14),a 37.2 min (i, i +
21)a
2 48 480 0.0065 s,a 12.1 sb (JRK-7); 0.076 s,a 8.2
sb (FK-11)
3 49 400−450 190 s (JRK-7),b not (FK-11), 15 s (i, i +
14),b 11 s (i, i + 15)b
4 50 437 ∼300 s (JRK-7)a
5 51 365 12.6 min (i, i + 11), 10.6 min (i, i + 14),
29.1 min (i, i + 19), 16.0 min (i, i +
21)
aAqueous phosphate buﬀer, pH 7.0, 25 °C. b50% MeOH in aqueous
phosphate buﬀer, pH 7.0, 25 °C.200,201,203−206
Figure 39. Schematic illustration of the unfolding/distortion of triple-
helix structure upon trans to cis isomerization. Reproduced with
permission from ref 208. Copyright 2006 Wiley-VCH Verlag GmbH &
Co. KGaA.
Table 6. DNA Binding Parameters for HDH-3, Dark
Adapted -HDH-3, and Irradiated -HDH-3 (ref 209)a
KD (nM)
QRE ERE MCK-S
dark-adapted HDH-3 7.5 ± 1.3 140 ± 11 >6000
irradiated HDH-3 140 ± 25 160 ± 15 >6000
native HDH-3 200 ± 11 175 ± 16 n.d.
aSequences: QRE = 5′-CGCAGTGTAATCCCCTCGAC-3′; ERE =
5′-CGCAGTGTAATTACCTCGAC-3′; MCK-S = 5′-CAGGCAG-
CAGGTGTTGG-3′.
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(photo-MyoD). Both the non-cross-linked and the trans-photo-
MyoD existed predominantly in a random coil conformation,
which is typical for the parent domain that adopts a helical
conformation only upon DNA binding. Irradiation at 360 nm
gave a PSS with 61% of cis isomer (determined by HPLC),
resulting in increased helicity in the region spanned by the
cross-linker, as determined by CD spectroscopy.210 The aﬃnity
of diﬀerent forms of MyoD was measured with MCK-S
oligonucleotide, which includes the MyoD recognition
sequence, “E-box” (CAGGTG). The KD values for trans-
photo-MyoD and non-cross-linked-MyoD were similar (1.5 ±
0.38 and 0.88 ± 0.22 × 10−14 M2, respectively). The stability of
the complex increased by 3 orders of magnitude following the
photoisomerization of the trans form to the cis form (KD = 4.4
± 0.16 × 10−18 M2). This constitutes an interesting approach
based on reinforcing the native structure of DNA-recognition
elements.
After establishing the precedence for photocontrol of coiled
coil interactions in a leucine zipper peptide GCN4-p1,211
Woolley et al. studied the reversible binding-dissocation of
azobenzene-modiﬁed GCN4-bZIP proteins to the AP1 tran-
scription factor binding site in DNA (5′-TGACTCA-3′, Figure
41).178 The azobenzene photochromic unit 42 (Figure 37) was
introduced by cross-linking Cys residues at positions 262 and
269 within a bZIP domain. The trans form of the azobenzene
destabilized the helical structure of the coiled-coil region of
GCN4-bZIP, resulting in lower DNA binding aﬃnities. trans to
cis photoisomerization resulted in a substantial increase of
helical content and a 20-fold increase in DNA-binding aﬃnity
as measured by kinetic capillary electrophoresis. This process
was fully reversible upon thermal isomerization of the
azobenzene unit. Further adaptation to this system could be
considered (i.e., location, spacing or number of cross-linked
azobenzenes) to obtain an even larger change in DNA binding
aﬃnities.
A similar system that allows for the photocontrol of AP1
transcription factor activity was recently reported (Figure
42a).212 AP1 is formed by dimerization of CJun and CFos
proteins. Photoswitchable cross-linker 42 was introduced into
AP-1 dominant, negative peptide AFosW, allowing photo-
control over helicity. Helical AFosW inhibits the heterodimer
cFos/cJun binding to DNA, but it is inactive in the unfolded
state (Figure 42a). As a result, the photoswitching between the
two states could allow for control over the activity of AP1 in a
living cell.
Azobenzene-modiﬁed AFosW (XAFosW) was transfected
into HEK293T cells, in which the luciferase reporter was under
the control of an AP-1 promoter. Activity ratios of luciferase
and β-galactosidase, the latter being under the control of a
constitutive promoter, were used as an indication of speciﬁc
inhibition of AP-1 activity (Figure 42b). Unmodiﬁed AFosW
was used as a control. The activity of AP1 was shown to
decrease by 40% upon irradiation. This eﬀect was observed
only for azobenzene-modiﬁed AFosW. Flow cytometry-based
determination of living/dead cells ratio’s excluded possible
eﬀects of UV phototoxicity. Ease in uptake of XAFosW,
combined with the diversity of the colied coil targets, renders
this approach a general strategy for the eﬀective control of a
broad range of activities in living systems.
Another interesting example showed photocontrolled pep-
tide binding to Bcl-xL (B-cell leukemia) proteins, which are
overexpressed in many cancer cells and inhibit apoptosis. The
photoresponsive peptides were based on the Bcl-xL-binding Bak
and Bid proteins. The azobenzene switch 42 (Figure 37) was
Figure 40. Reinforcing the native structure of DNA-recognition
elements. (a) Structures of MyoD and PhotoMyoD. (b) Model of the
complex between DNA and cis-photo-MyoD. Reprinted with
permission from ref 210. Copyright 2005 Wiley-VCH Verlag GmbH
& Co. KGaA.
Figure 41. Models showing the photocontrol of DNA binding by azo(i, i + 7) GCN4-bZIP. In the trans conformation, the cross-linker induces a
bend in the helix, which destabilized folding and consequently DNA binding (left). In contrast, the cis conformation of the cross-linker is compatible
with zipper formation and thus DNA binding (right). Reprinted with permission from ref 178. Copyright 2006 American Chemical Society.
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used as a cross-linker in three diﬀerent examples at i, i + 4, i, i +
7, and i, i + 11, respectively. The trans conﬁguration of the
azobenzene units in Bidi+4 and Baki+7 destabilized the helix
structure, preventing binding to Bcl-xL. Photoisomerization of
the switch to this cis form resulted in a 20-fold increase of the
binding aﬃnity of Bidi+4 and Baki+7. However, the photo-
isomerization of the azobenzene in Bak1+11 had little eﬀect on
binding aﬃnity (Table 7).213
An alternative approach for the introduction of azobenzene-
based photochromic cross-linker into peptides has been
reported recently by Beyermann and co-workers.214 This
methodology relies on the introduction of vinyl-azobenzene-
substituted amino acids, dubbed photoswitchable click amino
acids (PSCaa), into the sequence of the peptide, during solid
phase peptide synthesis. Additionally, cysteine residues were
introduced in the i + 4 position, enabling cross-coupling with
the vinyl group of the PSCaa via a light-induced thiol−ene
reaction (Figure 43). This approach results in the selective
formation of a photoresponsive bridge within a peptide and can
therefore be used in vivo. This is an advantage as compared to
the methods relying on cross-linking with activated compounds
41−52 (Figure 37), which may react nonspeciﬁcally with other
reactive thiols present in the cells.
This methodology was used for the control of the α-helix
formation in an artiﬁcial helical linker that connected the two
binding sites of urocortin-1 (Ucn). Ucn is an endogeneous
peptide that targets the CRF-R1 receptor responsible for the
response to stress and is involved in numerous diseases.215 The
cross-linked peptide elicited a disorded conformation that
switched to the α-helix upon photoisomerization of the
azobenzene unit to the cis state following the irradiation at λ
= 360 nm. The hybrid system, composed of the C- and N-
terminal Ucn binding sites connected with the photoresponsive
azobenzene unit, has been shown to be roughly ten times more
Figure 42. (a) Photocontrolled enhancement of helicity in an azobenzene-cross-linked, AP-1 dominant negative peptide XAFosW results in coiled-
coil formation with cJun protein, thereby inhibiting DNA binding. (b) Eﬀect of photoirradiation on cellular AP-1 activity in XAFosW-transfected
cells. Reprinted with permission from ref 212. Copyright 2010 Wiley-VCH Verlag GmbH & Co. KGaA.
Table 7. Dissociation Constants to Bcl-xL for Three Diﬀerent
Unmodiﬁed and azo-Modiﬁed Peptides213,207
KD (nM)





parent 134 ± 16 328 ± 19 117 ± 48
dark-adapted 825 ± 157 21 ± 1 1275 ± 139
irradiated 42 ± 9 48 ± 10 55 ± 4
Figure 43. Cross-linking of amino acid residues using the thiol-click
reaction. Reprinted with permission from ref 214. Copyright 2012
Wiley-VCH Verlag GmbH & Co. KGaA.
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eﬃcient in inducing the receptor activation in the cis form as
compared with the nonirradiated sample, although the activity
was 4 orders of magnitude lower than that of unmodiﬁed Ucn.
The helical structures discussed here illustrate the progress in
the understanding of photocontrol of peptides. It is also evident
that the introduction of a photoswitchable unit by cross-linking
holds great promise, as this approach retains the modularity
inherent in peptidic systems. That is, the photoswitchable unit
can be inserted in a number of sequences and at a number of
positions without disturbing folding until the proper wave-
length of light is used. We eagerly await attempts at applying
these photoactive and biologically relevant hybrid systems in
living organisms.
3.5. Concluding Remarks
The application of the ﬁrst of the methods described here, i.e.
the preparation of peptide polymers with photoresponsive
amino acid residues, demonstrates the feasibility of photo-
controlling peptide structures by switching photochromic
molecules. The eﬀect of the photoisomerization on the peptide
backbone is, however, usually small and depends heavily on the
experimental conditions (solvent, pH, temperature) and
number of chromophores present. Furthermore, the use of
photoactive peptides in a biological context is limited so far, as
these approaches seem to be focused more toward the
applications in material sciences.
Incorporating a photochromic switch in the backbone of a
peptide or by cross-linking the side chains of a peptide resulted
in more dramatic photoresponsive eﬀects on peptide
conformation. The most relevant structures in proteins (α-
helix, β-turn, β-hairpin) could be induced or distorted upon
irradiation of a photoswitch incorporated in the peptide.
Moreover, the approaches allowed for time-resolved ORD-, IR-,
and UV-studies showing, in most cases, an initial fast
photoisomerization of the chromophore followed by a
considerably slower reorganization of the peptide backbone.
These approaches also retain the modularity inherent in amino
acid-based systems, allowing for the chromophore to be
introduced at a number of positions with a range of structural
eﬀects.
A long-term goal of producing eﬃcient light-sensitive
peptides is complete photocontrol of conformation, allowing
for “on−oﬀ” switching of biologically relevant molecular
recognition events. This could enable scientists to investigate
the role of certain proteins in living systems or to create
photoresponsive biomaterials, such as light induced cell
adhesion on surfaces. However, switching between completely
ordered and disordered peptides has been shown to be
challenging, though many of the above systems are very well-
behaved. The eﬀects of limited conformational control on
peptide interactions in living systems remain to be seen. The
use of additional switchable units could induce larger
conformational changes, though it can be complicated to
introduce these units without disrupting the proper peptide
conformation too much.
Alternative photoswitches are also needed in order for the
photoresponsive peptides to be more useful for in vivo
applications. Irradiating cellular systems with UV light, for
instance, can lead to unwanted side reactions such as DNA
cross-linking. The use of longer switching wavelengths, such as
near-infrared, will be necessary for deeper penetration of
tissues. The reducing intracellular environment and the
possibility of proteolysis must also be taken into consideration,
as these kinetic events may be diﬃcult to foresee.
Therefore, more eﬃcient molecular switches could be
designed and investigated, and hemithioindigo switches,187
overcrowded alkenes,216 or the improved azobenzenes
discussed in this review seem to be the most promising
follow-up candidates.
4. PHOTOREGULATION OF ENZYMATIC ACTIVITY
Biocatalysts with light-regulated properties have many potential
applications, which stem mainly from the possibility of
controlling enzymatic activity with high spatial and temporal
resolution. These applications include the following: signal
Figure 44. Three general strategies for the preparation of enzymes with photocontrolled activity: (a) The use of photoswitchable inhibitors; (b)
application of photoresponsive environments; (c) direct incorporation of molecular photoswitches into the protein.
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ampliﬁcation, diagnostics, biosensoring, optobioelectronics,
aﬃnity separations, and photodynamic therapy.
In the following section, an overview of the methods for the
preparation of light-addressable biocatalysts and the photo-
control of enzyme function will be presented, focusing on three
general methods:1 the use of photoswitchable enzyme
inhibitors (section 4.1, Figure 44a), the embedding of proteins
in photoresponsive environments (sections 4.2 and 4.3, Figure
44b), and the incorporation of molecular photoswitches into
the structure of biocatalysts (sections 4.4 and 4.5, Figure 44c).
4.1. Photoregulation of Enzyme Function by
Photoswitchable Inhibitors and Activators
The activity of enzyme eﬀectors depends strongly on their
structure and conformation, which inﬂuence the strength of
their interactions with the proteins. By incorporating molecular
photoswitches into enzyme eﬀectors (i.e., inhibitors and
activators), it is possible to alter enzyme properties with light,
thus altering activity. This part of the review focuses on the
more recent implementations of this approach (since the year
2000), with selected earlier examples. For attempts at regulating
enzyme activity with photoswitchable eﬀectors prior to 2000,
the reader is referred to an earlier, extensive review by Willner
and Rubin.1
Two main strategies were used in the design of photo-
switchable enzyme eﬀectors (Figure 45). One of them relies on
the incorporation of a photochromic moiety into the structure
of a known eﬀector (Figure 45a). The photoisomerization
would then change the properties of the compound, thereby
changing its interactions with the target protein. The second
approach (Figure 45b) is applicable in the situations where two
ligands within the eﬀector interact with two binding sites in the
target. Introduction of a photoisomerizable linker between the
ligands enables photocontrolled changes in the distance and
alignment between the active groups and, thus, results in
changes in the eﬀector activity.
The prospect of using photoswitchable inhibitors of the ﬁrst
type (Figure 45a) was recognized as early as in 1969, with a
series of reports from the group of Erlanger on the
photoregulation of various enzymes. The initial research221
focused on the use of compound 53 (Figure 46), a
photoswitchable inhibitor of acetylcholinesterase (AChE, E.C.
3.1.1.7). The design of 53 was based upon a known reversible
AChE inhibitor 54222 (Figure 46), that contains trimethylam-
monium ion in its structure. Both photoisomers of 53 were
shown to be active as AChE inhibitors. The diﬀerences in
activity, albeit reproducible and reversibly addressable, did not
exceed 20%, with the trans isomer being a slightly more potent
inhibitor.221 These results were followed up with a study on
using sunlight and darkness for photocontrolling AChE activity
with compound 55 (X = I) and a discussion on possible
biological implications of this phenomenon.223
In a follow-up report,224 the group of Erlanger used AChE
inhibitors 53 and 55 (X = Cl) for the photoregulation of the
electric potential diﬀerence across the excitable membrane of
cells from the electric organ of electric eels. This membrane
undergoes depolarization in response to carbamylcholine. This
interaction is inhibited by compounds 53 and 55. For both
compounds 53 and 55, the trans isomer was more eﬃcient as
an inhibitor, since at a given concentration the loss in
depolarization is considerably higher than in the case of the
cis form. The control experiments ruled out the inﬂuence of
irradiation on the membrane in the presence of carbamylcho-
line. This research was one of the ﬁrst examples of directly
aﬀecting a biologically relevant system with the use of
photochromic molecular switches.
An attractive approach to photoregulating enzymatic activity
with a photoswitchable cofactor molecule was reported by
Sisido and co-workers.225 In this method, a photochromic
NAD+ (nicotinamide adenine dinucleotide) analog 56 (Figure
47a) and its reduced form bound reversibly and with
photocontrollable aﬃnity to an NAD+-speciﬁc monoclonal
antibody. Using light, these compounds could therefore be
eﬃciently and reversibly removed from the reaction system.
This system was used for the control of a bienzymatic redox
reaction, in which an alcohol dehydrogenase (ADH) oxidizes
ethanol using 56 as a cofactor. The reduced cofactor was
regenerated by the diaphorase-catalyzed reduction of blue 2,6-
dichlorophenol-indophenol sodium salt, which yields a color-
less product, allowing for the spectroscopic monitoring (Figure
47b).
When compound 56 was in its trans state, binding to the
antibody was very strong and no conversion was observed in
the enzymatic reaction. Photoisomerization to the cis-56 state
recovered 72% of the activity as compared to a reaction without
the antibody added, and this phenomenon was shown to be
reversible.225 This system, while demanding in terms of
antibody preparation, is promising due to the very high
inﬂuence of photoirradiation on the observed biological activity.
Proteases are enzymes that have been targeted the most with
photoswitchable inhibitors. These approaches began in the
early nineties with reports from Smith and co-workers.226
Bifunctional compounds 57 and 58 (Figure 48), which consist
of a photochromic portion and a recognition moiety (aldehyde
or boronic acid) known to bind reversibly to the enzyme active
site, were prepared and used as photoswitchable inhibitors of
papain (E.C. 3.4.22.2), α-chymotrypsin (E.C. 3.4.21.2), and
subtilisin (E.C. 3.4.21.62). The results are summarized in Table
8.
Figure 45. Schematic representation of the two main strategies used in
the design of photoswitchable eﬀectors (gray) of enzymes (blue).
Figure 46. Photoswitchable and model inhibitors of AChE.
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Compound 57 was used as a photoswitchable inhibitor of
papain,226 an enzyme from the group of cysteine proteases. A
clear diﬀerence in eﬃciency in response to photoswitching was
reported (Table 8, entry 1), and the activity of the enzyme
could be reversibly altered over two irradiation cycles. In the
case of chymotrypsin, the addition of stabilizers (KCl and
Figure 47. Photocontrol of enzymatic acitivity by changing aﬃnity of a photoswitchable cofactor to an antibody:225 (a) the structure of cofactor 56;
(b) bienzymatic catalytic system.
Figure 48. Photoswitchable inhibitors of proteases.226−230
Table 8. Photocontrolled Inhibition of Proteases
entry enzyme inhibitor Ki trans Kicis trans PSS cis PSS ref
1 papain 57 2.1 μM 8.8 μM not given 83% 226
2 α-chymotrypsin 58 11 μMa 41 μMa not given 80% 226
3 subtilisin 58 0.9 mMa 1.4 mMa not given 80% 226
0.5 mMb 0.3 mMb
4 α-chymotrypsin 59 240 nM 130 nM 74% 73% 227
5 α-chymotrypsin 60 80 nM 40 nM 72% 54% 227
6 α-chymotrypsin 61 1200 nM 360 nM 68% 75% 227
7 α-chymotrypsin 62 3.0 μM 4.7 μM >95% >95% 228
8 α-chymotrypsin 63 10 μM 7 μM >95% 60% 228
9c α-chymotrypsin 64 >65 μM 16 μM >95% 78% 229
10c α-chymotrypsin 65 32 μM 13 μM >95% 93% 229
11c α-chymotrypsin 66 46 μM 10 μM >95% 68% 229
12c α-chymotrypsin 67 >108 μM 23 μM 93% 77% 229
13c α-chymotrypsin 68 >86 μM 17 μM 89% 90% 229
14c α-chymotrypsin 69 46 μM 8.5 μM 92% 89% 229
15c α-chymotrypsin 70 >60 μM 27 μM >95% 86% 229
16 m-calpain 71 45 nM 175 nM 83% 81% 230
17 m-calpain 72 40 nM 100 nM 77% 79% 230
aThese results were obtained with KCl and bovine serum albumin as stabilizers. bThese results were obtained with only bovine serum albumin as a
stabilizer. cIC50 values are reported in these cases.
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bovine serum albumin) was necessary to ensure enzyme
stability during the assay. For compound 58, again the inhibitor
in the trans state proved to be ∼4 times more potent (Table 8,
entry 2), and its reversible behavior was demonstrated.226
Interestingly, when the photocontrolled inhibition of subtilisin
with 58 was studied, opposing eﬀects of irradiation on the
activity were reported in the presence and in the absence of
stabilizers (Table 8, entry 3). However, no explanation was
provided for this phenomenon.
Further developments in photocontrolled inhibition of α-
chymotrypsin were presented by the group of Abell in a series
of reports (Table 8, entries 4−15).227−229,231,232 All of the
studied compounds incorporated azobenzene in their structure,
linked to a phenylalanine that orients the compounds in the
active site. Additionally, a reactive electrophilic group (such as
ketoester, triﬂuoromethyl ketone, aldehyde, or boronic acid), to
which the catalytic serine of the enzyme reversibly binds (a so-
called “warhead”), is also attached. Initially,227 α-ketoesters 59−
61 (Figure 48) were used to serve the role of the “warhead”
(Table 8, entries 4−6). While the reported photostationary
states for both isomers were low, an over 3-fold change in
enzymatic activity upon irradiation was reported. The
preparation228 of inhibitors with a boronate ester moiety as
the warhead was subsequently presented. Two of these
derivatives, unsubstituted inhibitor 62 and its analog 63 with
an amino acid residue added to increase its peptidic character,
were used in a photocontrolled inhibition study (Table 8,
entries 7 and 8). While the photostationary states were
generally high, a low and irreproducible level of activity change
Figure 49. Photocontrolled binding of α-chymotrypsin to a gold surface. (a) The structure of the inhibitor 73. (b) Reversible protein binding. (c)
left graph: binding of the enzyme to a nonirradiated surface (see explanation in the text); right graph: reversible photocontrol of enzyme binding at
2.0 μM protein concentration; 1: nonirradiated surface; 2: UV-irradiated surface; 3: surface irradiated subsequently with UV and visible light.
Reprinted with permission from ref 232. Copyright 2007 American Chemical Society.
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upon irradiation was reported, which was explained by the
possible degradation of boronate ester upon irradiation.228
To overcome this hurdle, the triﬂuoromethyl ketone was
used as a “warhead” in the follow-up design (compounds 64−
70, Figure 48).229 In some of the molecules, a sulfonamide
linker was used instead of the amide, to increase the proteolytic
stability of the inhibitor. Additionally, in some compounds,
halide substituents were included in the 4′ position of the
azobenzene structure to increase its bulkiness. The photo-
chromic molecules could be switched with UV light (λ = 320−
380 nm) from trans isomers (PSS > 89%) to cis isomers (PSS =
68−93%) with high selectivity (Table 8, entries 9−15).
Compound 67, a sulfonamide derivative with a bromo-
substituent, proved to be the most eﬀective photoswitch with
an >4.7-fold change in activity upon photoirradiation.
An interesting extension of the designed inhibitors was
reported more recently by Abell and co-workers.231,232
Immobilization of a photoswitchable inhibitor 73 (Figure
49a) on a gold surface allowed photocontrol over protein
binding (Figure 49).232 The structure of compound 73 was
derived from a previously published inhibitor of α-chymo-
trypsin (64)229 with a substituted tetraethylene glycol chain,
bearing a terminal acetylene residue. This residue was used for
the attachment of compound 73 to an azide-decorated gold
surface via CuI-catalyzed azide−alkyne cycloaddition.
Compound 73 was ﬁrst studied in solution and showed a
reversible change in activity upon irradiation, giving the Ki
values of >51 μM for the trans isomer (92% PSS) and 14 μM
for the cis isomer (85% PSS).232 After immobilization of
compound 73 on a gold surface, the photocontrolled binding of
α-chymotrypsin to the surface was studied by SPR (Figure
49c). In the initial experiments, the enzyme was bound to the
nonirradiated surfaces at diﬀerent concentrations (Figure 49c,
left graph, enzyme injection at t = 70 s, binding time 300 s,
washing time 300 s) and the concentration-dependent response
was recorded. This showed that the surface with trans-73
attached was able to bind the protein. In the following
experiment, the surface was irradiated with UV light and the
enzyme binding was repeated at 2.0 μM protein concentration
(Figure 49c, right graph). A reversible inﬂuence of irradiation
was recorded with the UV irradiated surface being more
eﬃcient in protein binding. Subsequent attempts to optimize
the structure of the photoswitchable inhibitor failed to provide
a more pronounced eﬀect.231
An important structural insight into the change of activity of
protease inhibitors upon irradiation came from a report230 on
the use of photoswitchable dipeptide aldehydes 71 and 72
(Figure 50). These compounds are inhibitors of m-calpain
(E.C. 3.4.22.17), a Ca2+-dependent cysteine protease implicated
in the development of cataracts.233 In both cases, the extended
trans isomer proved to be more potent (Table 8, entries 16 and
17). This observation was explained by the results obtained
from molecular modeling (Figure 50), showing that the peptide
portion of the inhibitor binds in an extended β-strand
conformation, while the trans-azobenzene moiety extends
deep into the S3 binding pocket. The photochromic unit in
its cis form, on the other hand, has an unfavorable interaction
with the hydrophobic patch on the mobile loop that deﬁnes the
calpain active site.230 This model provides a structural
explanation for the light-induced diﬀerences in activity of
these photoswitchable enzyme inhibitors (Figure 50a).
Bis-azobenzene-based compound 74 (Figure 51a), a photo-
chromic inhibitor of bovine heart mitochondrial NADH
ubiquinone oxidoreductase (complex I), was studied by
Miyoshi and co-workers.234 Its design was inspired by the
inﬂuence on activity of the aromatic substitution pattern of
known inhibitor 75 (Figure 51a).235 Compound 75, with both
n-butyl groups in the para position, was a potent inhibitor of
mitochondrial complex I with an IC50 value of 0.83 nM.
234
When these groups were both present in the ortho position, no
inhibition activity was found. Upon the basis of these
observations, compound 74 (Figure 51a) was prepared, in
which the relative position of the n-butyl groups with respect to
the tetrahydrofuran moieties could be changed upon photo-
irradiation. The inﬂuence of the photoswitching on the activity
of the inhibitor is presented in Figure 51b.
The reversibly photocontrolled inhibition of mitochondrial
complex I activity was shown at two diﬀerent concentrations of
the inhibitor; albeit, the changes were relatively small. The low
photostationary state of cis,cis-74 in bovine heart submitochon-
drial particles and its possible residual activity were suggested as
the explanation for the unsatisfactory level of photocontrol.
König and co-workers used a diarylethene derivative 76
(Figure 52a) for the photocontrolled inhibition of human
carbonic anhydrase I (hCAI).236,237 This approach and the
others described below are examples of the second type of
inhibitor design (Figure 45b), in which two ligands in the
eﬀector are connected by a photoswitchable linker. Inspired by
literature reports,238 the diarylethene scaﬀold was function-
alized with a sulfonamide group that acts as an inhibitor and
with a copper(II) iminodiacetate moiety that reversibly
coordinates to the imidazole side chains of the histidine
residues in the active site of the enzyme.
Photoisomerization of 76 was achieved by irradiation with
312 nm light and yielded a very high photostationary state of
>99%.236 The closed form was found to be highly thermostable
and could be converted back to the open form by irradiation
with visible light. The inhibition study (Figure 52b) showed
that the open form was a much more potent carbonic
anhydrase inhibitor with an IC50 value of 8 nM. The closed
form shows an IC50 value of 400 nM, and its activity is similar
to the one of a known inhibitor, sulfanilamide. These
diﬀerences in activity were attributed to geometrical constraints
in the closed form.
Control experiments, performed with symmetrically sub-
stituted compounds 77−79 have shown that compounds 77
and 78, which include the structural elements of 76, also inhibit
the enzyme, albeit with activities lower than that of
sulfanilamide. Photoisomerization had no eﬀect on activity.
The lack of activity of compound 79 showed that the
diarylethene moiety has no inﬂuence on the enzyme.236 In
Figure 50. (a) Induced-ﬁt overlay of the S3 subsite of calpain with
docked trans-72 (blue) and cis-72 (red); (b) Structures of compounds
71 and 72. Reprinted with permission from ref 230. Copyright 2007
American Chemical Society.
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the follow-up report,237 the activity of compounds 76−79 was
assayed on a set of ﬁve physiologically relevant isoforms of
carbonic anhydrase. It was shown that, for select isoforms,
photocontrolled inhibition with symmetrically substituted
compounds 77−79 was also possible.
The strategy of designing bifunctional eﬀectors in which the
distance and alignment of both moieties that interact with the
target enzyme is controlled with a photoswitchable group
(Figure 45b) was applied in a more systematic manner by the
group of Liskamp.239,240 The chosen target was the spleen
tyrosine kinase (Syk) protein. This protein takes part in a
number of signaling pathways in human cells, including the
high aﬃnity IgE receptor (FcεRI) signaling cascade. The γ part
of this receptor contains the immunoreceptor tyrosine-based
activation motif (ITAM peptide, 80, Figure 53a). When the
ITAM of FcεRI is phosphorylated, the Syk binds to it and
becomes activated, triggering a series of events in the cell. An
important feature of the ITAM−Syk interactions is its
divalency; that is, two motifs (epitopes) in the ITAM peptide
are recognized by the two SH2 domains in Syk (Figure 53b).
This opens the possibility of controlling Syk activation by
ITAM-analogs where the distance and alignment of the
epitopes are controlled by a photoisomerizable linker.
Compounds 81−84 (Figure 53a) were prepared, in which
the epitopes were separated with photoswitchable linkers of
diﬀerent lenghts. Their binding to Syk was examined using
SPR, and the obtained KD values are summarized in Table 9.
Photoirradiation of compound 81 resulted in an over 10-fold
change in binding aﬃnity to Syk (Table 9, entry 1). This was
attributed to the change in the length of the linker, which forces
the activator to shift from a divalent interaction to a
monovalent one. The authors note, however, that the KD
value for the cis isomer still diﬀers from the one observed for
the pure monovalent interaction (KD = 27 μM). They attribute
this to the ﬂexibility of the linker that exists between the two
SH2 domains in Syk.239 This ﬂexibility allows Syk to adopt
diﬀerent conformations and adjust its geometry to the demands
Figure 51. Photocontrolled inhibition of mitochondrial complex I. (a) The photoresponsive inhibitor 74 and its parent structure 75; (b) the changes
in the activity of NADH oxidase, incubated with 74, upon alternating photoirradiation with UV and visible light. Two concentrations of 74 were
studied: 9.6 nM (dark gray bars) and 96 nM (light gray bars). Reprinted with permission from ref 234. Copyright 2006 American Chemical Society.
Figure 52. Photocontrolled inhibiton of human carbonic anhydrase I. (a) The structure of the inhibitors. (b) Activity proﬁle; (blue circles) 76 in an
opened form; (red squares) 76 in a closed form; (black diamonds) sulfanilamide, a known inhibitor of human carbonic anhydrase I. Reprinted with
permission from ref 236. Copyright 2008 Wiley-VCH Verlag GmbH & Co. KGaA.
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of the ITAM-analog. The inﬂuence of the ﬂexibility of the
ITAM-analog itself also cannot be excluded.239
In the follow-up study,240 compound 82 (Figure 53a), a
truncated analog of 81, was prepared and tested, showing a very
large change in activity upon photoirradiation (Table 9, entry
2). Since compound 82 binds Syk more strongly in its trans
conﬁguration and it was impossible to reach high PSS levels of
cis isomer upon photoirradiation, complete on−oﬀ photo-
control could not be achieved. Therefore, two more analogs, 83
and 84 (Figure 53b), were prepared. These analogs were
designed to better ﬁt to the SH2-SH2 domains distance (14.1−
16.4 Å) in their cis states. While this aim was achieved (Table 9,
entries 3 and 4), the diﬀerences in activity upon photo-
isomerization were considerably lower than in the case of
compound 82, indicating that not only distance constraints are
important.240
Figure 53. Photocontrolled activation of spleen tyrosine kinase.239,240 (a) The structure of inhibitors 80−84. (b) Schematic representation of
ITAM−Syk interactions. Adapted with permission from ref 239. Copyright 2008 Elsevier B. V.
Table 9. Photocontrolled Binding of ITAM-Analogs to the
SH2 Domains of Spleen Tyrosine Kinase240
trans cis
entry compd epitope dist KD (nM) epitope dist KD
a (nM)
1 81 18.6 Å 65 ± 8 7.2 Å 860
2 82 12.0 Å 91 ± 10 6.2 Å >10 000
3 83 23.4 Å 196 ± 35 11.0 Å 147
4 84 30.2 Å 77 ± 13 17.8 Å 49
aThese values were calculated for pure cis isomers, assuming 66% PSS
in the real samples.
Figure 54. Photoswitchable supports used for the immobilization of enzymes.241−244
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In summary, the use of photoisomerizable ligands for the
photocontrol of enzymatic activity is a valuable tool, which has
yet to show its full potential in in vivo studies. The results
published so far usually show small change in activity upon
irradiation, especially for designs of the ﬁrst type (Figure
45a).221,224,226−229 The second approach (Figure 45b) seems to
be more promising in terms of photocontrol236,237,239,240 but is
restricted to divalent systems. While the use of photo-
isomerizable eﬀectors is facile from an experimental point of
view, requiring less eﬀort than the site-selective, covalent
incorporation of photochromic residues into enzymes (see
sections 4.4 and 4.5 of this review), it is considered a drawback
that it has lower othogonality toward the other elements of the
studied systems. The eﬀector compounds may inﬂuence other
proteins present in living systems. Furthermore, the introduc-
tion of a photoswitch unit into the structure of the eﬀector can
have a considerable eﬀect on activity and often lowers the
aﬃnity to the enzyme.
4.2. Photoresponsive Immobilization Supports
One of the ﬁrst attempts toward regulation of enzymatic
activity by light was based upon the immobilization of a
biocatalyst in a membrane that had been modiﬁed by the
incorporation of molecular photoswitches. The group of Suzuki
reported241 the preparation of a collagen membrane modiﬁed
by spiropyran residues that underwent reversible isomerization
by irradiation with visible light (Figure 54). Urease (E.C.
3.5.1.5), an enzyme that hydrolyzes urea to ammonium ion and
bicarbonate, was entrapped in the photoresponsive support and
cross-linked with glutaraldehyde.
The study on the activity of the resulting immobilized
enzyme revealed that, in the dark, the kcat value was almost
twice as high as under visible light irradiation, while the KM
value remained virtually unchanged. Diﬀusion of urea and
ammonium ion through the membrane was reported to be the
rate limiting step in this system.242 However, more detailed
studies on the spiropyran-modiﬁed membrane revealed only a
slight diﬀerence of diﬀusion coeﬃcients of these compounds in
the dark and under irradiation. Therefore, the lack of change in
the KM values upon isomerization of the photoswitch led to the
conclusion that the diﬀerence in enzymatic activity was not
caused by the diﬀerences in diﬀusion. Instead, it was proposed
that, in the dark, the spiropyran residue is charged, which
results in the formation of hydrophilic microenvironment
around the enzyme, increasing its activity. A shift in the
optimum pH of the enzyme upon irradiation of the
immobilized enzyme was also reported.242
The concept of using photoresponsive supports for the
immobilization of enzymes has been further explored by the
group of Willner.243 The immobilization of α-chymotrypsin
(E.C. 3.4.21.1) was carried out by radical copolymerization of
acrylamide, N,N′-methylenebis(acrylamide) (as a cross-linker)
and photoswitchable azobenzene derived monomer (up to 1%)
in the presence of the enzyme (Figure 54). A strong inﬂuence
of the concentration of the photochromic component on the
activity of immobilized enzyme has been observed. At higher
loadings (0.75−1.0%), no diﬀerence in the enzymatic activity
could be observed upon irradiation by light. However, when
0.5% of the photoswitch was used in the polymerization
mixture, the change in activity of the immobilized biocatalyst
upon irradiation exceeded 90%. Further studies revealed that
the polymer in its trans state is virtually impermeable with
respect to the substrate as opposed to the cis state. This eﬀect is
considered to be at the origin of the diﬀerence in the rate of
product formation.
Subsequently, a variety of diﬀerent polymers were applied as
immobilization supports (Figure 54).244 In all cases, complete
and reversible control over enzymatic activity was obtained
after optimization; that is, the immobilized biocatalyst was
active in one photostate of the switch and inactive in the other.
Furthermore, it was estimated that ∼100−200 cycles of
enzyme-switchable activities can be achieved prior to
degradation of the polymers. Permeability studies using a
ﬂow-dialysis cell conﬁrmed that in all of the studied cases the
change of polymer permeability upon irradiation was
responsible for the observed eﬀects of light on enzymatic
activity.
The preparation of photoresponsive immobilized biocatalysts
is an interesting approach that gives remarkably good results
with respect to the degree of changes in enzyme activity upon
irradiation. It is, however, mainly dependent on the changes in
permeability of the support toward the substrate, which might
limit this methodology to selected cases.
4.3. Photoresponsive Surfactants
Photoisomerization of photoresponsive surfactants results in
changes in their polarity. This can eﬀect electrostatic
interactions with proteins, allowing for the manipulation of
their structure and activity.245,246 A representative example for
such an approach is presented below.
The group of Lee studied the changes in bovine serum
albumin (BSA) structure in response to the increasing
concentration of the trans and cis forms of azobenzene-based
photoswitchable surfactant 85 (Figure 55a) that interact with
the anionic residues on the surface of the protein.247,248
Four distinct protein structures have been observed using
small-angle neutron scattering (SANS) (Figure 55b), and their
distribution was strongly dependent on the concentration of
the cationic surfactant 85. Compound 85 was shown to have
diﬀerent eﬀects on the structure of BSA in its trans and cis
forms (Figure 55b). In general, the UV-irradiated samples
showed weaker inﬂuence of increasing surfactant concentration
on protein unfolding, as the cis from of the azobenzene is less
hydrophobic. At a ﬁxed concentration of 85, the changes of
Figure 55. Use of photoresponsive surfactant for the control of BSA
structure. (a) The structure of the photoresponsive surfactant. (b) The
inﬂuence of the concentration of surfactant in both forms on the
tertiary structure of bovine serum albumin. N: native heart-shaped
structure; Nd: distorted heart-shaped structure; F: partially unfolded;
E: elongated. Reprinted with permission from ref 248. Copyright 2006
American Chemical Society.
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protein structure in response to the photoisomerization were
shown to be reversible.247
Having established the proof of principle for the photo-
control of BSA folding/unfolding behavior, the group of Lee
also used photoswitchable surfactant 85 for the control of the
enzymatic activity of lysozyme (E.C. 3.2.1.17),246 an enzyme
responsible for damaging bacterial cell walls (Figure 56a).
The kinetic analysis of lysozyme activity in the presence of
0.2 mM 85 has revealed reversible changes in enzymatic activity
upon irradiation (Figure 56b). Interestingly, the activity was
increased ∼5-fold when the surfactant was in its more
hydrophobic, trans form and the protein was unfolded to a
greater extent. The sample irradiated at 350 nm exhibited
enzymatic activity comparable to that of the sample without
Figure 56. Use of photoresponsive surfactant for the control of lysozyme structure and activity. (a) In vitro conformations of lysozyme determined
from shape-reconstruction analysis of the SANS data at diﬀerent concentrations of photoresponsive surfactant 85 in trans and cis forms. Best-ﬁt
structures are shown in blue, and consensus envelopes are shown in red. The arrows in the upper part show the active-site cleft between α and β
domains. (b) Photoregulation of lysozyme activity with the reaction initiated with trans-85 (upper) and cis-85 (lower). The arrows indicate the
initiation of irradiation. Reprinted with permission from ref 246. Copyright 2007 American Chemical Society.
Figure 57. Compounds used for the random, semirandom, and directed incorporation of molecular switches into the structure of
enzymes.47,48,249−256,264,265,285−289,291
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surfactant. This eﬀect has been explained by the introduction of
additional ﬂexibility in the partially unfolded enzyme, which
promotes conformational changes along the reaction path-
way.246 However, additional experiments need to be performed
to gain insight into this intriguing dynamic eﬀect.
The use of photoresponsive surfactants for the photocontrol
of enzymatic activity is a simple solution, which may even lead
to the establishment of “superactivity”,246 i.e. the formation of
enzymes with increased catalytic properties as compared to the
native proteins. However, it is diﬃcult to envisage the
application of this protocol for the control of activity of a
biocatalyst in living systems without aﬀecting other enzymes/
proteins present in the studied system. This, together with the
potential disturbance of biological membranes by added
surfactants, currently limits these studies to fundamental
investigations of surfactants and proteins.
4.4. Random Incorporation of Molecular Switches into the
Structure of Enzymes
The ﬁrst reports on the random incorporation of molecular
photoswitches directly into the structure of biocatalysts date
back to the mid-1970s. Erlanger and co-workers studied the
incorporation of azobenzene derivative 86 (Figure 57) into
chymotrypsinogen A.249 The modiﬁcation had to be done at
the proenzyme stage, since activated chymotrypsin lost about
75% of its activity upon attachment of the photoswitch. The
level of incorporation of 86 into the proenzyme was estimated
by UV/vis measurements to be one switch molecule per
biocatalyst. The exposure of the modiﬁed chymotrypsinogen A
to trypsin released the activated, photoresponsive π-chymo-
trypsin. Kinetic studies revealed that it had similar KM values to
those of the unmodiﬁed enzyme, while the kcat was increased 4
times. Upon irradiation with 330 nm light, activity was reduced
2-fold. It was suggested that the increase of activity upon
modiﬁcation with the photoswitch is allosteric in nature.
The group of Suzuki250 described the random modiﬁcation
of urease with spiropyran residues and subsequent immobiliza-
tion of the photorosponsive biocatalyst. Nucleophilic groups on
the enzyme surface were modiﬁed using spiropyran anhydride
87 (Figure 57). The biocatalyst was subsequently puriﬁed and
immobilized on a collagen support. It was shown that the
enzyme retained 62% of its activity after UV irradiation and that
this eﬀect was derived from changes in kcat values, as the KM
remained the same. This observation was explained by the
interactions of the charged merocyanine with one of the
intermediates of the enzymatic reaction. A shift of the optimum
pH upon irradiation was also observed, but only in the case of
immobilized enzymes and not for soluble catalyst. Interestingly,
the immobilized enzyme modiﬁed with photoresponsive
residues showed higher thermostability than the unmodiﬁed
one. This observation was attributed to hydrophobic
intermolecular interactions between spiropyran moieties
attached to an enzyme molecule.
A similar approach was used47,48 for the preparation of
photoresponsive α-amylase (E.C. 3.2.1.1). Compound 87 was
employed for the random incorporation of spiropyran residues
via the amino groups of lysine side chains present in/on the
biocatalyst. The modiﬁed protein was puriﬁed from unreacted
protein with a DEAE-Sephadex column. It was shown that, on
average, two amino groups in the enzyme were conjugated with
the photoswitch. The incorporation was further conﬁrmed by
UV/vis spectra and isoelectric point measurements. The
photoresponsive α-amylase showed a 36% decrease in activity
upon UV irradiation, and the activity was fully recovered upon
incubation in the dark. The pH optimum shifted by
approximately 0.5 units upon photoswitching. Kinetic analysis
showed that the UV irradiation results in a change in the KM
value of the enzyme, and it was hence concluded that the
reduced aﬃnities of enzymes toward the substrates were
responsible for the observed changes of enzymatic activity upon
irradiation. This methodology was also applied to other
hydrolytic enzymes: α-chymotrypsin, β-glucosidase (E.C.
3.2.1.21), and β-amylase (E.C. 3.2.1.2).251 The results of the
studies are summarized in Table 10. The enzymes modiﬁed
with spiropyran derivative 87 showed up to 87% change in
activity (in case of β-amylase), and the eﬀect in all cases
originated from the diﬀerence in the change of aﬃnity of the
enzymes to the substrates upon photoirradiation.
Willner et al. have expanded the methodology of random
introduction of photoswitches into the structure of the protein
by optimizing the structure of the switch.252 Various
carboxyazobenzene isomers 88−90 (Figure 57), in the form
of activated esters, were introduced into lysine residues of
papain (E.C. 3.4.4.10) and were tested for their inﬂuence on
enzymatic activity. The enzyme modiﬁed with para-substituted
compound 90 was examined in more detail, as it showed the
least loss in activity upon modiﬁcation. The average eﬃciency
for the attachment of switch units was estimated by UV/vis
measurements to be about 54%; that is, on average 5 out of 10
lysine residues present in the protein structure were modiﬁed.
The enzyme, immobilized in alginate beads, showed a
moderate, yet reversible, change in activity upon irradiation.
Kinetic measurements revealed that the KM value changed upon
switching of the system, while kcat remained virtually the same.
This phenomenon, characteristic for competitive inhibition, was
attributed to structural changes in the protein that inﬂuenced
substrate binding but did not disturb the active site itself. It was
also suggested that only the lysine groups exposed to the
solvent could be modiﬁed with compounds 88−90, which may
have resulted in a rather low level of photocontrol.
The photoregulation of the activity of α-chymotrypsin,
randomly modiﬁed with thiophenefulgide derivative 91, has
been compared in aqueous and organic medium.253 While in
water no diﬀerence in activity upon irradiation was observed, in
cyclohexane the enzyme exhibited a 5-fold increase in activity
upon photoswitching. The diﬀerence in photoresponse
between the two solvents has been explained by increased
perturbation of enzyme-bound water molecules in nonaqueous
media. Interestingly, the change in activity upon irradiation was
less pronounced when enzyme imprinting was been used, i.e.
when the biocatalyst was crystallized in the presence of its
substrate, prior to being used as a catalyst in organic medium.
This was explained by an increase in enzyme rigidity, which
Table 10. Kinetic Parameters of the Enzymes Modiﬁed with
Spiropyran Derivative 87251
relative activity KM (mM)





100 150 15 4.3
β-glucosidase phenyl-β-D-glucoside 100 115 4.0 3.3
α-amylase amylose 100 64 12 15
β-amylase amylose 100 13 3.4 60
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made the enzyme less susceptible to undergoing light-eﬀected
perturbation.
The ampliﬁcation of light signals using photoresponsive
enzymes, obtained by the method of random incorporation of
photoswitches, was reported by Willner and co-workers in the
mid-1990s.254 Spiropyran derivative 92 (Figure 57) was
introduced into the structure of glucose oxidase (E.C.
1.1.3.4), resulting in the modiﬁcation of, on average, 21 out
of 54 lysine residues. The modiﬁed enzyme showed roughly a
50% change in activity upon irradiation. The biocatalyst was
immobilized on a rough gold electrode (Figure 58).
The addition of an electron mediator, ferrocene carboxylic
acid, facilitated electron transfer between the enzyme and the
electrode. When the enzyme was in its active state, the
bioelectrocatalyzed oxidation of glucose proceeded at a higher
rate and an anodic current was recorded (Figure 58, curve a).
UV irradiation transformed the enzyme into a less active state
(Figure 58, curve b). The changes were reversible (Figure 58,
inset), although a drop of activity was observed. This slow
inactivation was attributed to the denaturation of the enzyme
caused by UV irradiation, seen to an even higher extent for the
photoswitch-modiﬁed but nonimmobilized enzyme. Although it
does not show a complete on−oﬀ control of activity, this
system represents one of the few reported direct applications of
photoswitchable enzymes.
Additional insights into the phenomena responsible for
changes in enzymatic activity upon irradiation were provided by
Cullen and co-workers, when studying the EDC-mediated
modiﬁcation of horseradish peroxidase (E.C. 1.11.1.7) with
spiropyran derivative 93 (Figure 57).255 The eﬃciency of the
incorporation of 93 depended on the reaction time for
conjugation, and a maximum of nine switching units per
enzyme could be introduced. The level of photomodulation
was strongly inﬂuenced by the amount of the introduced
photoswitches. The diﬀerence in activity before and after
irradiation with UV light was as high as 92% and was observed
when, on average, 8.5 dye molecules per enzyme were attached.
Interestingly, spectroscopy studies on the biocatalyst after
irradiation revealed that only two to three photoswitches were
in the merocyanine state. From these observations, it was
concluded that the inﬂuence of the dye on the enzyme activity
occurred via local interaction with the active site.
A semirandom approach toward the preparation of light-
responsive biocatalysts has been recently reported by Trauner
and co-workers.256 They introduced the photoswitchable
aﬃnity label (PAL) concept, which relies on the use of a
bifunctionalized compound (e.g., molecule 94, Figure 57) for
enzyme modiﬁcation. The enzyme chosen for this study was
bovine carbonic anhydrase II (E.C. 4.2.1.1), which, as has been
previously mentioned, is inhibited by sulfanilide. The PAL is
comprised of three parts: the ligand that binds noncovalently
into the enzyme active site, the photoswitch, and the reactive
group (arylsulfonamide, azobenzene, and epoxide moieties in
94, respectively). The binding of the ligand to the active site
allows the reactive group to conjugate to the most geometri-
cally available nucleophile on the enzyme surface (Figure 59).
The yield of carbonic anhydrase modiﬁcation with PAL 94
was estimated by LC-MS to be in the range 65−85%, and the
level of reversible photocontrol was measured to be 50%. MS/
MS studies revealed that 94 was introduced to positions H2
and H3. The relatively low value of photocontrol was explained
by the fact that these histidine residues are placed at the ﬂexible
N-terminus of the enzyme, which does not always reside in the
vicinity of the active site. The obtained data pointed also to an
important observation: the photostationary state of the
Figure 58. Eﬀect of photoirradiation on glucose oxidase immobilized on a gold electrode. Reprinted with permission from ref 254. Copyright 2007
American Chemical Society.
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azobenzene switch changes signiﬁcantly upon bioconjuga-
tion.256
In summary, the random introduction of photoswitchable
compounds into the structure of enzymes is a simple method
for the preparation of photoresponsive biocatalysts, which in
selected cases allows up to >90% change in activity upon
irradiation.255 Whole systems can easily be optimized with
regard to the structure of the photoswitch, although the control
over the position and number of introduced molecules is
statistical at best,255 leading to the formation of heterogeneous
mixtures of diﬀerently modiﬁed enzymes. The recently
introduced PAL approach256 might help to solve this issue.
The studies on photoresponsive biocatalysts revealed that the
change of activity upon irradiation is mainly caused by the
alteration of enzyme’s aﬃnity to the substrate (KM),
47,48,251,252
which is caused by the switching of compounds in the vicinity
of the active site252,255 or allosteric sites.249 The changes of kcat
value upon irradiation were also reported in a few cases.249,250
4.5. Site-Selective Incorporation of Molecular Switches into
Enzymes
Site-selective incorporation of molecular switches into enzymes
oﬀers the possibility of structure-based design and optimization
of photoresponsive bioconjugates. Three major approached
have been followed (Figure 60): (a) preparation of a modiﬁed
fragment of an enzyme and its subsequent attachment to the
remaining part of the protein (section 4.5.1); (b) introduction
of a reactive amino acid side chain at a chosen position and
subsequent modiﬁcation thereof with a a photochromic unit
(section 4.5.2); and (c) introduction of photoswitchable amino
acids during in vivo or in vitro synthesis of the enzyme (section
4.5.3).
4.5.1. De Novo Synthesis of a Part of the Enzyme. The
simplest approach uses standard peptide synthesis methods
(Figure 60a) for the de novo preparation of a terminal fragment
of a catalytically active protein. This step allows for convenient
introduction of the photoswitchable amino acid(s) at a chosen
position(s). The prepared fragment is subsequently conjugated
to the main body of the protein. This approach was ﬁrst
reported in the preparation of photosensitive phospholipase A2
(E.C. 3.1.1.4), an enzyme responsible for the hydrolysis of
phosphoglycerides.257 It is known that the α-helix conformation
of the N-terminal fragment of this enzyme plays a key role in
the action of the interface-recognition site, which is responsible
for anchoring the enzyme at the lipid−water interface.258
Therefore, the N-terminal region of the enzyme was a
promising candidate for the incorporation of photoswitchable
compounds in order to achieve photoregulation of the catalytic
activity.
Azobenzene-derived amino acid 97 (Figure 61) was
introduced into the 3-position of the N-terminal tripeptide of
phospholipase A2.
257 The modiﬁed tripeptide was further
transformed into a N-hydroxysuccinimidyl ester. In parallel, the
Figure 59. Use of PAL for the photocontrol of enzymatic activity.
Reproduced with permission from ref 256. Copyright 2008 Wiley-
VCH Verlag GmbH & Co. KGaA.
Figure 60. Methodologies used for the site-selective incorporation of molecular switches into the structure of enzymes (see text for description).
Chemical Reviews Review
dx.doi.org/10.1021/cr300179f | Chem. Rev. 2013, 113, 6114−61786152
fully amidated enzyme was subjected to three cycles of Edman
degradation, yielding a protein missing the ﬁrst three N-
terminal residues. The coupling of the activated tripeptide with
the truncated protein followed by the removal of protecting
groups yielded a catalytically active enzyme. CD studies
conﬁrmed that the α-helix content of the protein was higher
when the azobenzene was in its cis form, as compared to the
trans form. This change in structure was reﬂected in a diﬀerence
in activity, which was higher for the cis form of the
bioconjugate. The eﬀect was attributed to better anchoring of
the cis form at the lipid−water interface.
Another enzyme targeted with the semisynthetic method was
ribonuclease S. This RNA hydrolyzing biocatalyst is a variant of
ribonuclease A (E.C. 3.1.27.5, Figure 62) in which the amide
bond between residues 20 and 21 has been hydrolyzed, giving
rise to two parts: a smaller 20 amino acid S-peptide and a larger
S-protein. Separately, these two parts are catalytically inactive,
while it was shown that by noncovalent self-assembly they can
form an active catalyst.259 The S-peptide was conveniently
prepared using standard, Fmoc-based solid phase peptide
synthesis, opening the possibility of facile introduction of
unnatural, photoswitchable amino acids into its structure.
This approach was independently investigated by the groups
of Woolley261 and Hamachi.262 The ﬁrst of these reports
describes the modiﬁcation of positions 4, 8, and 11 of peptide
S, while the latter focuses on residues 1, 8, 13, and 16. In the
ﬁrst case,261 a strong inﬂuence of the positioning of
photoswitch 97 was observed, as the S-peptide modiﬁed in
the 8-position failed to produce an active enzyme upon self-
assembly with the S-protein, and the variant modiﬁed in the 11-
position showed no activity change upon irradiation. The
enzyme modiﬁed in the 4-position of the S-peptide, however,
showed 4 times more activity in the cis state, as compared to
the trans state. A strong inﬂuence of the incorporation site was
conﬁrmed by the study of Hamachi and co-workers.262 Small
changes in activity upon irradiation were observed for the
enzyme modiﬁed in the 1- and 16-position of the S-peptide.
Introduction of compound 97 into position 8 or 13 resulted in
a decrease of activity; albeit, for position 13 almost complete
(on−oﬀ) and reversible photocontrol was reported. The
observations were explained by the proximity of the
ribonuclease active site histidine H12.
In a follow-up study,263 Woolley and co-workers determined
the kinetic parameters of ribonuclease S with amino acid 97
introduced in positions 4, 7, 8, 10, 11, and 13. The results
indicated that the response to the photoswitching was a
combined eﬀect of peptide binding, substrate binding, and the
rate constant of the reaction. Furthermore, the observation of
Hamachi and co-workers262 of the complete photocontrol of
the enzyme activity in the case of the variant modiﬁed in
postion 13 could not be conﬁrmed experimentally. It has also
been disproved on the grounds of incomplete photoswitching
of the azobenzene derivative under the given conditions.
In summary, the de novo approach for the preparation of light
responsive biocatalysts oﬀers tantalizing possibilities, as it allows
optimization of the position of the photoswitchable amino acid
and, potentially, the photochromic unit structure. It is
particularly useful in situations where either an easy assembly
of the synthesized peptide and the remaining part of the
enzyme is possible261−263 or the N-terminus of the protein
requires modiﬁcation.257
4.5.2. Introduction of a Reactive Amino Acid Side
Chain into the Structure of the Enzyme. Another approach
to site-selective introduction of photoswitches into the
structure of enzymes takes advantage of reactive groups present
in naturally occurring amino acid side chains (e.g., the amine
group of lysine or thiol group of cysteine). Codons for these
amino acids can be introduced into the gene of the target
enzyme by site-directed mutagenesis methods (Figure 60b).
Upon expression of such genes, a mutant protein is synthesized
with the reactive groups present at the chosen sites. Chemical
modiﬁcation of these residues with a photoswitchable molecule
yields a photoresponsive enzyme.
This approach was used for controlling the ATPase activity
of kinesin,264 an ATP fueled motor that is responsible for many
cellular processes, including transport, cell division, and signal
transduction. Two loops in the protein, depicted L11 and L12,
are considered to be responsible for motility (Figure 63). Five
amino acid residues (Figure 63a, highlighted in white), located
within these loops, were separately mutated to cysteines,
resulting in ﬁve mutants modiﬁed with azobenzene derivative
95 (Figure 57).
The results obtained upon incorporation of photoswitches
into L11 depended strongly on the choice of the introduction
site. Proteins modiﬁed in position 252 lost ATPase activity,
which was explained by the fact that the neck region in the
vicinity A252 of L11 is important for ATP binding and signal
transduction. Modiﬁcation of position 247, which is farther
away from this site, did not aﬀect the native ATPase activity;
however, no signiﬁcant changes upon irradiation were detected.
Promising results were obtained upon modiﬁcation of residue
249, as the resulting bioconjugate showed a reversible
photoregulation of activity. The modiﬁcation of loop L12
Figure 61. Photoswitchable amino acids used for the preparation of
photoresponsive proteins.257,269,272,290
Figure 62. Structure of ribonuclease A. The N-terminal fragment,
which corresponds to the S-peptide in ribonuclease S, is shown in
detail. Adapted from coordinate data (1FS3)260 of bovine pancreatic
ribonuclease A from the protein databank, using PyMOL software.
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yielded a variant modiﬁed in position 272, which showed no
change in activity upon irradiation, and a variant modiﬁed in
position 275, for which roughly 50% photocontrol could be
measured, expressed as a diﬀerence in activity between the two
states.
A detailed explanation of the mechanism of photoswitching
could not be provided for loop L11, due to a lack of structural
information. For the mutations located in L12, it was suggested
that changes in activity were caused by a change in
hydrophobicity of the azobenzene unit in the trans and cis
states. The more polar cis photoisomer points away from the α4
hydrophobic cluster (Figure 63b), and in this respect, it more
resembles the side chain of serine, which is present in position
275 in the wild-type protein. On the other hand, the more
hydrophobic trans state can interact with the α4 cluster,
inducing the distortion of L12. This hypothesis was conﬁrmed
by the activity proﬁle, as the cis form was less active than the
wild-type yet more active than the trans form. Preliminary
experiments based on the introduction of spiropyran switches
were reported to be successful,264 further conﬁrming the
inﬂuence of polarity changes of the photoswitch in the two
photostates rather than simply changes in sterics and geometry.
Pingoud and co-workers also employed this methodology for
the preparation of modiﬁed restriction enzyme R.PvuII.265
PvuII is a homodimeric protein (Figure 64) that has in each
subunit a catalytic triad formed from D58, E68, and K70. After
the introduction of pairs of cysteine residues by genetic
modiﬁcation, the enzyme was cross-linked with photoswitch-
able, bifunctional compound 96 (Figure 57), which was later
dubbed a “molecular spring”. In the crude mixture, the
existence of partially modiﬁed or non-cross-linked proteins
was detected. Therefore, the proteins were subjected to
puriﬁcation by a series of chromatographic steps.
Extensive optimization of the modiﬁcation sites was
presented. Over 30 variants of PvuII with pairs of cysteine
residues introduced in selected places were tested for levels of
photoresponsiveness after modiﬁcation with a bridging
azobenzene unit. These variants included proteins with one
or two azo-linkers per enzyme. Additional mutations of residues
in the active site (H83 and Y94, Figure 64) and in the linker
region (L1, Figure 64) were also introduced. The best variants
showed a 16-fold change in activity upon photoswitching, and
the eﬀects were shown to be reversible. Cross-linking cysteine
residues introduced close to the active site (positions 49 and
62, Figure 64) as well as the introduction of an additional
mutation Y94F proved to be the most eﬀective to achieve
photocontrol of enzyme activity. Kinetic analysis of these
variants has shown small changes in binding aﬃnity (KM) and
considerable change in kcat upon irradiation, an eﬀect that can
be explained by the modiﬁcation of the active site
conformation.265
As an alternative to the “molecular spring”, which is useful for
smaller proteins, a “molecular gate” approach was proposed
recently for the photocontrol of the activity of a larger,
homodimeric restriction enzyme R.SsoII. This approach
exploits the fact that in many enzymes the active site is buried
behind an entrance or tunnel through which the substrates/
products diﬀuse. The “molecular gate” strategy relies on the
incorporation of molecular photoswitches at such an entrance
to the active site of an enzyme (Figure 65a) in an attempt to
change the binding of the substrate upon irradiation.266
Site-selective introduction of molecular photoswitches 99
and 100 (Figure 65b) was achieved by introducing cysteine
mutations into selected positions and subsequent modiﬁcation
using maleimide modiﬁed switches. Two mutations (C33S and
C60S, Figure 65c) had to be introduced to prevent the
modiﬁcation of naturally occurring cysteines with photo-
switches. This is an intrinsic problem for the strategy described
in this section, as the activated photochromic units cannot be
expected to react only with the active amino acid side chains
Figure 63. (a) Fragment of kinesin structure addressed by
mutagenesis; (b) Loop L12 of kinesin. Reproduced with permission
from ref 264. Copyright 2007 Oxford University Press.
Figure 64. Structure of R.PvuII. Residues shown in orange (D58, E68,
and K70) form the active site. Highlighted residues were used for
cross-linking with a bifunctional azobenzene photochromic unit 96
(see text). Reproduced with permission from ref 265. Copyright 2010
National Academy of Sciences, USA.
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introduced by mutagenesis but will also modify the active
residues that occur naturally on the surface of the protein.
Five sites were chosen for Cys mutation (Figure 65c), and a
library of 11 mutants was prepared, including ﬁve single-point
mutants and six combined variants. The assay, based upon the
hydrolysis of a model DNA substrate, revealed that
introduction of Cys residues close to the active site had a
detrimental eﬀect on the activity. Modiﬁcation of seven of the
most active mutants with compound 99 proceeded with up to
95% yield, and the highest level of photocontrol (2.4 ± 0.4),
expressed as a rate of the activity of the nonirradiated and
irradiated enzymes, was found for the R174C/A224C mutant
(Figure 65d). Kinetic analysis for this mutant revealed that it
had a 4-fold higher KM as compared to the wild-type, while the
Vmax was comparable. This observation is in agreement with the
“molecular gate” model presented in Figure 65a. In the next
step, the mutant S171C was coupled to the molecular
photoswitch 100 with a cysteine-derived amino acid terminus,
which was able to form chelates with Ni2+ and Co2+, thereby
stabilizing the closure of the gate. The level of photocontrol
increased from the value of 1.1 ± 0.1 to 2.2 ± 0.2 when 1 mM
NiCl2 was added, providing an initial conﬁrmation of the
“molecular gate” model.266
These examples show the possibilities oﬀered by the
introduction of a reactive amino acid side chain into the
structure of a peptide/protein and its subsequent modiﬁcation
with a photoresponsive compound. It enables both the
optimization of the switch anchoring position and, possibly,
the structure of the photoswitch. It is limited, however, by the
occurrence of natural reactive side chains on the surface of the
wild-type protein, which can in principle also be modiﬁed
during the bioconjugation, giving rise to unexpected results.
4.5.3. Introduction of Photoswitchable Amino Acids
during in Vivo or in Vitro Synthesis of the Enzyme. Two
methods have been used for the biosynthetic incorporation of
photoswitchable amino acids into proteins (Figure 60c): the
nonsense-suppression method (Figure 66a) and the frame-shift
suppression method (Figure 66b). The nonsense-suppression
method (Figure 66a), established by Schultz,267 relies on the
use of orthogonal tRNA-aminoacyl−tRNA synthetase pairs for
the suppression of the amber nonsense codon. The tRNA
synthetase, which is engineered in such a way that it is able to
acylate the tRNA with a unnatural amino acid, is expressed
within the host cell. The cells are grown in the medium that
contains the unnatural amino acid. Upon entering the cell, the
amino acid is ligated to tRNA, which can act as a nonsense
suppressor, allowing for the synthesis of a protein with
Figure 65. (a) “Molecular gate” approach for the photocontrol of restriction enzyme R.SsoII. (b) Molecular photoswitches used for the
photoregulation of R.SsoII activity. (c) Mutations introduced for the site-selective incorporation of molecular photoswitches. (d) Model of the
R174C/A224C mutant modiﬁed with 100. Reprinted with permission from ref 266. Copyright 2011 American Chemical Society.
Figure 66. Strategies used for the biosynthetic incorporation of
photoswitchable amino acids into proteins. (a) Nonsense-suppression
method. (b) Frame-shift suppression method (Adapted with
permission from ref 268. Copyright 1996 American Chemical Society).
UNAAunnatural amino acid. See text for detailed description.
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unnatural amino acid incorporated at the position where
normally the nonsense codon is present.
The frame-shift suppression method, pioneered by the group
of Sisido,268 uses a four letter codon tRNA, aminoacylated with
the unnatural amino acid, to compete with the natural, three
letter tRNA during the in vitro protein synthesis. Upon
successful use of the modiﬁed tRNA, the synthesis of the
protein is continued. If the natural tRNA is used by the
translation machinery of the cell, the stop codon is activated
and the biosynthesis stops (Figure 66b).
The frame-shift suppression methodology was ﬁrst used for
the preparation of photoresponsive horseradish peroxidase
(E.C. 1.11.1.7),269 an enzyme widely used in biochemistry for
signal ampliﬁcation. Sixteen variants of the enzyme were
prepared, with photoswitchable amino acid 97 (Figure 61)
introduced in various positions. Only four of the variants
retained up to 10% of peroxidase activity. This was explained by
unfavorable inﬂuence of compound 97 on protein folding after
introduction. One of these enzymes, modiﬁed in position 179
with the photochromic amino acid 97, showed complete (on−
oﬀ), reversible photoswitching. This was attributed to the close
proximity of position 179 to the substrate binding site,269
although no KM values were presented to support this
assumption.
The frame-shift suppression method also enabled the
preparation of modiﬁed restriction enzyme BamHI (E.C.
3.1.21.4) with a diﬀerent strategy used for the selection of
the introduction site.270 BamHI is a protein that is catalytically
active only in its dimeric state. This state is stabilized by the
formation of a salt bridge on the interface between two α-
helices that originate from the two monomers (Figure 67).
Three variants of BamHI were prepared, in which the
photoswitchable amino acid 97 was introduced at the dimer
interface in place of residues 132, 167, and 170. Incorporation
was determined to be 52%, 64%, and 43%, respectively. One of
the mutants, modiﬁed in position 132, showed a very high
(above 30-fold diﬀerence in enzyme activity) degree of
photoregulation, as its activity was almost completely sup-
pressed when the azobenzene moiety was in the trans state and
almost completely recovered upon UV irradiation. This result
was explained by lower steric hindrance for the dimer formation
process when the photoswitch was in the cis state. The other
two mutants, modiﬁed in positions 167 and 170, were inactive,
attributed to misfolding of the enzyme. Finally, a correlation
between the activity recovery and the irradiation time was
shown as a method to control enzymatic activity. Unfortu-
nately, the increase in activity upon UV irradiation was
irreversible, as the dimeric protein did not lose its activity
upon irradiation with visible light (436 nm).
In a follow up study, the group of Majima introduced amino
acid 98 (Figure 61), an analog of 97, into position 132 of
BamHI.272 Compound 98 has an additional carboxyl group in
the aromatic ring, which is ionized under the assay conditions,
and was expected to induce a local structural change in the
enzyme. Comparison of the light-mediated activity recovery in
mutants containing amino acids 97 and 98 revealed that the
presence of the carboxyl anion in the photoswitch promoted
the initial activation of the enzyme. This was rationalized by the
diﬀerence in steric interactions or by changes in the structure of
the interfacial region of the enzyme.
Site-selective introduction of photoswitchable amino acids
during in vivo or in vitro synthesis of enzymes is a powerful
method, which allows for the optimization of the position
within the enzyme in which the switch operates.270 It is free
from limitations of the previously described methods that rely
on the introduction and subsequent functionalization of a
reactive amino acid side chain, because there is no possibility of
undesired functionalization of residues important for enzymatic
activity. However, the optimization of photoswitch structure
and properties using this methodology is diﬃcult, as it requires
the development of new tRNA synthetase mutants (in the
nonsense suppression method) or preparation of aminoacylated
tRNA molecules (in the frameshift suppression method).
4.6. Incorporation of Natural Photoactive Domains
This method relies on the in vivo production of a chimeric
protein, which comprises the catalytically active part and the
natural photoactive domain, e.g. the light-oxygen-voltage
(LOV) sensitive domain of the photoactive yellow pro-
tein.273−277 Light-induced changes in the conformation of the
LOV domain inﬂuence the activity of the enzymatic component
of the chimeric protein. This purely biochemical approach lies
beyond the scope of this review and is only brieﬂy mentioned
here. It has been recently used for the photocontrol of such
enzymes as dihydrofolate reductase (E.C. 1.5.1.3),278,279
kinases,280,281 and GTPases,282 among others. It has also
been used for the photocontrol of DNA binding by
proteins.283,284
4.7. Concluding Remarks
The preparation of light-responsive biocatalysts remains a
major challenge which requires an interdisciplinary approach,
and as of yet no generic, widely applicable methodology has
been designed to achieve this goal. Diﬀerent strategies have
been employed, focusing either on the important role of precise
positioning, i.e. the introduction site,261,264,269 or on the
properties of the photochromic compound.272 It has been
shown that the sites in the biocatalyst structure, which can
successfully be addressed toward high activity photoregulation,
include the immediate surrounding of the active
site,252,255,256,263,265 the dimer interface,270,272 and the allosteric
site.249 The optimization of the attachment point is important,
as even small diﬀerences in the positioning of the photoswitch
may lead to substantial diﬀerences in photocontrol264,265 or
result in misfolding of the enzyme.270 Very good results were
obtained with switches that were able to bridge two reactive
sites in one enzyme.265
Figure 67. Fragment of BamHI with the salt bridge that stabilizes the
dimeric structure highlighted in color. Adapted from coordinate data
(1BHM)271 of Bacillus amyloliquefaciens BamHI from the protein
databank, using PyMOL software.
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The properties (structure, functional groups, hydrophobic/
hydrophilic nature) of the molecular photoswitch introduced
into the biocatalyst also play a crucial role. It has been shown
that changes both in geometry270 and in polarity264 upon
irradiation can be responsible for photocontrol of enzyme
activity. Even small changes in the structure of the photo-
chromic molecule may have strong impact on the eﬃciency of
photocontrol.272
While both the introduction site and the structure of the
photoswitch are key to success, most of the methods used for
the incorporation of molecular photoswitches into enzymes
allow for convenient optimization of only one of these features.
Site optimization can be performed using in vitro or in vivo
biosynthesis of the protein (section 4.5.3), while the structure
of the photoswitch can be easily altered in an approach where
the photochromic unit is randomly incorporated into the
enzyme (section 4.4). The method of introduction and
subsequent functionalization of reactive amino acid side chains
(section 4.5.2) seems to be the most generic with respect to
optimization studies.
In general, the following important observations can be
drawn from the studies reported in the literature. The
incorporation of a molecular photoswitch into the structure
of a protein may result in the loss of enzymatic activity269 and a
change in the PSS of the photoswitch.256 Most methods used
for the bioconjugation result in the formation of heterogeneous
mixtures48,249,251 in which enzymes with diﬀerent levels/
positions of introduced photochromic units are present. This
implies the use of laborious puriﬁcation steps.265 The
photoswitching eﬀect can be caused by the changes in both
substrate binding (KM)
47,48,251,252 and reaction rate
(kcat)
241,249,250,265 or by changes in both binding and rate,263
and it can depend on the polarity of the medium.253
To date, few successful examples of photoresponsive
enzymes exist in the literature.244,255,265,269 In some cases, a
complete, on−oﬀ control of activity has been reported,
although the enzyme activity was drastically reduced by the
incorporation of the molecular photoswitch.269 Nevertheless, a
generic methodology is still to be developed, and most of the
potential applications have not yet been tested and conﬁrmed,
leaving a breadth of space for novel approaches.
5. PHOTOMODULATION OF LIGAND BINDING BY
INCORPORATION OF MOLECULAR SWITCHES INTO
SOLUBLE PROTEINS
The incorporation of molecular photoswitches into proteins has
not only been used for the control of enzymatic activity. The
following section focuses on the photoregulation of protein
interactions with ligands.
The ﬁrst reports on the alteration of protein aﬃnity to small
molecules were focused on modiﬁcation of concavalin A, which
is a lectin, i.e. sugar-binding protein. Random modiﬁcation of
concavalin A with thiophenefulgide derivative 91 (Figure 57)
allowed for the photochemical control of the aﬃnity toward a
model ligand, 4-nitrophenyl α-D-mannopyranoside (Table
11).285
The loading degree, determined by UV−vis spectroscopy,
proved to have a crucial inﬂuence on the eﬃciency of
photocontrol. When all 12 lysine residues in the protein were
modiﬁed with photoswitches, no diﬀerence in ligand binding
was observed upon irradiation. At the average modiﬁcation of 9
and 6 lysines, the photoswitching eﬀect was detectable and the
aﬃnity could be repeatedly changed in time (Table 11).
The group of Willner studied the kinetics of binding of
concavalin A, modiﬁed with spiropyran derivative 92 (Figure
57), in monosaccharide-functionalized self-assembled mono-
layers.286 The derivatives of three diﬀerent sugars, α-D-
mannopyranose (101), α-D-glucopyranose (102), and β-D-
glucopyranose (103), were covalently bound to monolayers on
polished gold electrodes (Figure 68).
The electrodes were immersed into a buﬀer that contained
Fe(CN)6
4− as an electroactive component. Upon binding of the
protein to the electrodes, a time-dependent decrease in the
amperometric response of the cyclic voltammogram was
observed, which was attributed to the insulation of the
electrode by the protein.286 This phenomenon allowed for
studying the kinetics of binding. The results are summarized in
Table 12.
A high level of photocontrol was observed for monolayers
modiﬁed with compounds 101 and 102, i.e. monosacharides
that associate to a speciﬁc binding site in the protein. In a
control experiment, compound 103 was used, which does not
exhibit speciﬁc binding to concavalin A, and the measured level
of photocontrol was negligible. On the basis of these data, the
photostimulated binding was explained by the perturbation of
the protein binding site.
This eﬀect was further conﬁrmed by the studies of the
conformational dynamics of modiﬁed concavalin A, using time-
resolved light scattering.287,288 It was shown that the protein
undergoes a “shrinkage” upon isomerization of the photo-
switch. At high loading of the photochromic compound, when
on average 8 of the 12 lysine residues were modiﬁed with 92, a
rapid shrinkage of concavalin A was observed (τ1/2 = 60 μs)
upon irradiation. It was followed by a slower (τ1/2 = 250 μs)
conformational change leading to the formation of a more
compact structure.
Hoﬀman and co-workers have studied the possibility of
obtaining light regulated control over streptavidin−biotin
interactions with potential applications for photoregulation of
aﬃnity separations.289 Site-selective incorporation of photo-
responsive polymers (Figure 69a) into the structure of the
protein was achieved by the preparation of an E116C mutant of
streptavidin (Figure 69b). Further modiﬁcation of the reactive
side chain of the introduced Cys was performed using a vinyl
sulfone terminus in the polymer. The eﬃciency of conjugation
was estimated to be 12−20%.
The DMAA and DMAAm polymers (see Figure 69) used in
this study express opposite solubility in diﬀerent photochromic
states. While DMAA is soluble under UV irradiation and
insoluble in visible light, DMAAm shows better solubility under
visible light and precipitates upon UV irradiation. These
features of both polymers were exploited in the binding
behavior of their bioconjugates (Figure 70). The interaction
with biotin could be reversibly changed by UV irradiation from
about 33% to 80% of the native binding in the case of DMAA
Table 11. Aﬃnity of Concavalin A, Modiﬁed with
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(SA-DMAA curve, Figure 70) and from 90% to about 50% for
DMAAm (SA-DMAAm curve, Figure 70). It has also been
conﬁrmed,that the presence of unconjugated polymer had no
inﬂuence on the photoresponse (SA+DMAA(m) curves, Figure
70) and that the unmodiﬁed E116C mutant was also not
photoresponsive with respect to biotin binding (SA(E116C)
curve, Figure 70).
What distinguishes the photoresponsive polymer-based
approach from the use of small photoswitchable molecules is
the fact that the thermal reisomerization of the photochromic
units in the polymer is not simultaneously accompanied by the
changes in the overall structure of the polymer. The polymer
reorganization happens very slowly, on the time scale of days.
This results in much higher thermal stability of the photo-
irradiated state. It has also been shown that when a single
azobenzene unit was introduced into streptavidin E116C, using
activated derivative 95 (Figure 57), no photocontrol of binding
was observed. This research presents an important alternative
to small photoswitchable molecules as photocontrol elements.
The photocontrol of cAMP binding to E. coli catabolite
activator protein, CAP, has been studied by Schultz and co-
Figure 68. Formation of sugar-decorated, self-assembled monolayers on gold electrodes.286
Table 12. Time Constants for Concavalin A Binding to
Monosaccharide-Functionalized Self-Assembled Monolayers
on Gold Electrodes286
time constants τ1/2 (s)
concavalin A modiﬁed with 92
monosacharide concavalin A closed opened
101 40 60 160
102 85 220 670
103 100 100 110
Figure 69. Elements used in the preparation of photocontrolled streptavidin. (a) Photoresponsive polymer. (b) The tetrameric structure of
streptavidin. Mutated residue 116 is highlighted in green. The biotin binding site is marked by a black sphere. Reprinted with permission from ref
289. Copyright 2002 American Chemical Society.
Chemical Reviews Review
dx.doi.org/10.1021/cr300179f | Chem. Rev. 2013, 113, 6114−61786158
workers.290 CAP is a dimeric transcriptional activator that upon
binding of cAMP interacts strongly with its promoter, resulting
in enhanced transcription and regulation of a number of
operons in E. coli. Using the nonsense suppression method (see
section 4.5.3), photoswitchable amino acid 97 (Figure 61) was
introduced into position 71 of CAP, which lies in close
proximity with the residues that are responsible for the binding
interactions with cAMP.
While the photosationary state of the incorporated
azobenzene was estimated to be only about 50%, a 4-fold
drop in binding to a Lac promoter was observed upon
irradiation (Table 13). This surprisingly high level of
photocontrol has been attributed to the fact that the protein
is a dimer, which results in roughly 75% of dimers having at
least one photoisomerized molecular switch in their structure.
In a recent study, the group of Maruta has shown the
photocontrol of calmodulin interacting with a target peptide.291
Calmodulin is a Ca2+-binding protein that plays a crucial role in
calcium-dependent processes. Therefore, the regulation of its
binding to target proteins might oﬀer a valuable tool for the
photoregulation of important events in the cell, such as
apoptosis and metabolism. The protein has four Ca2+-binding
sites (so-called “EF-hands”): two in the N-terminal domain and
two in the C-terminal domain (Figure 71).
The site-selective incorporation of photoswitches was
obtained by the preparation of cysteine mutants and their
modiﬁcation with azobenzene derivative 95 (Figure 57).291
Seven diﬀerent mutation points were used in order to optimize
the attachment site (Figure 71). They were chosen on the basis
of the assumption that the photoswitch introduction site should
be slightly away from the area that interacts directly with the
target peptide in order not to completely abolish the binding.
Three points (A57, N60, and D64) were focused around the N-
terminal portion, which is responsible for the Ca2+-dependent
regulation of physiological CaM function. Four other muta-
genesis sites (M124, E127, A128, and M144) were located in
the C-terminal portion, which is responsible for the interaction
with the model target peptide. For the latter role, the M13
peptide was chosen, which is a fragment of skeletal muscle
myosin light chain kinase. To facilitate the analysis, it was
conjugated to yellow ﬂuorescent protein.
Eﬃcient photocontrol was observed in the cases of three
incorporation sites (Figure 71) located both in the N-terminal
Ca2+-binding site (positions 60 and 64) and in the peptide
binding site (position 124). While the level of photocontrol was
relatively low (about 3-fold change in binding aﬃnity upon
photoswitching), this study presents an interesting approach to
the choice of photoswitch attachment points.
The photocontrol of ligand binding to proteins provides
outstanding possibilities, as these recognition events are at the
basis of many important biological processes. Therefore, in this
area a substantial increase of activity can be expected in the
coming years. Thus far, complete photocontrol of binding has
not been reported, and the largest changes in aﬃnity upon
irradiation were around 4-fold.290,291 An interesting ap-
proach289 for the preparation of photoswitchable biomolecules
was also reported, in which the protein of interest was modiﬁed
with a copolymer comprising regular and photoactive units.
This resulted in a much higher thermostability of the
photostationary state and showed promise in the applications
in which the protein’s function had to be turned on or oﬀ for a
longer period of time.
6. MOLECULAR PHOTOSWITCHES IN RECEPTORS
AND CHANNELS
Controlling receptor and channel function with light has been
of interest to researchers for several decades and has led to a
variety of photocontrolled systems.4,5,293−298 By incorporating
molecular photoswitches into cellular receptors and trans-
membrane channels, it is possible to spatially and temporally
control cellular signaling and function using light. Switching
cellular functions on and oﬀ, by the use of an external stimulus
that does not interfere with normal cell functioning, allows
studying cellular processes in a unique manner. Furthermore,
one can imagine that by engineering photoswitchable
endogenous receptors and channels, a new generation of
treatment options for various diseases could become available.
To date, most receptors addressed with photoswitchable
molecules are ligand-gated ion channels. In order to obtain
information about their functionality, it is important to measure
changes in current through the ion channel or across the
membrane. The method of choice is usually the patch clamp
Figure 70. Light-induced changes of biotin binding aﬃnity by streptavidin modiﬁed with photoresponsive polymers. DMAA, N,N-
dimethylacrylamide-co-4-phenylazophenyl acrylate; DMAAm, N,N-dimethylacrylamide-co-4-phenylazophenyl acrylamide. Reprinted with permission
from ref 289. Copyright 2002 American Chemical Society.
Table 13. Photocontrolled Binding Aﬃnities of CAP to
cAMP290
CAP variant binding constant Kb
wt 16 × 106 M−1
I7197 4 × 106 M−1
I7197 irradiated 1 × 106 M−1
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technique.299,300 In short, a thin glass pipet, which functions as
an electrode, is sealed onto the surface of a cell-membrane. This
part of the cell-membrane surface, or patch, contains one or
multiple ion channels of interest. The pipet is ﬁlled with a
conductive solution in contact with a recording electrode. This
electrode is connected to a low-noise current ampliﬁer,
enabling recording of the current across the membrane (see
Figure 79 for an example of an electrophysiological recording of
current over time). A cell can also be current clamped, which
keeps the current constant and allows the voltage to be
measured instead of the current. Multiple variations of the
patch clamp technique exist, depending on the requirements of
the study.299
6.1. Nicotinic Acetylcholine Receptor
The ﬁrst steps toward a photocontrolled receptor were
performed in the late 1960s with studies on the nicotinic
acetylcholine (nACh) receptor. Acetylcholine (ACh) functions
as a neurotransmitter in the human body and plays an
important role in the central nervous system. Physiological
functions, such as pain processing, sleep, anxiety, and cognitive
function, are aﬀected by acetylcholine.301 There are two main
receptor types on which ACh acts: the muscarinic ACh
receptor and the nACh receptor.301−303 The nACh receptors
are believed to be pentameric, ligand-gated ion channels found
in various tissues of the human body.301 Upon binding of
acetylcholine, the nACh ion channel opens, allowing sodium
and potassium ions to ﬂow through the channel and causing a
depolarization, i.e. a change in the cell’s membrane potential.
This process can, for example, lead to muscle contraction.304
The discovery by Karlin et al. that disulﬁde bonds in the
nACh receptor are easily reduced and thereby form sulfhydryl
groups that can react with electrophilic partners led to the
design and synthesis of covalently bound (conjugated) nACh
receptor agonists.305,306 These compounds contain a fragment
with known aﬃnity for the binding site of the nACh receptor
and an electrophilic anchor, allowing the ligand to irreversibly
conjugate with the receptor near the binding site. These studies
were conducted around the same time Erlanger et al. reported
two photoswitchable inhibitors (53 and 55, Figure 46) of the
nACh receptor.224 These inhibitors were derivatives of the
known nACh receptor agonists, carbamylcholine and phenyl-
trimethylammonium ion, and they bore a photoswitchable
azobenzene moiety.
The biological activity of compounds 53 and 55 was tested
on monocellular electroplax of Electrophorus electricus. The
membrane of these cells is known to depolarize following
exposure to compounds that interact with the ACh receptor.
This process could be measured with intracellular electro-
des.224,307,308 The trans isomers of 53 and 55 were stronger
nACh receptor inhibitors than the cis isomers. By switching
between the trans and cis states of these inhibitors, it was
possible to regulate the cell-membrane depolarization with light
(see section 4.1).
Figure 71. Upper panel: Chosen mutation sites in calmodulin (in yellow). Bound Ca2+ atoms are shown in black. Adapted from coordinate data
(1CLL)292 of Homo sapiens CaM from the protein databank, using PyMOL software. Lower panel: results obtained for chosen mutants, showing the
highest level of photocontrol for the mutant in which the cysteine was introduced in position 60. Reprinted with permission from ref 291. Copyright
2009 Oxford University Press.
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Although the above-described results showed the functioning
of photoswitchable inhibitors, combining this concept with
covalently bound agonists led to the ﬁrst photoactivated
receptor.309 Compound 104 (Figure 72) consists of a
photoswitchable azobenzene, functionalized with a bromide at
one end and a trimethylammonium (TMA) group at the other
end. The TMA group is a known ligand for the nACh receptor
binding pocket.309 Before reduction of the disulﬁde bonds in
the nACh receptor, the uncoupled trans isomer of 104 (5 ×
10−7 M) caused a depolarization of 3 mV. After reduction, 104
could be conjugated with the receptor and covalently bound
104 caused a depolarization of 5 mV. Also, the depolarization
of the membrane by carbamylcholine304 was completely
inhibited by the covalently bound 104. The observed eﬀect
of conjugated 104 was explained by the TMA group of the trans
isomer interacting with the binding site, causing channel
opening, followed by depolarization of the membrane. When
the ligand was isomerized to the cis form using light, the TMA
group was no longer able to bind the active site; therefore, no
depolarization was detected (Figure 73).
This was the ﬁrst time that a photoswitchable, engineered
receptor was reported, and the usefulness of this technique for
studying receptor function was shown over the next
decade.310−312 As the ligand was conjugated with the receptor,
the interaction between ligand and receptor was independent of
ligand and binding pocket encounter events. This enabled the
study of pharmacodynamics in a unique way.310,311 For
example, Lester et al. investigated the transition between an
open- and closed-nACh receptor.310 Two hypotheses for the
rate-limiting step were initially suggested: (i) the binding and
Figure 72. Compounds used for engineering photoswitchable receptors and ion channels.62,309,318,319,325,332,353,355
Figure 73. Photoswitchable nACh receptor.309 When 104 was in its trans form, the trimethylammonium (TMA) group interacted with one of the
nACh receptor binding sites (red sphere), causing the ion channel to change its conformation and allowing ion ﬂow. cis−trans isomerization of 104,
induced by irradiation at λ = 360 nm, weakened the interaction of the TMA group with the binding pocket of the receptor, which resulted in the
closing of the channel.
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dissociation of the agonist at the active site of the receptor and
(ii) a conformational change in the receptor when the agonist
was bound. It was found that the conductance induced by the
conjugated receptor agonist 104 was comparable to the one
induced by reversibly bound agonists. From this observation it
was assumed that the rate-limiting step was not the encounter
of agonist and receptor binding site, since this should have been
faster for the covalently bound agonist. However, the authors
could not unequivocally establish what the rate-limiting step
was.
Another example of an application of a photocontrolled
nACh receptor was reported by Chabala and Lester.312 When
one or more ligands bind to the nACh receptor, the channel
opens and closes for a certain amount of time.313 All of these
single opening events contribute to the total conductance
measured. The authors characterized the lifetime and
conductance of these single opening periods using 104. They
found that the major increase in conductance resulted from
nACh channel openings with a lifetime of ∼5 ms, which
contributed to 80% of the total conductance.
These two examples of photocontrol of a receptor improved
the understanding of receptor function. Furthermore, not only
the covalently bound ligands but also the nonconjugated
photoswitchable ligands were shown to be useful for nACh
receptor research.314−316 It was later found315 that the trans
isomer of 105 is a highly potent ACh receptor activator with an
activity that is 50-fold higher than that of acetylcholine.
However, the cis isomer has less than 1% of the activity of the
trans isomer. This led to the conclusion that the binding of a
ligand to the ACh receptor binding site required multiple
intermolecular interactions that were previously unknown. To
test this, derivatives of 105 with slightly diﬀerent molecular
structures were synthesized.315 When comparing the activities
of these derivatives, the molecular features that were important
for a ligand in order to bind to the nACh receptor binding site
were elucidated (vide inf ra).315 This information gave new
structural insight into the nACh receptor binding site. It was
concluded that the ACh receptor has a planar hydrophobic
region in its binding site that interacts with both hydrophobic
and electron-donating functional groups. Furthermore, it was
proposed that the ACh receptor binding site possesses two
anionic regions. This study shows how photoswitchable
compounds can not only elicit spatial and temporal control
but also help with fundamental research on the nature of
receptors.
Recently, a successful engineering of a photocontrolled
nACh receptor was achieved using a more widely applicable
method,317 applied earlier to create a photocontrollable Shaker
Channel318 and ionotropic glutamate receptor319 (see sections
6.4 and 6.5, respectively). The method is similar to the
approach exploited by Erlanger et al.309 in that an azobenzene
photoswitch was used with at one side an agonist
(trimethylammonium group) and at the other side a maleimide
moiety that can covalently bind to the receptor protein (106,
Figure 72). Maleimides react selectively with cysteine residues,
covalently anchoring the photoswitch to the receptor. Cysteine
residues can be genetically introduced into receptor proteins,
which renders this method widely applicable. When a suitable
site for cysteine introduction is chosen, the agonist attached to
the photoswitch can interact with the receptor binding pocket
in one photoisomeric form of the molecule. However, when the
compound is photoisomerized, the agonist is not in the
proximity of the binding pocket and cannot interact with it. In
the case of the nACh receptor, three suitable mutation sites
were selected, including the E61 of the β4 subunit of the
heteropentameric neuronal nACh receptor.317 This mutant
receptor was expressed in Xenopus oocytes and screened for
activity using voltage-clamp recordings. Following the in-
cubation with 106, exposure to 380 nm light produced an
inward current of 6.8 ± 1.3% of the saturating cholinergic
current. This eﬀect could be reversed by irradiation with 500
nm light, after which the receptor still responded normally to
acetylcholine. Oocytes expressing mutated nACh receptors
with introduced cysteines at the two other selected sites
showed similar results.
6.2. Gramicidin A
A diﬀerent approach for using light to control ion channel
function was exploited in the early 1990s.320 Gramicidin A is an
antibiotic peptide that is synthesized by Bacillus brevis and is
supposed to dimerize in amphiphilic environments, such as
lipid vesicles and membranes, to form a pore-like structure.321
Figure 74. Proposed mechanism for the action of a photoswitchable gramicidin A channel. Two gramicidin A monomers coupled at both ends of an
azobenzene moiety were expected to form one long pore through a lipid bilayer when the azobenzene was in its cis form, allowing ion ﬂow. By
increasing the temperature, the trans form was favored and the two monomers were not properly aligned, inhibiting ion ﬂow. Adapted with
permission from ref 320. Copyright 1991 Elsevier B.V.
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Monovalent cationic ions and water molecules are able to pass
through these pores.322 Gramicidin A channels are of interest
for transmembrane research because of their size, their
availability, and their susceptibility for chemical modiﬁca-
tion.323,324
Two gramicidin A monomers were linked with an
azobenzene switch in such a way that when the switch was in
its cis form, the two monomers form one long pore spanning
the lipid membrane (Figure 74), allowing ion transport.320 It
was hypothesized that when the azobenzene moiety was
switched to its trans form, the monomers should no longer be
able to align, limiting ion transport (Figure 74). It was possible
to modulate the conductance of these ion channels with light,
which was measured using electrophysiological recordings.
The trans isomer showed a conductance of about 9 pA at a
membrane potential of 200 mV, where it was expected to show
no conductance at all.320 On the other hand, irradiation with
light at wavelengths between 320 and 400 nm, which favored
isomerization to the cis isomer, led to channels with “ﬂickering”
behavior. An open time of about 40 ms and a closed time of 13
ms were measured. During the open time, the channels showed
a conductance of 14 pA at a membrane potential of 200 mV,
which is comparable to the conductance of a normal gramicidin
A channel. The attempts at explaining the unexpected results
using a single model were unsuccessful.320 However, these
studies did prove the possibility of photomodulating channel
conductance.
A diﬀerent approach for photocontrolling the opening and
closing of gramicidin A channels was exploited a few years
later.325 It was discovered that coupling an alkylamine to the C-
terminal end of a gramicidin A via a carbamate linkage (Figure
75) could block the cation ﬂux across the membrane.327 This
blockage was shown to be dependent on the length of the
linker (Figure 76), where the use of longer alkyl chains resulted
in decreased channel blockage.325 Introducing an azobenzene
photoswitch into this linker (107, Figure 72) enabled the
change of linker length by switching between the cis and trans
forms upon irradiation with light (Figure 76), and channel
opening and closing could be photocontrolled.325 A con-
ductance of 14.9 pA at a potential of 200 mV was measured
using single channel recordings in a lipid bilayer when both
azobenzenes at the entrance and the exit of the channel were in
their trans state. Irradiation with 337 nm light resulted in
isomerization to 85% of the cis isomer, and a maximum
conductance of 12.8 pA was measured. Here, four diﬀerent
levels of conductance were observed, corresponding with trans/
trans, trans(in)/cis(out), cis(in)/trans(out), and cis/cis. The
changes in conductance between the diﬀerent levels were 1.1,
2.6, and 3.5 pA, respectively. Additionally, the opening and
closing of the channels was shown to be reversible.
A third attempt at creating a photoswitchable gramicidin A
channel was exploited using a photoswitchable amino acid,
substituted into the gramicidin A peptide (for the introduction
of photoswitchable amino acids into proteins, see also sections
4.4 and 4.5).62 A hemithioindigo-derived switch was ligated to
an amino acid, giving rise to compound 108 (Figure 72).
Subsequently, the amino acid was incorporated into the
gramicidin A peptide at position one, replacing valine.
Irradiation with 406 nm light resulted in Z to E isomerization,
with a photostationary state of 72% E. Irradiation with 480 nm
light produced ∼100% of the Z isomer. The dipole moment
was calculated to be 2.8 D for the Z isomer and 1.2 D for the E
isomer. Furthermore, it was believed that the distance between
the cation in the pore and the carbonyl oxygen (negative
dipole) of 108 inﬂuenced the energy of dipole−ion interaction
(Figure 77). In the Z form, this distance was 12.5−13.5 Å, and
for the E form, this distance was 8.5−11.8 Å.62 From these data,
it was predicted that the channel would have a higher
conductance with the switch in the E form. Next, the modiﬁed
gramicidin peptide was added to membranes of diphytanoyl-
phosphatidylcholine/decane and single channel currents were
recorded. As with the previous photoswitchable gramicidin A
example, four diﬀerent conducting states were observed
corresponding to E/E, E/Z, Z/E, and Z/Z isomers. When
using Na+ as the cation and a voltage of 200 mV, a current of
1.33 pA was measured for the Z/Z conﬁguration, 1.75 pA for
E/E, and 1.50 pA for both of the intermediate states. When Cs+
was used, the relative diﬀerences in conducting states decreased
to 6.0 pA, 6.5 pA, and 7.0 pA for the Z/Z, E/E, and
intermediate conﬁgurations, respectively.62
The studies with gramicidin A proved that it is relatively easy
to manipulate photoswitchable peptide channels.62,320,325,327
Furthermore, it was feasible to exploit various approaches, all
resulting in photocontrol over gramicidin A channel opening
and closing. Some of them even were shown to be highly
sensitive, which was apparent from the observation of three or
four conducting levels corresponding to the E and Z forms of
the various photoswitches.62,325
Figure 75. Structure of gramicidin A dimer and attachment/
modiﬁcation points shown in red. (a and b) Top and side view of
gramicidin A dimer with the N-terminal end highlighted in red as
attachment point of the azobenzene switch as described by Stankovic
et al.320 This is the same position as the amino acid valine, which was
replaced by a hemithioindigo-based amino acid by Lougheed et al.62 (c
and d) Top and side views of gramicidin A dimer with the C-terminal
ends highlighted in red. This position was used by Lien et al.325 to
attach their azobenzene group by a carbamate linkage. Adapted from
coordinate data (1MAG)326 of Brevibacillus brevis gramicidin A from
the protein databank, using PyMOL software.
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Follow-up experiments could focus on the use of these
channels in more biologically relevant environments, such as
cells. For example, it could be possible to incorporate these
photoswitchable channels in a bacterial cell membrane by
simply adding these molecules to the bacteria’s surrounding
environment, allowing the potential for bacterial cell death to
be controlled by light. This approach would result in
photoswitchable antibiotic agents.
6.3. Mechanosensitive Channel of Large Conductance
The mechanosensitive channel of large conductance (MscL)
helps bacteria adapt to changes in osmotic pressure.328−330 The
channel opens in response to mechanical force on the cell
membrane caused by an inﬂux of water. It consists of ﬁve
helices that contract via hydrophobic interactions. These
interactions can be disrupted by polar groups that attract
water and lead to hydration of the pore.331 To engineer a
photosensitive MscL, ﬁrst the glycine at position 22 of the
channel was mutated to a cysteine (Figure 78).332 Then an
uncharged spiropyran core modiﬁed with an iodoacetate
moiety, 109 (Figure 72), was reacted with this cysteine.
When the spiropyran moiety was exposed to 366 nm light, its
ring-opening resulted in a charged zwitterionic merocyanine
structure (Figure 78). This charged molecule disrupted the
hydrophobic interactions in the channel, causing it to open.
When the photoactive protein was embedded in a lipid
membrane, patch clamp recordings showed that the channel
could be opened and closed by changing the wavelength of
light used for irradiation. When exposed to 366 nm light,
currents of 20 pA were measured at a set potential of 20 mV,
indicating the opening of the channel. Subsequent exposure to
visible light signiﬁcantly reduced the channel opening events,
and the currents were decreased to almost 0 pA (Figure 79).
The fact that the structure and functioning of this channel
was well described made it simpler to predict how it could be
mutated and made photoswitchable. Although the number of
channels that can be controlled via manipulation of hydro-
phobic eﬀects may be limited, the proof of concept is a valuable
step. When these photoswitchable channels were incorporated
in vesicles or capsules, content release could be externally
controlled, making this concept highly interesting for
application in (drug) delivery systems.332,334
6.4. Shaker Channel
In 2004 a photoswitchable ion channel was reported by
Kramer, Trauner, and co-workers,318 developed using a method
similar to the one used to obtain a photoswitchable nACh
receptor.309 In this case,318 the ion channel of interest was the
voltage-dependent Shaker K+ channel. This channel responds
to a change in membrane potential and opens when the
potential reaches a certain positive threshold.335 After this
activation, the channel enters a state of inactivity in which it is
nonconducting and cannot be activated again by depolariza-
tion.336 The Shaker K+ ion channel can be blocked by
tetraethylammonium (TEA) ions.337 To make the blocking of
this channel photoresponsive, a quaternary ammonium moiety
was coupled to an azobenzene group. To conjugate this
molecule with the channel, a maleimide group was coupled to
the other end of the azobenzene moiety (110, Figure 72). The
maleimide was used to selectively bind to cysteines present on
the surface of a Shaker channel. The distance between glutamic
acid residue 422 in the channel protein and the channel’s exit
corresponded to the length of the photoswitchable molecule in
its trans form. Thus, this glutamic acid was chosen for mutation
to a cysteine for a ligation site for the maleimide group of 110.
When the maleimide was covalently bound to the cysteine, the
Figure 76. (a) Modiﬁed gramicidin used to study the inﬂuence of linker length on channel blockage.325 (b) A photoswitchable gramicidin A
channel.325 An azobenzene tether with a cationic group at the end was attached to the entry and the exit of a gramicidin A channel. When the
azobenzene was in its trans form, the channel was unblocked and ion ﬂow was possible. Irradiation at λ = 337 nm induced the isomerization of the
azobenzene to its cis form, which resulted in blocking of the channel, and ion ﬂow was reduced. The channel could be unblocked by irradiating the
azobenzene switch with visible light.
Figure 77. Change in distance between a cation in the middle of a gramicidin A channel and negative dipole of a hemithioindigo amino acid upon
switching. The distance between the cation and carbonyl oxygen changed, while the distance between the cation and double bond carbon in the
thioindoxyl ring remained constant. This change in distance was believed to inﬂuence the energy between a cation and the dipole. Adapted with
permission from ref 62. Copyright 2004 Royal Society of Chemistry.
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TEA group of 110 was within proximity to block the Shaker
channel with the photoswitch in the trans form (Figure 80a).
However, when the azobenzene was switched to the cis form,
the length of the photoswitchable molecule was insuﬃcient for
the TEA group to block the channel (Figure 80a). Experiments,
performed on mutated Xenopus laevis oocytes and cultured
hippocampal neurons, revealed that during exposure to UV
light the channel was open and conducting, and a current of ∼1
nA was measured using patch clamp recordings on an oocyte
expressing the mutated Shaker channel (Figure 80b). When,
instead of exposure to UV light, visible light was used, the
current dropped dramatically to ∼100 pA, indicating that the
channel was blocked. These cycles could be repeated several
times. When the light-activated channels were expressed in
hippocampal pyramidal neurons,318 similar results were
observed, indicating photocontrol of neuronal excitability was
achieved.
From a bioengineering perspective, these experiments are a
major step forward compared to the photomodulation of
gramicidin A and MscL channels. While these photoswitchable
systems clearly proved the concept and feasibility of photo-
switchable receptors and channels, the Shaker channel
experiments were taken to a next level, since the method was
tested on living cells instead of artiﬁcial lipid bilayers and
vesicles. With this, photocontrol over cellular communication
became an even more realistic possibility.
6.5. Ionotropic Glutamate Receptor
After developing a photoswitchable Shaker channel, Trauner
and co-workers changed their focus to the ionotropic glutamate
receptor (iGluR).319 The glutamate receptor (GluR) plays an
important role in neuronal communication in the brain.338
Diﬀerent subtypes of GluRs have been described, i.e. ionotropic
as well as metabotropic.339 Its ligand, L-glutamate, is the major
excitatory neurotransmitter in the mammalian central nervous
system.340 The GluRs are also involved in the pathophysiology
of brain functioning.341
A similar approach as with the Shaker channel318 was
exploited. Namely, a tethered agonist was synthesized
consisting of an azobenzene with an electrophilic maleimide
at one end and glutamate (acting as an agonist) at the other
end (compound 111, Figure 72).319 A well established cell line,
HEK293, which is easy to grow and transfect,342 was used to
study the activity of this tethered agonist 111.
iGluR were mutated at the 439 position to bear a cysteine
group to which the maleimide could bind. After attachment of
111, iGluR was successfully turned on and oﬀ by irradiating the
cells with diﬀerent wavelengths of light. The wavelength range
from 300 to 500 nm was scanned, and at 380 nm the greatest
conductance of 900 pA was measured at a voltage of −60 mV,
indicating that this was the optimum wavelength for opening
the channel. The optimum wavelength for closing the channel
was found by irradiating the opened form with light of
wavelengths ranging from 400 to 600 nm. At 500 nm the
smallest conductance of almost 0 pA was measured, and this
was chosen as the optimum wavelength for closing the channel.
A major improvement over the methodology presented for
the Shaker channel318 consists of using a ligand that binds to
the binding site of the receptor and does not block the channel
itself. In other words, the receptor could be allosterically
controlled.
One might consider, for instance, addressing metabotropic
receptors343 as well. G protein coupled receptors (GPCRs) are
a class of transmembrane receptors that activate signal
transduction upon binding of a ligand.344 Interestingly, a
widely used model for studying GPCRs is rhodopsin, a
photoreceptor found in the retina of vertebrates.345 Rhodopsin
is covalently attached to a photoswitchable compound, retinal.
Exposure to light causes a cis to trans isomerization of retinal,
which leads to conformational changes within rhodopsin
initiating signal transduction.344 It might be possible to address
other GPCRs using photoswitchable tethered agonists allowing
photocontrol of signal transduction.
In follow-up studies with 111,24,346−349 Isacoﬀ, Trauner, and
co-workers studied the mechanisms by which 111 was
conjugated to iGluR.24 It was assumed that the maleimide
moiety could not bind to the cysteine at the same time as the
glutamate moiety of trans-111 was interacting with the binding
site of the receptor. For this, the distance between the two
groups was too large. However, cis-111 did have the right
distance between the two groups, allowing them to interact at
the same time. Taking advantage of this would enable selective
Figure 78. (a) Structure of the MscL protein. The attachment site of
the photoswitch332 is shown in red. Adapted from coordinate data
(2OAR)333 from the protein databank, using PyMOL software. (b)
Photoswitching between an uncharged spiropyran state and a charged
zwitterionic merocyanine state.332 In the merocyanine state, the
charges disrupted the hydrophobic interactions in the inside of the
channel, which caused the channel to open. When switched back upon
irradiation with visible light, the merocyanine state returns to the
uncharged spiropyran state, which restored the hydrophobic
interactions and closed the channel. Adapted with permission from
ref 332. Copyright 2005 National Academy of Sciences.
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conjugation of one of the photoisomers of 111 with the
mutated iGluR by aﬃnity labeling.
This phenomenon was studied using calcium imaging.24 In
this technique, a ﬂuorescent calcium indicator gives a signal
when calcium concentration is high, which was the case when
the calcium permeable iGluR is open. Therefore, a high signal
corresponds with a high number of open iGluR channels,
expected to be triggered by 111. Incubating HEK293 cells
transfected with the mutated iGluR with 111, under visible light
irradiation, resulted in a weak signal of 10.7%. A more than 3-
fold higher signal of 36.1% was measured when the cells were
incubated with 111 under UV irradiating conditions, favoring
the cis form of the switch. To prove the aﬃnity labeling, a
control experiment was performed, in which the cells were
incubated with cis-111 and competing concentrations of free
glutamate. Subsequent calcium imaging produced a 3-fold
lower signal as compared to the receptor incubated without free
glutamate, indicating that in the latter case aﬃnity labeling
occurs.
Additionally, when only a small part of a cell culture was
irradiated with light of a wavelength that favored the cis form
and the rest of the cells were irradiated with light of a
wavelength that favors the trans form, only the former could
conjugate with 111 by aﬃnity labeling (Figure 81). This
resulted in a high concentration of conjugated 111 in only a
small, spatially designated part of the cell culture. This
experiment showed it was possible to spatially control
photoswitchable agonist conjugation. This method could
possibly allow controlling the conjugation of diﬀerent photo-
switchable agonists in a single cell culture. Further experiments
could be performed to study the behavior of cells in one culture
conjugated to diﬀerent photoswitchable agonists and to gauge
how light controls the intercellular communication.
Another follow-up study focused on the usage of 111 in
vivo.346 Experiments were performed on zebraﬁsh.346 Normally,
zebraﬁsh respond to mechanical pressure by moving away.
First, the gene for mutated iGluR bearing the cysteine residue
was introduced in embryonic zebraﬁsh. When the mutated ﬁsh
were incubated with 111, normal behavior was observed.
Following irradiation with UV light favoring the cis form of 111,
28% of the ﬁsh did not elicit a touch response. When these ﬁsh
were subsequently irradiated with light favoring the trans form
of 111, 81% of the nonresponding ﬁsh regained a normal touch
response. These results indicate that 111 was capable of
reversibly interfering with neuronal signaling in vivo.
Furthermore, 111 gave no evidence of toxicity, and delivery
of this compound to the active site was relatively easy.346
More recently, a hybrid glutamate receptor, developed from a
mammalian and a prokaryotic glutamate receptor, was reported
to be addressable with light using the same strategy as with the
natural occurring iGluR.347 This shows that not only naturally
occurring receptors can be altered with photoswitchable
compounds, but that it is possible to expand the scope by
designing and engineering new hybrid receptors that can be
chemically modiﬁed to become photoresponsive.
It is believed that in some diseases which result in blindness
the photoreceptors lose their function while the retinal neurons
remain alive.350 Adeno-associated viral vectors (AAV), which
have proven to be capable of introducing genes in vivo,351 were
used for expressing mutated iGluR receptors in blind rd1 mice
retinal ganglion cells (RGCs),352 which are known to lack
photoreceptors. Visually evoked ﬁeld recordings (VEPs) were
taken from the primary visual cortex of wild-type mice and rd1
Figure 79. Electrophysiological recordings of the modiﬁed MscL channel exposed to UV and visible light. (a) The current was measured at 20 mV,
and current peaks correlated with channel openings. (b) Close up of the electrophysiological recordings from part a. Figures 1, 2, and 3 correspond
to the area designated in part a. Reproduced with permission from ref 332. Copyright 2005 AAAS.
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mice expressing the mutated iGluR, in the presence and
absence of 111. VEPs were used as a measure for light
responsiveness. Electrodes were placed just below the surface of
the cortex, contralateral to the stimulated eye, and the response
to light was recorded as VEPs. VEPs were restored to 50% in
rd1 mice incubated with 111 compared to wild-type mice when
exposed to 380 nm light (Figure 82a).352
Furthermore, iGluR, in combination with 111, was capable of
restoring the pupillary reﬂex. This reﬂex makes the pupil
contract when exposed to light. iGluR and 111 restored almost
60% of the pupillary response in triple knockout mice that lack
phototransduction and papillary reﬂexes (Figure 82b).352
This work shows the great potential molecular photoswitches
have for usage in the biomedical ﬁeld, and they might be used
in the future to treat illnesses. Furthermore, it clearly proves the
importance of interdisciplinary research in order to make
achievements like this possible.
6.6. Endogenous Ion Channels
While the methods developed for the photocontrol of the
iGluRs are highly promising,319,346,348,349,352 their in vivo use is
limited by the need to mutate the receptors to introduce a
cysteine site to which the molecular photoswitch binds. To
overcome this problem, Kramer, Trauner, and co-workers
introduced a method based on photoswitches that ligated with
naturally occurring nucleophilic amino acids of voltage-gated
K+ channels, thereby avoiding the need to mutate the receptor
ﬁrst.353 These photoisomerizable small molecules were
regarded as photoswitchable aﬃnity labels (PALs) (see also
section 4.4).
The photoswitchable ligands used by Trauner and co-
workers353 consisted of a photochrome functionalized with a
quartenary ammonium group, that blocks K+ channels, at one
end and an electrophilic group at the other end. The
electrophiles acrylamide (112, Figure 72), chloroacetamide
(113, Figure 72), and an epoxide (114, Figure 72) were tested.
These electrophilic groups were chosen to react with
nucleophilic amino acids present in the natural receptor, unlike
the maleimide moiety in 111, which relied on an artiﬁcially
introduced cysteine for conjugation. In cultured neurons, trans-
112 blocked 72% of the voltage-gated K+ currents. Exposure to
380 nm light relieved channel blockage, and 117% of the
current was recovered as compared to pretreatment. Similar
results were observed with 113, while 114 appeared to be toxic.
To test whether this method could be applicable in tissues,
rat cerebellar slices were subjected to treatment with compound
112.353 This research aimed to address the concerns focused on
the wavelength of the light used to switch the photoswitchable
ligands, as UV light may not be able to penetrate the tissue
deep enough to reach the switch. Furthermore, photo-
switchable ligands may not have been able to reach the active
site. However, 112 could block and unblock K+ channels in
cerebellar slices when irradiated with 500 and 360 nm light,
respectively. Later it was suggested that, in contrast to the
assumption that guided the design of PALs, compound 112
does not covalently bind to the receptor protein, but that it
remains in proximity of the binding site by association with the
plasma membrane.354 This could provide an alternative
explanation for the long lasting channel blockage of 112.
Figure 80. (a) Photoswitchable Shaker Channel. The channel was open when the azobenzene was in its cis form. However, when the azobenzene
was switched to the trans form, the TEA group blocked the exit of the channel. Adapted with permission from ref 318. (b) Patch clamp recording of
an oocyte treated with 100 μM 85 for 30 min. When exposed to UV light (λ = 380 nm), a current of approximately 1 nA was measured. Under
visible light (λ = 500 nm), a channel current of 100 pA was measured, indicating the channel was blocked. Reprinted with permission from ref 318.
Copyright 2004 Nature Publishing Group.
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Penetrating isolated tissue is still diﬀerent from penetrating
tissues in a human body, because light has to travel further to
reach the site of action. However, the use of photoswitchable
aﬃnity labeling to address the function of endogenous channels
represents a large leap in this ﬁeld, because genetic
manipulation of cells is no longer a requirement. Therefore,
this method can be exploited on endogenous cells and possibly
even living organisms.
6.7. SecYEG
Recently, Driessen, Feringa, and co-workers reported a
photocontrolled protein transport channel, SecYEG.355 In
bacteria, some of the proteins produced in the cell need to
be transported to the periplasm or even outside the cell. An
important route that facilitates this secretory process is the Sec
pathway.356 Three integral membrane proteins, SecY, SecE, and
SecG, form a channel through which preproteins can be
transported.356,357 SecA, which is an ATPase, recognizes
proteins that need to be translocated and uses ATP hydrolysis
to perform this process.356 The pore width of SecYEG is
important relative to the size of proteins that are allowed to use
this system for translocation. The size of this pore has recently
been probed by using spherical molecules of diﬀerent sizes
conjugated to preproteins.358 It was found that when the
opening of a lateral gate present in SecY was limited by
introducing a disulﬁde bridge or a chemical cross-link of 5 Å or
less, the SecYEG complex lost its translocation function. When
the size of this linker was increased, translocation was
sustained.359 The authors hypothesized that by using an
azobenzene switch the size of the linker could be altered by
photostimulation, dictating the opening and closing of that
channel.355 Inner-membrane vesicles expressing SecY con-
jugated with 115 (Figure 72) were assessed with a translocation
assay using a ﬂuorescent preprotein. The translocation of the
preprotein was similar for the 115 conjugated in the trans form
and nonconjugated SecY subunits and showed around 13−16%
eﬃciency.355 However, irradiation with UV light, favoring the
cis form, resulted in a 3- to 5-fold decrease in translocation
eﬃciency. Furthermore, opening and closing the channel was
shown to be reversible upon irradiation with visible and UV
light.355
Figure 81. Controlling 111 conjugation by patterned illumination. By
irradiating only a part of a cell culture while incubating with 111, it was
possible to control conjugation in diﬀerent parts of a culture by taking
advantage of aﬃnity labeling. Reproduced with permission from ref 24.
Copyright 2007 National Academy of Sciences, USA.
Figure 82. (a) Peak response amplitude in diﬀerent groups. Rd1 mice showed almost no response. Rd1 mice expressing mutated iGluR and
incubated with MAG (111) showed a peak response of 371.75 ± 35.70 μV compared to 766.00 ± 100.51 μV for the wild-type group (WT). (b)
Pupil contraction in wild-type (WT), triple knockout (TKO), and triple knockout mice expressing mutated iGluR and incubated with MAG (111).
The latter group had 60% contraction compared to the WT group after exposure to 380 nm light. Reprinted with permission from ref 352. Copyright
2011 Nature Publishing Group.
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Most receptors addressed with photoswitches were able to
control movement of ions over a membrane. Photoswitchable
SecYEG is unique in that it allows photocontrol over
transportation of preproteins. This unique function shows the
potential of photocontrolled transport of not only small ions
but also much larger molecules.
6.8. Concluding Remarks
In the past decade, considerable progress has been made in the
ﬁeld of photocontrolled receptors and ion channels. Various
approaches have been exploited and were shown to be
successful in controlling ion channel and receptor functioning
with light. The ﬁrst experiments in vivo were executed and
resulted in photocontrol of channel functioning in mammals.
Another great achievement in the ﬁeld has been addressing
endogenous receptors.
Although still in an early stage of development, these large
leaps in photocontrol of biological systems allow noninvasive
interference with many biological functions and numerous
exciting possibilities lie ahead. When the photoswitches are
tuned in such a way that the diﬀerent receptors can be turned
on with diﬀerent wavelengths of light, it will be possible to
independently turn various cellular processes on and oﬀ. This
could ultimately result in total control over cell function with
the use of light, enabling the study of cell signaling in a unique
manner.
Most photocontrolled receptors and ion channels described
to date are found in cell membranes. Addressing intracellular
receptors could oﬀer new targets and possibilities. Using the
approach of a tethered agonist requires the uptake of this
molecule by the cell, which may not be trivial. Therefore,
methods will need to be developed that allow the photo-
switchable receptor ligands to be taken up by the cell.
A major hurdle that needs further work continues to be the
transition from in vitro to in vivo application. To become of any
interest for drug development and pharmacotherapy, it is
necessary that this research area proves itself in vivo. For that,
more endogenous receptors will need to be addressed. For this
to be successful, the photoswitch should ﬁrst reach the active
site. While this was shown to work in organ slices353 and
zebraﬁsh,346,347 it will be diﬃcult to achieve this in mammals,
although preliminary applications in tissues have proven to be
promising.353 Next, the photoswitch has to conjugate with the
endogenous receptor. An even greater challenge is to achieve
control of photoswitching by irradiating with the right
wavelength within the body. It was shown to be possible to
irradiate photoswitches in zebraﬁsh and organ slices of several
millimeters, but it is clearly more challenging to penetrate
higher eukaryotes, such as mice, with light, in order to control
photoswitching in vivo. Most of the photoswitches described
here are responsive to light of a wavelength between 300 and
500 nm. These wavelengths are too short to penetrate tissue
deep enough to reach the photoswitches at the site of action.360
This is one of the major concerns when trying to make
photoswitchable compounds useful for in vivo application. By
changing the substituents of the photoswitch, switching
wavelengths can be tuned,205,361 but designing eﬀective
photoswitches that can operate at wavelengths, such as infrared,
that can penetrate mammalian tissue, remains a major
challenge.
7. SUMMARY AND OUTLOOK
The ability to modulate structure and function in response to
energy input and external signals is an essential feature of a
biological system, which allows it to, for example, sense, move,
adapt, and replicate. In the broader context of synthetic and
chemical biology, while exploring the use of small molecule
approaches to manipulate biological function, the incorporation
of molecular switches as responsive elements oﬀers tremendous
opportunities for noninvasive control. As outlined above, the
opportunities are numerous with respect to both biological
targets and molecular switches, while this rapidly emerging ﬁeld
also has bright prospects to design a wealth of biohybrid
materials with intrinsic adaptive behavior. Although scientists
have mastered the construction of discrete objects of
nanometer dimensions, it has been very diﬃcult to develop
molecular systems and devices that can adapt their structure,
function, or activity in response to environmental triggers in a
way anywhere close to what we see in Nature’s highly
integrated and complex dynamic systems. Nevertheless,
reversible tuning of peptide structure using synthetic molecular
switches has recently culminated in the control of processes by
light in the living cell.
Photochemical switches, in particular those based on
azobenzenes, have been highly successful in modulating, for
example, DNA, peptides and proteins, transmembrane
receptors, and transporters. The development of azobenzenes,
switchable in both directions with visible light,26,33 and the
conﬁrmation of photochromic behavior and metabolic stability
of azobenzenes in living organisms32−34 are major recent
advances. Methodology is now available for solid phase
synthesis of oligonucleotides which include photochromic
units. This allows modular approaches for the preparation of
light-responsive nucleic acid oligomers and systematic evalua-
tion of their “addressable” properties, including hybridization
and information transfer. The most relevant structures in
proteins, i.e. α-helix, β-sheet, and β-hairpin, can now
conﬁdently be induced or distorted upon irradiation of a
photoswitch incorporated in the peptide. The synthetic
approaches also retain the modularity inherent in amino acid-
based systems, allowing for the chromophore to be introduced
at a number of speciﬁc positions which elicit a range of
structural eﬀects. In recent years, several methods for the
incorporation of photoswitches into proteins have been
established. The introduction of a reactive amino acid (e.g.,
thiol, amine) into a chosen site by mutagenesis and subsequent
modiﬁcation of the residue by anchoring an activated
photoswitch oﬀers high modularity in the approach regarding
the introduction site and the nature of the photoswitch. These
basic studies toward responsive biohybrid systems have recently
initiated the application of photoswitches for manipulating
processes in cells. These include a photoswitchable peptide for
inﬂuencing the amplitude of shortening of the sarcomere length
in skeletal muscle ﬁbers from Flexor digitorum brevis (FDB) of
mice.32 Furthermore, photocontrol of AP1 transcription factor
activity in HEK293T cells was achieved using a light-switchable
peptide, while a photoswitchable iGluR receptor was used to
inﬂuence calcium ﬂux in HEK293 cells.24 The great prospect of
these approaches for controlling processes in living organisms is
perhaps best illustrated by the recent use of photoswitchable
iGluR receptor to partially restore light responsiveness in
retinal ganglion cells of rd1 mice.352
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Beyond the study of in vivo peptide, protein, and
oligonucleotide function, the ultimate goal of the approaches
discussed here, based on the incorporation of molecular
switches, is to manipulate the biological function in a reversible
manner in systems ranging from living cells to whole organisms.
This presents numerous challenges, which will have to be met
in the coming years. First, our current toolbox needs expansion
toward novel classes of switches, in particular those photo-
responsive molecules that operate in the near-IR, for better
tissue penetration. Second, the issue of crossing the biological
membranes by the photoresponsive compound or biomolecules
will have to be solved, and ﬁrst steps toward this goal have been
made with the conﬁrmed incorporation of a photoresponsive
peptide into the cells of skeletal muscle ﬁbers32 and rat
tissues.353 Third, the issues of metabolic stability and toxicity of
xenobiotic photoswitches and photoswitch-modiﬁed biomole-
cules will have to be addressed. Considerable advances were
achieved recently toward the in vivo approaches based on
azobenzene switches,32−34 but these developments are still at
an early stage, and more studies are eagerly awaited.
By no means is the ﬁeld of responsive biomolecules limited
to the incorporation of photoswitches, as, for example,
magnetic responsiveness, small molecule eﬀectuators, or
catalytic functions also oﬀer opportunities to address biological
function. A major advantage of light is, of course, spatial-
temporal control, the possibility of tuning wavelengths, and the
ability to couple the switching function to ﬂuorescence
detection. In particular, multiple switching with on−oﬀ control
of multiple ﬂuorescence reporters is highly challenging but
possesses exciting prospects in the context of dynamic control
of integrated metabolic pathways or protein networks in cells.
In addition, the use of photoswitchable nucleic acids in vivo to
allow translation, transcription, and replication to be activated
and deactivated by light in a fully reversible manner seems to
have high potential to allow one to interfere with cellular
processes.
To reach a high level of control, the precise incorporation of
the photoswitch in the target biomacromolecule is essential.
This is often a formidable task, as is evident from the challenge
to achieve complete on/oﬀ photochemical control of enzyme
function without considerable loss of its activity. The
development of a more general and easy methodology for the
site selective incorporation of molecular photoswitches into
proteins that would allow for convenient optimization of the
introduction site as well as the magnitude of the responsive
eﬀect will greatly stimulate further breakthroughs in this ﬁeld.
Once we understand better how to address in a fully reversible
manner protein structure and function in its native environ-
ment, the more distant future holds promise for the control of a
range of cellular functions, including neurobiological, sensory,
motoric, or metabolic processes. The ability to switch
selectively on−oﬀ one or more pathways in cellular networks
or reversibly control membrane receptor functions might be
particularly helpful in the process of drug discovery. The
development of photoswitchable biosystems oﬀers not only the
delight of merging the power of synthetic chemistry with the
beauty of biomacromolecule function, but also the intellectual
challenge to interfere with biological processes and the ultimate
prospect to treat malfunction of the living system by precise
control at the molecular level.
8. UPDATE
While this manuscript was under review and revision, a number
of important contributions to the ﬁeld were published, which
are summarized below.
8.1. Molecular Photoswitches
8.1.1. The groups of Brouwer and Hecht have reported an
azobenzene structure 116 (Figure 83),362 in which ﬂuorine
atoms are introduced in all four ortho positions. Optimization
of spectral properties, by incorporation of electron-donating
and electron-withdrawing groups, resulted in photoswitches
which can be addressed with visible light and which possess a
highly thermostable cis isomer, with a half-life of about 700 days
at 25 °C.
8.1.2. The group of Feringa has introduced a novel
azobenzene architecture 117 (Figure 83), in which a ligation
tag responsible for the Staudinger−Bertozzi ligation was
Figure 83. Recently introduced structures of molecular photoswitches relevant for the photocontrol of biological processes.
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introduced into the structure of the photochrome.363 Products
obtained after the reaction with model azides showed up to
95% of cis isomer in the UV-irradiated samples. Ligation of 117
to azide groups, site-selectively introduced into a model
enzyme,363 conﬁrms the possibility of using the presented
methodology to optimize the photocontrol of protein function
by changing both the photoswitch structure and attachment
point.
8.2. Photocontrol of Nucleic Acids
The diarylethene-modiﬁed nucleotide 13 (Figure 7), reported
previously from the group of Jaeschke,84 has been incorporated
into oligonucleotides.364 With these new photoresponsive
structures a partial photocontrol of transcription has been
presented.364
8.3. Photoswitchable Peptides
8.3.1. The group of Inouye has used a diarylethene-based
photoswitch to regulate the helicity of a DNA-binding peptide,
by cross-linking ornithine residues with compound 118 (Figure
83).365 When the switch was in the open form, the peptides
folded into stable α-helices and interacted strongly with target
DNA strands. UV irradiation resulted in the photocyclization of
diarylethene, destabilization of the α-helices, and weaker
interactions with DNA.
8.3.2. The groups of Hoppmann and Beyermann have used
the AMPB azobenzene (Figure 22) as a backbone-modiﬁer
(Figure 18b) introduced into the structure of the 42-residue,
linear amyloid β-peptide, relevant in the development of
Alzheimer’s disease.366 While the neuronal toxicity of the
hybrid was found to be almost independent of the photostate of
the switch, the inﬂuence of the photoirradiation on the
distribution of amyloid peptide oligomers was conﬁrmed.366
The latter provides important insight into the role of oligomers,
resolubilized from plaques, on the death of the cell.
8.3.3. Woolley and co-workers used a bridged azobenzene
119, based on a structure introduced earler by Siewertsen et
al.,26 for a bidirectional control of peptide conformation, using
the cysteine cross-linking strategy (Figure 18c).367 In this class
of azobenzenes, there is a large separation (∼85 nm) between
the n−π* absorption bands of the photoisomers, which allows
for the selective isomerization between the trans (less table)
and cis (more stable) isomers. Indeed, the authors report367 an
impressive >400-fold change in the population of the cis isomer
upon irradiation with green (λ = 500−550 nm) light.
Irradiation with violet light produced 70% of the trans state.
Reversible photochromism of the 119-bridged model peptide
could be conﬁrmed in >100 cycles of irradiation. The stability
in the presence of reduced glutathione was also studied and
revealed that the strained trans isomer undergoes a slow
bleaching process.
8.3.4. Hemithioindigo switches 120 and 121 (Figure 83)
were introduced into the backbone of model linear and cyclic
peptides (Figure 18b), and their photoisomerization was
subsequently studied by ultrafast spectroscopy in visible and
IR ranges.368 For the smaller, linear peptide, modiﬁed with
compound 121, the photoisomerization was slower than for the
isolated switch but was closely followed by the changes in the
peptide conformation. The larger, cyclic, β-hairpin forming
peptide underwent a much slower change in conformation,
which did not match the time scale of the isomerization of the
photochromic units.368 These results are in agreement with the
previous studies on azobenzene-bridged cyclic peptides.23
8.4. Photocontrol of Receptors and Channels
8.4.1. The groups of Sigel and Trauner used a small
photoswitchable propofol derivative 122 (Figure 83) to
modulate GABAA receptors.
369 This photochromic potentiator
was able to alter the strength of GABA-induced currents upon
light irradiation. Furthermore, the anesthetic eﬀect of 122 was
shown on albino Xenopus laevis tadpoles, which could be
anesthetized by 122 and revived after UV light irradiation.
8.4.2. Trauner and co-workers developed a photochromic
agonist of AMPA receptors.370 Azobenzene-based agonist 123
(Figure 83) was a derivative of AMPA and could trigger
neuronal ﬁring, which was silenced after irradiation with blue-
green light.
8.4.3. The groups of Kramer and Trauner reported the
photocontrol of nociception.371 The designed compound 124
(Figure 83) could selectively enter pain-sensing neurons and
block voltage-gated ion channels. Switching 124 to the cis
isomer with 380 nm light completely removed the blockage.371
In a follow-up publication,372 Trauner and co-workers
investigated the possibility of tuning the spectral properties of
124. For this purpose, compound 125 (Figure 83), an
ortho,ortho′-dimethoxy analog of 124, was synthesized. The
absorption maximum was red-shifted, and compound trans-125
could be converted into the cis isomer with visible light.372
8.4.4. A follow-up study on a previously reported paper352
was conducted by the group of Kramer.373 It was shown that
compound 112 (Figure 72) could restore light-sensitivity and





†J.M.B.: University of California, Irvine, 5003 Reines Hall,
Irvine, CA 92697.
‡H.A.V.K.: Universiteit Leiden, Leiden Institute of Chemistry
(Gorlaeus Laboratories), Einsteinweg 55, 2333 CC, Leiden,
The Netherlands.
Notes
The authors declare no competing ﬁnancial interest.
Biographies
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